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INTRODUCCIÓN  
 
Enterocococcus faecalis es una bacteria Gram-positiva que se encuentra de 
forma comensal en el tracto gastrointestinal humano. Sin embargo, como patógeno 
oportunista puede causar graves infecciones como endocarditis y bacteriemia. En esta 
bacteria, la identificación de factores de virulencia aumentó considerablemente tras la 
publicación de la secuencia del genoma de la estirpe V583 (Paulsen et al., 2003). Sin 
embargo, el conocimiento de los mecanismos moleculares que controlan su virulencia 
sigue siendo escaso. En general, los reguladores globales que modulan la 
transcripción de múltiples genes en respuesta a señales ambientales específicas son 
esenciales en la adaptación de las bacterias patógenas a nichos particulares del 
hospedador. Mediante búsquedas en las bases de datos, encontramos que el gen 
EF3013 (llamado maEfa en este trabajo) de E. faecalis V583 codifica una proteína 
(MAEfa) que presenta similitud de secuencia con los reguladores globales de la familia 
Mga/AtxA. La estirpe OG1RF también codifica la proteína MAEfa (OG1RF_12293). La 
familia Mga/AtxA incluye a los reguladores de virulencia AtxA, Mga y MgaSpn de las 
bacterias Gram-positivas patógenas Bacillus anthracis, Streptococcus pyogenes y 
Streptococcus pneumoniae, respectivamente. Dichos reguladores controlan la 
expresión de numerosos genes y están implicados en la patogénesis de estas 
bacterias (Fouet, 2010; Hemsley et al., 2003; McIver, 2009; Solano-Collado et al., 
2012). El trabajo de investigación presentado en esta Tesis ha estado centrado en la 
caracterización funcional de la proteína MAEfa de E. faecalis.  
 
OBJETIVOS 
Para determinar si MAEfa es un nuevo miembro de la familia Mga/AtxA de 
reguladores globales, hemos desarrollado los siguientes objetivos específicos: 
1. Construcción de vectores plasmídicos para ensayar promotores y terminadores 
transcripcionales en E. faecalis 
2. Construcción de vectores de expresión para E. faecalis basados en plásmidos 
3. Análisis de la expresión del gen maEfa en células enterocócicas 
4. Purificación de la proteína MAEfa y análisis de su estado de oligomerización 
5. Estudio de la interacción de MAEfa con DNA lineal de cadena doble 
6. Análisis del efecto de MAEfa en expresión génica global y virulencia 
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APORTACIONES FUNDAMENTALES Y CONCLUSIONES 
 
1. Herramientas genéticas para E. faecalis basadas en plásmidos 
A pesar del creciente interés clínico en E. faecalis, las herramientas disponibles 
para su manipulación genética son limitadas. Por ello, hemos construido un vector que 
permite ensayar promotores (plásmido pAST) y un vector que permite ensayar 
terminadores transcripcionales (plásmido pAS), ambos basados en el plásmido 
promiscuo pMV158 (del Solar et al., 1993). El gen reportero utilizado es una variante 
del gen gfp (proteína fluorescente verde). Para analizar la funcionalidad de estos 
vectores, insertamos diferentes señales promotoras y terminadoras en pAST y pAS, 
respectivamente. Mediante ensayos de fluorescencia demostramos que ambos 
vectores son de gran utilidad para evaluar la actividad de promotores y terminadores 
(ya sean homólogos o heterólogos) tanto en E. faecalis como en S. pneumoniae. 
Además, hemos desarrollado dos vectores de expresión (pDLF y pDLS) para E. 
faecalis basados en pDL287, un plásmido de amplio espectro de huésped (LeBlanc et 
al., 1993). El vector pDLF contiene un promotor de E. faecalis (P2493) y el vector 
pDLS contiene un promotor de S. pneumoniae (PsulA). La funcionalidad de estos 
vectores se confirmó mediante el clonaje del gen maEfa.  
 
2. Transcripción in vivo del gen maEfa 
Mediante experimentos de RT-PCR, hemos demostrado que hay transcripción 
del gen maEfa en diferentes estirpes de E. faecalis (V583, OG1RF y JH2-2) cuando 
las bacterias crecen en condiciones de laboratorio estándar. A partir de 
aproximaciones in vivo tales como el uso de fusiones transcripcionales (plásmido 
pAST-Pma) y experimentos de primer extension, hemos identificado: (i) el promotor del 
gen maEfa (Pma) y (ii) el inicio de transcripción de maEfa, que está localizado 15 
nucleótidos upstream del codón de inicio predicho. Además, utilizando el vector pAS 
confirmamos que el promotor Pma está precedido por un terminador transcripcional 
intrínseco.  
 
3. Características de la proteína MAEfa 
Hemos establecido un protocolo para sobreproducir y purificar la proteína 
MAEfa. El protocolo de purificación consiste esencialmente en cuatro etapas: (i) 
precipitación de los ácidos nucleicos y MAEfa con polietilenimina (PEI) a baja fuerza 
iónica; (ii) elución de MAEfa del pellet de PEI empleando un tampón de mayor fuerza 
iónica; (iii) cromatografía de afinidad utilizando columnas de heparina y (iv) 
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cromatografía de filtración en gel. Mediante ensayos de filtración en gel y 
experimentos de ultracentrifugación analítica, demostramos que MAEfa forma dímeros 
en solución.  
 
4. Interacción de la proteína MAEfa con DNA 
 
Hemos analizado la interacción de MAEfa con DNA lineal de cadena doble 
mediante ensayos de retraso en gel (EMSA) y experimentos de protección frente a la 
digestión con DNasa I. Mediante EMSA mostramos que: (i) MAEfa genera complejos 
multiméricos sobre DNA lineal de cadena doble; (ii) MAEfa no parece reconocer una 
secuencia nucleotídica específica cuando interacciona con DNA lineal de cadena 
doble y (iii) MAEfa-His, una versión de MAEfa con cola de histidinas, también forma 
múltiples complejos proteína-DNA. En los ensayos de digestión con DNasa I, 
utilizamos fragmentos que contenían el promotor Pma. En dichos fragmentos, MAEfa 
reconoce preferentemente un sitio localizado upstream del promotor. Este sitio 
contiene una curvatura intrínseca potencial. 
  
5. Efecto de MAEfa en expresión génica global y virulencia 
 
Para investigar si MAEfa funciona como un regulador global, construimos la 
estirpe OG1RFΔmaEfa, un derivado de OG1RF que carece del gen maEfa. Mediante 
análisis de microarrays, RT-PCR cuantitativa y estudios de complementación, 
mostramos que MAEfa influye positivamente en la transcripción de numerosos genes. 
Muchos de ellos codifican componentes de transportadores PTS, componentes de 
transportadores ABC y proteínas implicadas en el metabolismo de fuentes de carbono. 
Asociado a este hecho, el crecimiento de la estirpe OG1RFΔmaEfa está afectado en 
medios de cultivo que contienen glicerol, maltosa o manitol. Además, estudiamos el 
papel de MAEfa en virulencia. Este estudio fue realizado en el Helmholtz Centre for 
Infection Research bajo la supervisión del Dr. Oliver Goldmann. Empleando un modelo 
de peritonitis murina descubrimos que la estirpe OG1RFΔmaEfa induce menor 
inflamación en la cavidad peritoneal comparada con la estirpe OG1RF. Nuestros 
resultados sugieren que MAEfa facilita la adaptación de E. faecalis controlando la 
transcripción de numerosos genes y, en consecuencia, contribuye a su posible 
virulencia.  
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INTRODUCTION AND OBJECTIVES 
 
The Gram-positive bacterium Enterococcus faecalis is a natural inhabitant of the 
human gastrointestinal tract. However, as an opportunistic pathogen, it is able to cause 
infections such as urinary tract infections, endocarditis, and bacteremia. Although the  
identification of virulence determinants increased considerably after the publication of the 
genome sequence of E. faecalis strain V583, a vancomycin-resistant clinical isolate 
(Paulsen et al., 2003), our understanding of the molecular mechanisms that control the 
virulence of this bacterium is still very limited. In general, global transcriptional regulators 
that activate and/or repress the transcription of multiple genes in response to specific 
environmental signals are essential in the adaptation of pathogenic bacteria to new host 
niches. Searching for homologies, we found that the EF3013 gene (named maEfa 
herein) of E. faecalis strain V583 encodes a protein (MAEfa; 482 residues) that has 
sequence similarity to global transcriptional regulators of the Mga/AtxA family. The 
enterococcal OG1RF genome also encodes the MAEfa protein (OG1RF_12293). The 
Mga/AtxA family includes the virulence regulators AtxA, Mga and MgaSpn from the 
Gram-positive pathogens Bacillus anthracis, Streptococcus pyogenes and Streptococcus 
pneumoniae, respectively. Such regulators control the expression of numerous genes 
and play an important role in the pathogenicity of these bacteria (Fouet, 2010; Hemsley 
et al., 2003; McIver, 2009; Solano-Collado et al., 2012). This Thesis has been focused 
on the functional characterization of MAEfa. To investigate whether MAEfa is a new 
member of the Mga/AtxA family of global regulators, we have worked on the following 
specific objectives: 
 
1. Construction of promoter-probe and terminator-probe plasmid vectors in E. faecalis 
2. Construction of expression plasmid vectors in E. faecalis 
3. Analysis of maEfa gene expression in enterococcal cells  
4. Purification of the MAEfa protein and analysis of its oligomerization state  
5. Study of the interaction of MAEfa with linear double-stranded DNA 
6. Analysis of the effect of MAEfa on global gene expression and virulence 
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RESULTS AND CONCLUSIONS 
 
1. Plasmid-based genetic tools for E. faecalis 
 
Despite the increasing clinical significance of E. faecalis, the tools available for 
its genetic manipulation are still very scarce. We have constructed a promoter-probe 
vector (pAST) and a terminator-probe vector (pAS) based on the broad-host range 
plasmid pMV158. As reporter gene, a gfp allele (green fluorescent protein) was used. 
To analyse the functionality of these vectors, we inserted promoter and terminator 
signals into pAST and pAS, respectively. We demonstrated by fluorescence assays 
that both vectors are suitable to assess the activity of promoters and terminators (both 
homologous and heterologous) not only in E. faecalis but also in S. pneumoniae. In 
addition we have developed two expression vectors based on the broad-host range 
plasmid pDL287: vector pDLF carries an enterococcal promoter (P2493) and vector 
pDLS carries a pneumococcal promoter (PsulA). The usefulness of these vectors was 
confirmed by cloning the maEfa gene. 
 
2. In vivo transcription of the enterococcal maEfa gene 
 
By RT-PCR experiments, we have demonstrated that the maEfa gene is 
transcribed in different E. faecalis strains (V583, OG1RF and JH2-2) under standard 
bacterial growth conditions Using in vivo approaches such as promoter-reporter fusions 
(plasmid pAST-Pma) and primer extension experiments we identified the promoter 
(Pma) of the maEfa gene. Its transcription initiation site is located 15 nucleotides 
upstream of the predicted translation codon. Moreover, using the terminator-probe 
vector pAS, we found that there is a functional transcriptional terminator upstream of 
the Pma promoter. 
 
3. Features of the MAEfa protein 
 
We have set up a protocol to overproduce and purify an untagged form of the 
MAEfa protein. It involved essentially four steps: (i) nucleic acids and MAEfa were 
precipitated with polyethylenimine (PEI) at a low ionic strength; (ii) MAEfa was eluted 
from the PEI pellet using a higher ionic strength buffer; (iii) the sample was subjected to 
heparin affinity chromatography, and (iv) the protein preparation was loaded onto a gel-
filtration column. By gel filtration chromatography and analytical ultracentrifugation 
experiments we demonstrated that MAEfa form dimers in solution.  
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4. Interaction of the MAEfa protein with DNA 
 
The interaction of MAEfa with linear double-stranded DNA was analysed by 
electrophoretic mobility shift assays (EMSA) and DNase I footprinting. By EMSA, we 
have shown that: (i) MAEfa is able to generate multimeric complexes on linear double- 
stranded DNA, (ii) MAEfa binds to linear double-stranded DNA with little or no 
sequence specificity, (iii) a His-tagged MAEfa protein (MAEfa-His) also forms multiple 
DNA-protein complexes, and (iv) the minimum DNA size required for MAEfa binding is 
between 26 bp and 32 bp. Moreover, by DNase I footprinting assays using DNA 
fragments that contain the Pma promoter we have shown that MAEfa recognizes 
preferentially a site located upstream of Pma. This site has a potential intrinsic 
curvature. The presence of such a binding site on a Pma-gfp transcriptional fusion 
does not affect the activity of Pma in cells overproducing MAEfa (cells carrying pAST-
Pma and pDLFmaEfa; fluorescence assays).  
 
5. Effect of MAEfa on global gene expression and virulence 
To investigate whether MAEfa functions as a global transcriptional regulator, we 
constructed an OG1RF derivative that is not able to synthesize MAEfa 
(OG1RFΔmaEfa). By genome-wide microarrays, quantitative RT-PCR assays, and 
complementation studies we have shown that MAEfa influences positively the 
transcription of numerous genes. Many of them encode components of PTS-type 
transporters, components of ABC-type transporters, and proteins involved in the 
metabolism of carbon sources.  Associated to this fact, the growth of the maEfa 
deletion mutant strain is impaired in media containing glycerol, maltose or mannitol. 
Furthermore, the potential role of MAEfa in virulence was studied at the Helmholtz 
Centre for Infection Research under the supervision of Dr. Oliver Goldmann. Using a 
mouse peritonitis infection model, we found that the OG1RFΔmaEfa strain induces a 
significant lower degree of inflammation in the peritoneal cavity of mice compared to 
the wild-type strain. Thus, E. faecalis cells deficient in MAEfa are less virulent. Our 
results suggest that MAEfa facilitates the adaptation of E. faecalis to particular host 
niches through the transcriptional regulation of numerous genes and consequently, it 
contributes to its potential virulence. 
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1.The opportunistic pathogen Enterococcus faecalis 
 
The Gram-positive bacterium Enterococcus faecalis is a facultatively anaerobic 
organism, ovoid in shape, which appears in pairs or chains (Lebreton et al., 2014; 
Murray, 1990). It occupies a variety of habitats ranging from different environmental 
sources to the commensal presence in numerous animals and humans (Fisher and 
Phillips, 2009; Lebreton et al., 2014). However, as an opportunistic pathogen it is able 
to cause infections such as urinary tract infections, endocarditis and bacteremia, 
among other less frequent infections. Moreover, in the last decades, E. faecalis has 
emerged as a leading cause of nosocomial infections (Agudelo Higuita and Huycke, 
2014; Fisher and Phillips, 2009). The ubiquitous nature of this bacterium is related with 
its metabolic versatility and capacity to withstand harsh conditions, along with its 
increasing antimicrobial resistance and its malleable genome (Arias and Murray, 2012; 
Ramsey et al., 2014).  
 
E. faecalis is usually simply described as a lactic-acid-producing bacterium, but 
its metabolic potential is enormous. It can use numerous energy sources, including, 
among others, more than ten carbohydrates, glycerol, citrate and lactate (Ramsey et 
al., 2014). In addition, as other enterococci, it is able to grow in a wide range of 
temperature (from 10 to 45ºC) and pH (from 4.5 to 10). It tolerates high concentrations 
of NaCl (6.5%), bile salts (40%), metals and oxidants. Despite E. faecalis cannot form 
spores, it is highly resistant to desiccation (reviewed in (Lebreton et al., 2014; Ramsey 
et al., 2014, Fisher and Phillips, 2009). These characteristics as well as its increasing 
antibiotic resistance allow its survival in healthcare environments such as hospitals, 
thus contributing to the rise of enterococci as nosocomial pathogens (Arias and Murray, 
2012). E. faecalis is inherently resistant to several antibiotics and can acquire new 
antibiotic resistances through sporadic mutations in intrinsic genes or by horizontal 
gene transfer. Additionally, they can disseminate the resistance genes to other 
pathogens (Arias and Murray, 2012; Hollenbeck and Rice, 2012). The ability of E. 
faecalis to exchange genetic material also results in the acquisition of new adaptive 
traits such as bacteriocins, metabolic genes and virulence determinants (Clewell et al., 
2014).  
 
E. faecalis is an organism which usually displays low levels of virulence (Arias 
and Murray, 2012). In fact, this bacterium is a natural inhabitant of the gastrointestinal 
tract in most humans and it has been used for decades as probiotic in humans as well 
as in food production (Agudelo Higuita and Huycke, 2014). However, it may possess 
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potential virulence determinants that contribute to cause diseases (reviewed in 
(Agudelo Higuita and Huycke, 2014; Arias and Murray, 2012; Garsin et al., 2014; Sava 
et al., 2010).  
 
Several virulence determinants of E. faecalis are localized in the cell surface 
(Fig. 1). The enterococcal cell wall is a complex structure formed by peptidoglycan, 
proteins, polysaccharides, lipids, lipoproteins and several glycoconjugates (Sava et al., 
2010). In Gram-positive bacteria, the polysaccharydes are usually involved in the 
evasion of the immune system. The enterococcal polysaccharide antigen (Epa) is 
widespread among E. faecalis strains. This carbohydrate is antigenic (Xu et al., 1997). 
The epa locus contains 16 genes involved in the biosynthesis of this polysaccharide 
(Xu et al., 2000). The disruption of this locus decreased biofilm formation and 
enterocyte translocation (Mohamed et al., 2005; Zeng et al., 2004); increased 
susceptibility to killing by polymorphonuclear neutrophils (Teng et al., 2002); and 
reduced virulence in mouse peritonitis and urinary tract infection models (Mohamed et 
al., 2005; Singh et al., 2009a ; Teng et al., 2002; Xu et al., 2000; Zeng et al., 2004). In 
contrast, the cps locus, which consists of 8 or 9 genes, has been found only in some E. 
faecalis strains (Hancock and Gilmore, 2002). This locus encodes a capsular 
polysaccharide and is present in serotypes C and D strains out of the four serogroups 
described by Hufnagel et al. (2004a). The capsular polysaccharide of these serotypes 
masks lipoteichoic acid, and confers resistance to opsonophagocyitosis mediated by 
the complement (Hancock and Gilmore, 2002; Thurlow et al., 2009a). The lipoteichoic 
acid and the cell membrane glycolipids also seem to play a role in the pathogenesis of 
E. faecalis (Fabretti et al., 2006; Theilacker et al., 2009).  
 
 
 
Figure 1. Main virulence determinants of E. faecalis. Important virulence determinants of E. 
faecalis include cell surface proteins (Ace, Esp and AS proteins); cell surface polysaccharides 
(Epa and Cps) and secreted factors (Cyl, GelE and SprE). The global regulators FsrA, PerA, 
Ers and SlyA are also involved in the virulence of E. faecalis.  
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In the early stages of E. faecalis infection, an important step is the attachment 
to proteins of the host extracellular matrix (Arias and Murray, 2012). The Ace protein, 
which belongs to the MSCRAMMs family (microbial surface components recognizing 
adhesive matrix molecules), binds to collagen and laminin (Nallapareddy et al., 2000a; 
Rich et al., 1999). This protein is produced by most of E. faecalis strains during human 
endocarditis and is antigenic (Nallapareddy et al., 2000b). In animal models, it has 
been shown that an ace deletion leads to attenuated endocarditis and urinary tract 
infections (Lebreton et al., 2009; Singh et al., 2009b). Another protein which has been 
involved in experimental urinary tract infections is the enterococcal surface protein Esp 
(Shankar et al., 2001), which is encoded on a pathogenicity island (Shankar et al., 
2002). Ace and Esp contain LPXTG-like motifs, which are specific amino acid 
sequences necessary for the specific attachment of the protein to the cell wall 
peptidoglycan (Hendrickx et al., 2009). Such a motif is also present in the family of 
aggregation substance proteins (AS proteins). They are a group of surface-localized 
proteins encoded on pheromone-inducible conjugative plasmids that mediate binding of 
donor bacterial cells to recipient cells and promote conjugation (Sava et al., 2010, Arias 
and Murray, 2012, Olmsted, 1991). AS proteins are associated with an increase of E. 
faecalis binding to renal tubular cells (Kreft et al., 1992); internalization by intestinal 
cells (Sartingen et al., 2000); and survival within macrophages and neutrofils (Rakita et 
al., 1999; Süssmuth et al., 2000). In addition, these proteins also increased the 
virulence of E. faecalis in a rabbit model of infective endocarditis (Schlievert et al., 
1998).  
 
Pili of Gram-positive organisms have an important role in infection, participating 
in adhesion to human cells and biofilm formation. In E. faecalis, Ebp pili (endocarditis 
and biofilm-associated pili) and its associated sortase are involved in adhesion to 
components of the extracellular matrix and platelets (Nallapareddy et al., 2011). The 
Ebp subunits, which also contain LPXTG motifs, have been reported to be antigenic 
during human endocarditis (Sillanpäa et al., 2004). In addition, its contribution to biofilm 
formation has been linked to the pathogenesis of experimental endocarditis and urinary 
tract infections (Kemp et al., 2007; Nallapareddy et al., 2006). Other genes related to 
biofilm formation have been shown to be important for virulence, such as the bopABCD 
operon (biofilm on plastic surfaces) or bgsA (biofilm-associated glycolipid synthesis A 
gene) (Hufnagel et al., 2004b; Theilacker et al., 2009). 
 
E. faecalis is able to secrete proteins to the extracellular medium that contribute 
to the severity of the infection (Garsin et al., 2014). The cytolysin-haemolysin (Cyl) is a 
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toxin produced by some strains of E. faecalis (Arias and Murray, 2012). It is encoded 
on pheromone responsive plasmids or pathogenicity islands (Van Tyne et al., 2013). 
Cyl lyses a broad range of cells including Gram-positive bacteria and eukaryotic cells 
such as human erythrocytes (Van Tyne et al., 2013). Its contribution to the virulence of 
E. faecalis has been clearly demonstrated in all the animal models tested, ranging from 
invertebrates to mammals (Garsin et al., 2001; Ike et al., 1984; Singh et al., 1998). 
Epidemiological data has shown that Cyl is also associated with increased toxicity in 
human infections (Huycke and Gilmore, 1995; Huycke et al., 1991; Ike et al., 1987). 
Other secreted virulence factor is the metalloprotease gelatinase (GelE). It degrades 
host tissues and components of the host immune response (Park et al., 2008). It also 
activates an autolysin that leads to biofilm formation (Thomas et al., 2009). The sprE 
gene, which is located downstream of gelE, encodes another secreted protein, the 
serine proteinase (SprE). Both genes are cotranscribed (Qin et al., 2000) and have 
been shown to affect the pathogenesis of E. faecalis in numerous animal models and 
experimental infections (Engelbert et al., 2004; Singh et al., 2005; Singh et al., 1998 ; 
Thurlow et al., 2009c).  
  
Even though a number of virulence determinants have been identified in E. 
faecalis, our understanding of the regulation mechanisms involved in its pathogenicity is 
still very limited. In general, the infection process can be conceived as an adaptation of 
the bacterium to particular host niches, and this adaptation requires a coordinated 
regulation in gene expression. In this context, global response regulators that activate 
and/or repress transcription of multiple genes in response to specific environmental 
signals are doubtless key elements. Among the global response regulators of E. faecalis, 
some of them form part of two-component signal transduction systems (TCSs). The 
TCSs consists of a membrane-associated histidine kinase receptor and a cytoplasmatic 
response regulator, which is usually a transcriptional regulator. In response to a specific 
signal, the histidine protein kinase is autophosphorylated. Then, it transfers the 
phosphoryl group to the cognate response regulator thus activating its function (Capra 
and Laub, 2012; Hancock and Perego, 2002). The well-studied fsr TCS has been 
implicated in the pathogenicity of E. faecalis (Mylonakis et al., 2002; Qin et al., 2000; Sifri 
et al., 2002). It consists of the fsrA and fsrC genes. Both genes, along with fsrB and fsrD 
constitute the Fsr quorum sensing system (Nakayama et al., 2006). The FsrC kinase 
responds to the signal peptide accumulation activating the global response regulator 
FsrA. Then, FsrA regulates the expression of numerous genes, including several 
virulence genes such as gelE and sprE (Bourgogne et al., 2006; Qin et al., 2000). In the 
last years, other global regulators not associated to sensor histidine kinases have been 
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reported as important for E. faecalis virulence. Among them, SlyA that belongs to the 
MarR/SlyA family (Michaux et al.), an AraC-type regulator designated PerA (Coburn et 
al., 2008; Maddox et al.), and Ers that is a member of the Crp/Fnr family (Riboulet-
Bisson et al., 2008). Nevertheless, we are only beginning to unravel the regulatory 
networks of E. faecalis. To enhance our understanding of the gene regulation 
mechanisms that contribute to the pathogenesis of this bacterium, we have been 
working on the molecular characterization of MAEfa (this Thesis), a putative global 
regulator of the Mga/AtxA family. This family includes the virulence regulators AtxA, Mga 
and MgaSpn from the Gram-positive pathogens Bacillus anthracis, Streptococcus 
pyogenes, and Streptococcus pneumoniae, respectively. 
 
2. The Mga/AtxA family of global response regulators 
 
AtxA from Bacillus anthracis 
 
B. anthracis, the etiological agent of anthrax, is a Gram-positive bacterium. 
Anthrax is mainly a disease of herbivores, but humans are also susceptible. Virulence 
of this bacterium is associated with the production of two major virulence factors, the 
tripartite toxin and the capsule. The toxin consists of three proteins, protective antigen, 
lethal factor and edema factor. The genes encoding these proteins (pagA, lef and cya, 
respectively) are located on the pXO1 virulence plasmid. The capsule biosynthesis 
operon, capBCADE, is located on pXO2, another virulence plasmid. AtxA (anthrax 
toxin activator) controls positively the expression of both virulence determinants. The 
atxA gene is located on plasmid pXO1, and its transcription level depends on 
temperature, redox potential, growth phase, and carbohydrate availability (reviewed in 
(Fouet, 2010)). Although some regulators have been implicated in the control of its 
transcription, only AbrB was shown to bind directly to the atxA promoter region 
(Strauch et al., 2005). At the post-transcriptional level, CO2 has been shown to affect 
AtxA activity (Dai and Koehler, 1997; Hammerstrom et al., 2011). Moreover, it has 
been reported that CodY controls the intracellular accumulation of AtxA by an unknown 
mechanism (van Schaik et al., 2009). In addition to control the expression of key 
virulence genes, AtxA has been shown to function as a global regulator of gene 
expression. It regulates the expression of many genes located on the virulence 
plasmids and the chromosome. The regulated targets (positively or negatively) include 
genes predicted to encode secreted proteins and proteins with roles in transcriptional 
regulation and signaling (Bourgogne et al., 2003). Although the promoter regions of 
such genes do not seem to share sequence similarities, in silico and in vitro analyses 
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revealed that the promoter regions of several target genes are intrinsically curved 
(Hadjifrangiskou and Koehler, 2008). Currently, in vitro studies on the interaction of 
AtxA with DNA have not been reported and, therefore, its mechanism of action remains 
unknown. 
 
AtxA is a 56 kDa protein (475 residues) whose three dimensional structure has 
been recently solved (Hammerstrom et al., 2015). AtxA crystallizes as a dimer and 
each monomer shows five distinct domains, which is in agreement with the previous 
predictions (Hammerstrom et al., 2011). The first two domains at the N-terminal region 
have structures indicative of DNA-binding. Residues 7 to 74 form a winged helix-turn-
helix motif (HTH1 in Fig. 2) and residues 76 to 162 form a helix-turn-helix motif (HTH2 
in Fig.2). The third and the fourth domains are phosphoenolpyruvate:carbohydrate 
phosphotranspherase system (PTS) regulation domains (PRDs), PRD1 (residues 170 
to 262) and PRD2 (residues 276 to 391). The PRDs have been found in several 
transcriptional antiterminators and transcriptional activators that control the expression 
of genes involved in the uptake and metabolism of carbohydrates. The activity of such 
regulators is modulated by PTS-mediated phosphorylation. In response to the 
metabolic state of the cell and/or to the presence of a carbohydrate, the PTS 
components phosphorylate conserved histidine residues within the PRD domains 
(Deutscher et al.). In the case of AtxA, its activity is modulated by phosphorylation at 
H199 within PRD1 and H379 within PRD2 (Hammerstrom et al., 2015; Tsvetanova et 
al., 2007). At the C-terminal region of AtxA there is a domain (residues 391 to 475) that 
resembles an EIIB-like motif. Such a motif has been reported to be involved in AtxA 
multimerization (Hammerstrom et al., 2011) 
 
 
 
Figure 2. Organization of functional domains in AtxA, Mga and MgaSpn. AtxA has two N-
terminal DNA-binding domains (HTH1 and HTH2). The third and fourth domains are PRDs. The 
C-terminal domain resembles an EIIB-like domain (Hammerstrom et al., 2015). Mga contains two 
helix-turn-helix motifs (HTH3 and HTH4) and a conserved region (CMD) at the N-terminus. The 
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central region has two putative PRDs. (PRD1 and PRD2). The C-terminal region contains a PTS 
EIIB-like domain (Hondorp et al., 2013). MgaSpn has two putative DNA-binding domains at the N-
terminal region (wHTH and HTH motifs). The central region has structural homology to a PRD 
and the C-terminal region shows structural homology to an EIIB-like domain (Solano-Collado, 
2014) 
 
Mga from Streptococcus pyogenes 
 
The Gram-positive bacterium S. pyogenes (group A Streptococcus (GAS)) is a 
strict human pathogen, causing a wide array of diseases ranging from trivial self-
limiting infections to immune sequelae and life-threatening invasive disorders (Bisno et 
al., 2003; Cunningham, 2000). S. pyogenes is able to adapt and persist in various 
niches within the human body. In response to changing environmental conditions, a 
combination of TCSs and ‘stand-alone’ transcriptional regulators coordinate the control 
of gene expression (McIver, 2009). The term ‘stand-alone’ has been used to describe 
global response regulators that are not associated to a membrane-bound sensor 
histidine kinase. In many cases, their sensory components have yet to be fully defined. 
A key ‘stand-alone’ regulator of S. pyogenes is the global regulator Mga (multiple gene 
activator of GAS), which controls the expression of approximately 10% of the genome 
during the exponential phase of growth (Ribardo and McIver, 2006). The main Mga-
activated regulon includes well established virulence genes, such as emm (M-protein), 
scpA (C5a peptidase), sclA (streptococcal collagen-like protein A), fba and sof 
(fibronecting binding proteins) and sic (streptococcal inhibitor of complement). These 
genes are important for adherence to host tissues, internalization into non-phagocytic 
cells and evasion of the host immune response (McIver, 2009; Ribardo and McIver, 
2006). In addition, Mga activates or represses, possibly by an indirect mode, the 
expression of genes involved in the transport and utilization of carbohydrates as well as 
iron and amino acids (Ribardo and McIver, 2006).  
 
The mga gene has been found in all strains examined and two divergent alleles 
have been identified (mga-1 and mga-2). Expression of this regulatory gene has been 
linked to elevated CO2, normal body temperature, increased iron levels and 
metabolizable sugars. Several regulators modulate the expression of mga (Hondorp 
and McIver, 2007; McIver, 2009). In addition, Mga activates directly the expression of 
its own gene (McIver et al., 1999). 
 
Mga (62 kDa; 530 amino acids) binds to regions located upstream of its target 
promoters. The interaction of Mga with DNA was analyzed by EMSA and DNase I 
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protection experiments (McIver et al., 1995; McIver et al., 1999). In these experiments 
Mga fusion proteins were used, either Mga fused to a maltose binding protein (MBP) or 
a His-tagged Mga protein. Three categories of Mga-regulated promoters have been 
proposed based on the number of binding sites and their position relative to the start of 
transcription (Almengor and McIver, 2004). Sequence alignments of all established 
Mga-binding sites revealed that they exhibit very low sequence identity. Moreover, a 
mutational analysis in some target promoters indicated that Mga binds to DNA in a 
promoter-specific manner (Hause and McIver, 2012). The mechanism of transcriptional 
activation upon Mga binding to DNA remains unclear.  
 
It has been predicted the organization of functional domains in Mga (Fig. 2) 
(Hondorp et al., 2013). At the N-terminal region, it has a conserved Mga domain (CMD, 
residues 10 to 15), a classical helix-turn-helix motif (HTH-3, residues 53 to 72) and a 
winged-helix-turn-helix motif (HTH-4, residues 107 to 126). Such motifs were shown to 
be involved in DNA binding and transcriptional activation. The HTH-4 motif is 
absolutely required for DNA binding to all Mga binding sites tested (Vahling and 
McIver, 2006). In the central region of Mga, two PRDs were identified: PRD1 (residues 
170 to 287) and PRD2 (residues 288 to 390). Mga can be phosphorylated in vitro by 
components of the PTS system. This phosphorylation event was shown to inhibit the in 
vitro transcription of an Mga-regulated gene (Hondorp et al., 2013). Recently, it has 
been shown that Mga is phosphorylated in vivo at histidine residues (Sanson et al., 
2015). Moreover, phosphorylation and non-phosphorylation mimicking substitutions at 
different histidines within the PRDs indicated that phosphorylation might modulate Mga 
activity (Hondorp et al., 2013; Sanson et al., 2015). The C-terminal region of Mga 
contains an EIIB-like domain. Elimination of this domain was reported to impair the 
ability of Mga to activate transcription in vivo and also its capacity to oligomerize in vitro 
(Hondorp et al., 2012). 
 
MgaSpn from Streptococcus pneumoniae 
 
S. pneumoniae usually resides in the nasopharynx of healthy humans. 
However, when the immune system weakens, it is also a major cause of life-
threatening infections, such as pneumonia, meningitis and septicemia (Bogaert et al., 
2004; Scott, 2007). In this Gram-positive bacterium, several genes important for its 
virulence have been identified by signature-tagged mutagenesis in the TIGR4 strain 
(Hava and Camilli, 2002). Among them, the sp1800 gene, which encodes a protein that 
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was first named MgrA (Hemsley et al., 2003) and later MgaSpn (Solano-Collado et al., 
2012). MgaSpn (493 residues) exhibits homology (42.6% similarity) to the Mga 
regulator of S. pyogenes. MgaSpn was shown to play a significant role in lung infection 
and nasopharyngeal carriage in a murine model. Additionally, MgaSpn was shown to 
represses the expression of several genes located within the rlrA pathogenicity islet 
(Hemsley et al., 2003). This islet has been found in a reduced number of strains 
(Paterson and Mitchell, 2006), whereas the mgaSpn gene is highly conserved among 
the pneumococcal genomes (Solano-Collado, 2014). 
 
In MgaSpn (59 kDa), the predicted organization of functional domains is similar 
to that found in AtxA and Mga (Fig. 2). MgaSpn has two putative DNA-binding domains 
within the N-terminal region, the so-called HTH_Mga (residues 6 to 65) and Mga 
(residues 71 to 158) domains. The central region of MgaSpn has a putative PRD 
(residues 173 to 392) and the C-terminal region contains a putative EIIB-like domain 
(amino acids 399 to 487) (Solano-Collado, 2014). MgaSpn activates directly the 
transcription of a neighbouring four-gene operon of unknown function. This activation 
requires binding of MgaSpn to a site located upstream of the target promoter (Solano-
Collado et al., 2012). Furthermore, the interaction of an untagged form of MgaSpn with 
linear double-stranded DNAs was analyzed by gel retardation, footprinting and electron 
microscopy experiments. These studies suggested that MgaSpn might recognize 
particular DNA conformations to achieve DNA-binding specificity. Upon binding to a 
primary site, MgaSpn is able to spread along the adjacent DNA regions generating 
multimeric protein-DNA-complexes (Solano-Collado et al., 2013).  
 
3. The MAEfa protein of Enterococcus faecalis 
 
Our understanding of the molecular mechanisms that control the virulence of E. 
faecalis is still very limited, even though the interest in the identification of virulence 
regulators increased considerably after the publication of the genome sequence of E. 
faecalis strain V583, the first vancomycin-resistant clinical isolate reported in the United 
States (Paulsen et al., 2003). Such a genome revealed that more than a quarter of the 
genome consists of mobile and/or exogenously acquired DNA, including probable 
integrated phage regions, insertion elements, conjugative transposons, a putative 
pathogenicity island, and integrated plasmid genes. Curiously, as pointed out by 
Paulsen et al. (2003), E. faecalis V583 possesses a modest collection of regulatory 
genes, in spite of the stress resistance capabilities of this bacterium. Several years 
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later, Bourgogne et al. (2008) published the genome sequence of E. faecalis strain 
OG1RF, a rifampicin and fusidic acid-resistant derivative of the OG1 human isolate. 
This strain has been largely used in the laboratories for genetic manipulation and 
virulence studies. Compared to V583, the OG1RF genome contains 227 unique open 
reading frames but has fewer mobile genetic elements. Furthermore, unlike strain 
V583, which harbours three plasmids, OG1RF is a plasmid-free strain. In 2008, 
searching for homologies, we found that the EF3013 gene (named maEfa herein) of 
the V583 strain encodes a protein (MAEfa) of 482 residues that has sequence similarity 
to regulators of the Mga/AtxA family. According to EMBOSS needle global sequence 
alignment (Rice et al., 2000), MAEfa has 40.7/22.1%, 31.3/19.6% and 38.8/23.7% of 
similarity/identity with AtxA (475 residues; strain Ames Ancestor), Mga (530 residues; 
strain MGAS10394) and MgaSpn (493 residues; strain R6), respectively. The 
enterococcal OG1RF genome also encodes the MAEfa protein (gene OG1RF_12293). 
Based on these observations, we proposed that MAEfa might function as a global 
transcriptional regulator involved in virulence, and since then we have been working on 
this hypothesis. First, we constructed several plasmid-based genetic tools for E. 
faecalis because, despite the increasing clinical significance of this bacterium, the tools 
available for its genetic manipulation are still very scarce. Then, we analyzed the 
expression of maEfa in enterococcal cells, studied the DNA-binding properties of 
MAEfa, and investigated its potential role in global regulation of gene expression. In 
2011, when this Thesis was in progress, the three-dimensional structure of MAEfa was 
solved by X-ray crystallography and deposited in the Protein Data Bank (PDB 3SQN) 
(J. Osipiuk, R. Wu, S. Moy and A. Joachimiak, unpublished results). The functional 
characterization of MAEfa presented in this Thesis supports the notion that MAEfa is a 
new member of the Mga/AtxA family of global regulators. It might facilitate the 
adaptation of E. faecalis to particular host niches and, consequently, contribute to its 
potential virulence. 
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We are interested in the molecular mechanisms that control the virulence of the 
opportunistic pathogen E. faecalis. Searching for homologies, we found that the 
EF3013 gene (named maEfa herein) of E. faecalis strain V583 encodes a protein 
(MAEfa; 482 amino acids) that has sequence similarity to regulators of the Mga/AtxA 
family. The enterococcal OG1RF genome also encodes the MAEfa protein (gene 
OG1RF_12293). This Thesis has been focused on the functional characterization of 
MAEfa. Our main aim has been to investigate whether MAEfa is a new member of the 
Mga/AtxA family of global regulators. To this end, we have worked on the following 
specific objectives: 
 
1. Construction of promoter-probe and terminator-probe plasmid vectors in E. faecalis 
2. Construction of expression plasmid vectors in E. faecalis 
3. Analysis of maEfa gene expression in enterococcal cells  
4. Purification of the MAEfa protein and analysis of its oligomerization state  
5. Study of the interaction of MAEfa with linear double-stranded DNA 
6. Analysis of the effect of MAEfa on global gene expression and virulence 
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MATERIALS 
 
1. Bacterial strains 
 
Table 1. Bacterial strains used in this work  
Strains Features Source 
E. faecalis OG1RF gelE+, sprE +, fsrABCD+, GelE+, 
SprE+ RifR, FusR. Plasmid-free 
(Dunny et al., 
1978) 
E. faecalis JH2-2 gelE+, sprE+, fsrABCD-, GelE−, 
SprE- RifR; FusR. Plasmid-free 
(Jacob and 
Hobbs, 1974) 
E. faecalis V583 gelE+, sprE+, fsrABCD+, GelE+, 
SprE + VanR 
(Sahm et al., 
1989) 
E. faecalis OG1RFΔmaEfa Strain derived from OG1RF. It 
lacks the maEfa gene.  
This work 
E. faecalis JH2-2ΔmaEfa Strain derived from JH2-2. It lacks 
the maEfa gene. 
This work 
S. pneumoniae 708 end-1, exo-1, trt-1, hex-4, 
malM594. Plasmid-free 
(Lacks and 
Greenberg, 1977) 
E. coli BL21 (DE3) λ DE3 (lacI lacUV5-T7 gene 1 ind1 
sam7 nin5) F- dcm ompT hsdS(rB -
mB+) gal. Plasmid-free.  
(Studier and 
Moffatt, 1986) 
 
2. Animals  
The animals used in this work were female BALB/c mice (8–10 weeks old) 
purchased from Harlan Laboratories. Mice were housed in a pathogen-free animal 
facility at the Helmholtz Centre for Infection Research (Braunschweig, Germany) and 
maintained under standard conditions according to institutional guidelines. 
 
MATERIALS AND METHODS 
 
 
32 
 
3. Culture media 
 
E. faecalis was grown in Brain Heart Infusion (BHI) medium unless otherwise 
noted. Enterococcal cells harbouring plasmids were grown in media supplemented with 
tetracycline (Tc; 4 µg/ml), kanamycin (Km; 250-500 µg/ml) or erythromycin (Em; 5 
µg/ml). Competent cells were grown in SG-ESTY medium (ESTY medium 
supplemented with 0.5 M of sucrose and 7-8% of glycine depending on the strain). 
After transformation, cells were incubated in S-ESTY-MC medium (ESTY containing 
0.5 M of sucrose, 10 mM of MgCl2 and 10 mM of CaCl2). Tryptone-yeast extract (TY) 
medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl) (Maniatis et al., 1982) was used 
during the construction of the deletion mutant strains. To evaluate the utilization of 
different carbon sources, bacteria were grown in M9 minimal medium (Maniatis et al., 
1982) supplemented with 0.5% yeast extract (M9YE medium) and the indicated carbon 
source (1% glycerol, 0.5% maltose or 0.5% mannitol). When glycerol was used as 
carbon source, the medium was also supplemented with 0.26% fumarate.  
 
For bacterial growth on solid media different agar plates were used. TY plates 
(TY and 1.5% agar) were used for routine growth. The medium was supplemented with 
X-Gal (5-bromo-4-chloro-3-indolyl-beta-D-galacto-pyranoside) (100 µg/ml) and/or Em 
(5 µg/ml) when required to generate the chromosomal deletion. SR medium (Shepard 
and Gilmore, 1995) supplemented with the appropriate antibiotic was used to select 
transformant cells. Bile esculin azide (BEA) plates were used to determine the amount 
of viable bacteria recovered after the intraperitoneal mice infections. 
 
S. pneumoniae cells were grown in AGCH medium (Lacks, 1966; Ruiz-Cruz et 
al.) supplemented with 0.2% yeast extract and 0.3% sucrose. The medium contained 
Tc (1 μg/ml) or Km (30-50 μg/ml) when the pneumococcal cells carried plasmids. 
Competent cells were grown in AGCH medium supplemented with 0.2% sucrose and 
70 μM CaCl2. Plates for bacterial growth in solid medium were freshly prepared as it is 
reported in Methods, Section 1. 
 
E. coli cells were grown in tryptone-yeast extract (TY) medium. In the case of 
plasmid harbouring cells, the medium was supplemented with Km (30-50 μg/ml). Plates 
were prepared with TY and 1.5% agar. For competence of E. coli, SOB medium 
(Hanahan, 1983) was used. After transformation, cells were recovered in SOC medium 
(SOB medium containing 20 mM glucose). 
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4. Enzymes, chemical products and reactives 
 
Restriction enzymes, T4 DNA ligase, T4 polynucleotide kinase and bovine 
serum albumin (BSA) were acquired from New England BioLabs. DNase I RNase-free, 
isopropyl-β-Dgalactopyranoside (IPTG), proteases inhibitor cocktail EDTA free 
complete, proteases inhibitor cocktail complete, High Pure Plasmid Isolation kit, dNTPs 
and Taq DNA polymerase were provided by Roche Applied Science. Phusion High-
Fidelity DNA Polymerase (Finnzymes) was used. ThermoScript reverse transcriptase 
and protein pre-stained standard SeeBlue Plus were purchased to Invitrogen. NZYDNA 
Ladder III weight marker was from NZYTech. Proteinase K, RNase A, lysozyme, Tc, 
Km, Em, mutanolysin, fucose, sucrose, polyethylenimine (PEI), imidazole, His-select 
nickel affinity gel, acrylamide:bis-acrylamide 40% solution (29:1 ratio) and DMSO were 
from Sigma Aldrich. GelRed was adquired from Biotium. Ethanol absolute, hydrochloric 
acid, chloroform, isopropanol, methanol, aminoacids, vitamins, glucose and 
magnesium were purchased to Merck. The saturated phenol was from AppliChem. 
Culture media components were from Pronadisa, Merck, Sigma, BD and Difco. Low 
molecular weight protein marker and the HiLoad Superdex 200 column were from 
Amersham Biosciences. DNA sequencing kit (Sequenase Version 2.0) and X-Gal were 
from USB Corporation. Radioactive nucleotides were purchased to Perkin-Elmer or 
Hartmann. Agarose, acrylamide:bis-acrylamide 30% solution (37.5:1 ratio), ammonium 
persulfate (PSA), β-mercaptoethanol, TEMED, sodium dodecyl sulfate (SDS), Triton-
X100, Bio-Safe Coomassie Stain, Aurum Total RNA Mini kit, iScript Select cDNA 
synthesis kit, iQ SYBR Green Supermix, Immun-blot PVDF membranes and Immun-
StarTM HRP substrate kit were provided by Bio-Rad. Acrylamide:bis-acrylamide 40% 
solution (19:1 ratio) was from National Diagnostics. The HiTrap Heparin HP and 
HisTrap HP columns and Illustra MicroSpinTM G-25 columns were from GE 
Healthcare. QIAquick Gel Extraction kit and RNeasy Mini Kit were from QIAGEN. 
Bacterial genomic isolation kit was purchased to Norgen Biotek Corporation. Dialysis 
membranes were from Spectrum. Slide-A-Lyzer™ Dialysis Cassettes were adquired 
from Thermo Scientific. Nitrocellulose filters of pore size 0.22 and 0.45 µm were from 
Millipore. Autoradiography films were acquired from Kodak (X-Omat S). Cronex 
Lightning Plus amplifying X-ray screens were from Dupont. Imaging plates to visualize 
radioactive labelling using the Fujifilm Image Analyzer FLA-3000 were from Fuji. 
Centrifugal filters Micro-sep and Nano-sep for protein concentration were from Pall. 96-
well plates for fluorescence measurements were from Millipore. Electroporation 
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cuvettes of 2 mm were from Cell Projects. RNAsin Plus RNAse Inhibitor and DTT were 
acquired from Promega.  
 
5. Nucleic acids 
 
5.1. Plasmids 
 
Table 2. Plasmids used in this work. 
Plasmid Size (bp) Description Source 
pLS1 4,408 
Derivative of pMV158 that lacks the 
1,132-bp EcoRI restriction fragment; 
non-mobilizable; TcR 
(Stassi et 
al., 1981) 
pGreenTir 3,484 
Derivative of pUC1813 that carries a 
gfp allele fused to an optimized 
translation initiation region; AmpR 
(Miller and 
Lindow, 
1997) 
pPR54 5,240 
Expression vector for Bacillus subtilis 
based on plasmid pUB110. It contains 
the transcriptional termination sites of 
the E. coli ribosomal RNA operon 
(Brosius, 1981).  
(Serrano-
Heras et al., 
2005) 
pAS 5,210 
Terminator-probe vector. Derivative of 
pLS1 that carries the gfp reporter 
cassette of the pGreenTIR plasmid; 
TcR 
This work 
pAST 5,456 
Promoter-probe vector. Derivative of 
pAS that carries the transcriptional 
termination sites T1T2 of the E. coli 
rrnB ribosomal RNA operon 
downstream of the tetL gene; TcR 
This work 
pAST2T1rrnB 5,456 
Derivative of pAS that carries the 
transcriptional termination sites T1T2 
of the E. coli rrnB ribosomal RNA 
operon in the opposite orientation 
(compared to the pAST vector); TcR 
This work 
MATERIALS AND METHODS 
 
 
35 
 
Plasmid Size (bp) Description Source 
pASTrsiV 5,475 
Derivative of pAS that carries the 
transcriptional terminator of the E. 
faecalis rsiV gene; TcR 
This work 
pASTpolA 5,448 
Derivative of pAS that carries the 
transcriptional terminator of the S. 
pneumoniae polA gene; TcR 
This work 
pAST-PsulA 5,622 
Derivative of pAST that carries the 
promoter of the S. pneumoniae sulA 
gene; TcR 
This work 
pAST-Pung 5,615 
Derivative of pAST that carries the 
promoter of the S. pneumoniae ung 
gene; TcR 
This work 
pAST-PuppS 5,620 
Derivative of pAST that carries the 
promoter of the E. faecalis uppS gene; 
TcR  
This work 
pAST-P2493 5,616 
Derivative of pAST that carries the 
promoter of  the E. faecalis EF2493 
gene or cpsC gene; TcR 
This work 
pAST-P2962 5,614 
Derivative of pAST that carries the 
putative promoter of the E. faecalis 
EF2962 gene; TcR 
This work 
pAST-PfcsK 5,573 
Derivative of pAST that carries the 
inducible promoter of the S. 
pneumoniae fcsK gene; TcR 
This work 
pAST-oPfcsK 5,573 
Derivative of pAST that carries the 
inducible promoter of the S. 
pneumoniae fcsK gene in the opposite 
orientation ( compared to pAST-
PfcsK); TcR 
This work 
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Plasmid Size (bp) Description Source 
pAST-Pma 5,670 
Derivative of pAST that carries the 
promoter region of the maEfa gene; 
TcR 
This work 
pAST-PmaΔ19 5,653 
Derivative of pAS that carries the Pma 
region, but the last 19 nucleotides 
have been removed, including the -10 
box; TcR 
This work 
pAS-PmaΔ19 5,407 
Derivative of pAST that carries the 
Pma region, but the last 19 
nucleotides have been removed, 
including the - 10 box; TcR 
This work 
pET-24b 5,309 
E. coli expression vector based on the 
Φ10 promoter of phage T7; KmR Novagen 
pET-maEfa 6,703 
Derivative of pET-24b that encodes an 
untagged MAEfa protein; KmR 
This work 
pET-maEfa-His 6,790 
Derivative of pET-24b that encodes a 
His-tagged MAEfa protein; KmR  This work 
pDL287 5,740 Derivative of pVA380-1; KmR (LeBlanc et 
al., 1993) 
pDLF 5,911 
Expression vector. Derivative of 
pDL287 that carries the promoter of E. 
faecalis EF2493 or cpsC gene; KmR 
This work 
pDLS 5,921 
Expression vector. Derivative of 
pDL287 that carries the promoter of S. 
pneumoniae sulA gene; KmR 
This work 
pDLFmaEfaV583 7,425 
Derivative of pDLF that carries the E. 
faecalis V583 maEfa gene under the 
control of the promoter P2493; KmR 
This work 
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Plasmid Size (bp) Description Source 
pDLSmaEfaV583 ~4,500 
Derivative of pDLF that carries the E 
.faecalis V583 maEfa gene under the 
control of the promoter of S. 
pneumoniae sulA gene; KmR 
This work 
pBVGh 5,980 
Vector for chromosomal modification. 
Based on the pG+host replicon. It 
carries a constitutive β-galactosidase 
gene; EmR 
(Blancato 
and Magni, 
2010) 
pBVΔmaEfa 6,967 
Derivative of pBVGh used to delete 
the maEfa gene. EmR  
This work 
pDLFmaEfaOG1RF 7,425 
Derivative of pDLF that carries the E. 
faecalis OG1RF maEfa gene under 
the control of the promoter P2493; 
KmR 
This work 
pMV158GFP 6,900 
Derivative of pMV158 that carries the 
gfp gene under the control of an 
inducible promoter Pm of S. 
pneumoniae ; TcR 
(Nieto and 
Espinosa, 
2003) 
 
5.2 Oligonucleotides 
 
The oligonucleotides used in this work were all synthesized at the CIB-Protein 
Chemistry Facility (Applied Biosystems 3400 synthesizer), purified by HPLC and 
resuspended in water to a final concentration of 100 μM.  
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Table 3. Oligonucleotides used in this study. 
Name Sequence (5’-3’) Applications 
F-gfp 
R-gfp 
CCATGATTACGCCAAGCTTGG 
CCCCCGGGTACCAAGCTTGAATTCC 
Construction of 
pAS 
Up-gfp 
Dw-gfp 
CAAGAGGGCAATGGCTGATA 
GCTCTTCTTGGTACTGTTTTC 
pAS sequencing 
Int-gfp CATCACCATCTAATTCAACAAG 
Primer 
extension 
F-T1T2rrnB 
R-T1T2rrnB 
CGATGGTAGTGTGGGGTCGACCCATGCGAGA 
TGACGACAGGAAGAGTTTGTCGACACGCAA 
Construction of 
pAST 
F-TrsiV 
R-TrsiV 
GGATGCCCCCAGTGATGGTCGACCCTTC 
TGTTATGCTTAATTCTAGTCGACGCTTCT 
Construction of  
pASTrsiV 
F-TpolA      
R-TpolA 
ACTAAGATGCTGTTACAAGTCGACGATGAA 
CTTGGATTGATAAATTGTCGACTCATAG 
Construction of 
pASTpolA 
F-PsulA 
R-PsulA 
ACATGATTGTTAATGGGATCCCTTTCTG 
TCACTCCCTCAAGGATCCTCATCATAT 
Construction of  
pAST-PsulA 
F-Pung 
R-Pung 
 
CGAAAGAGGTAGTAGGATCCTTAATGAT 
TGTTCCATAGCCGACTGGATCCTTTTTACTGC 
CTC 
Construction of   
pAST-Pung 
F-PuppS 
R-PuppS 
AAAATTTTAGAGCTCGGCAGATAC   
CCCTCCATTCCAAGAGCTCTATCTTAATT   
Construction of 
pAST-PuppS 
F-P2493 
R-P2493 
AATTAAATAGGAGCTCGGATGTTAAATATC   
CACGATTGAACAAGGAGCTCAAATACATTATT   
Construction of 
pAST-P2493 
F-P2962 
R-P2962 
CAATTAAGGCCCTGGATCCAGCAAAAAGT   
CGCGCCCATTCACCGGATCCCTTAATC  
Construction of 
pAST-P2962 
F-PfcsK 
R-PfcsK 
TATTATAGCACAATCTAGAGGAATTTG   
CCATTTTTCTTCTCTCTAGATCCTTGATTAAC   
Construction of 
pAST-PfcsK 
UpmaEfa 
DwmaEfa 
DwmaEfaHis 
GCAAAAGGAGGTTTTCATATGTACTCCATG  
AGCCAAAAAACTCGAGAATGTCCTCGCTAG  
CCTCGCTAGTTCTCGAGAAAATAAGAATGA 
Construction of 
pET-maEfa and 
pET-maEfa-His 
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Name Sequence (5’-3’) Applications 
A 
B 
C 
D 
GATTAGCTGAATGGTCATCGTGG 
GTTAAAACGTGTGATAACGG 
GACCAATCCCCTTTTTATCCG 
AATGAAGAGTGAGCTCTGCTAG 
RT-PCR 
UpPma 
DwPma 
DwPmaΔ19 
AGGAATCAGTGGAGCTCCTGTCGGTAA 
GTACATGGCAAGAGCTCCTTTTGCTT 
CTCCTTTTGCTTAAGAGCTCGGATAAAAAG 
Construction of 
pAST-Pma, 
pAST-PmaΔ19 
and                
pAS-PmaΔ19 
P2493Cla-F 
P2493Cla-R 
 
AATAGGTGATCGATTGTTAAATATCTG 
AACTCTCACATCGATTGAACAAGCATGCAAAA 
TAC 
Construction of 
pDLF 
PsulCla-F 
PsulCla-R 
 
TGTTAATGGGATCGATTTCTGTTTG 
GACATATCGATCACTCCCGCATGCATTTTCAT
C 
Construction of 
pDLS 
maSph-F 
maSph-R 
TTTTTATCCGTATTCGCATGCAAAAGGAGG 
AACCAAACGATGCATGCCGAAAGAAAGC 
Construction of 
pDLFmaEfa, 
pDLFmaEfaV  
and 
pDLSmaEfaV 
3012EMb 
maEMb 
mac 
AGGAATGGCTGTTGTAACCA 
CAACTGTTCCAACAAACG 
AACAAACGAATTTGCCGAAGC 
EMSA, 
footprintings 
0091G2 
0092A2 
EM1 
26A 
GGCTATTTTGATGCACATATCTG 
CCCGCCTTCCTTCCCTTGCTC 
AGTTGAATGTTTAAAGAAATGATGG 
TTCTTTGTGGTATAATTGCAAGAGGT 
EMSA 
Oligo 40 
 
Oligo 40pC 
 
26A 
26B 
Oligo 32A 
Oligo 32B 
Oligo 2 
Oligo 2C 
TATATCATGCTATACCTATTCTTTGTGGTATAA 
TTGCAAG 
CTTGCAATTATACCACAAAGAATAGGTATAGC 
ATGATATA 
TTCTTTGTGGTATAATTGCAAGAGGT 
ACCTCTTGCAATTATACCACAAAGAA 
TTCTTTGTGGTATAATTGCAAGAGGTTTAATC 
GATTAAACCTCTTGCAATTATACCACAAAGAA 
TATATTGTCTCCGTAGTGTT 
AACACTACGGAGACAATATA 
EMSA (small 
DNA fragments) 
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Name Sequence (5’-3’) Applications 
Up12292 
Rv12294 
Int12294 
CTAATCCGCCAGCGAATGTCTTTAACGAGG 
GCAATGATTTTCGTCCATGTTGTGAGTCTG 
ATACGATTGCTAAAGCCGTG 
Chromosome 
DNA 
sequencing 
12292Nco 
maClaR 
maClaF 
12294Nco 
CGCAAACCTTTCCATGGTCAATACGACGC 
CCTCCTTTTGCTTAAGAATATCGATAAAAAG 
CAAGAATTAATGATCGATCAAGCCGCAG 
ATAACCAAACGATCCATGGCGAAAGAAAG 
Construction of 
pBVΔmaEfa 
bga-R ACACTCCATCAGACGGTTCG 
pBVΔmaEfa 
sequencing 
recA-F         
recA-R     
GCAACGAAATGGTGGAACAG 
AAGGCATCGGCAATCTCTAAG 
qRT-PCR 
OG1RF_12439 
mtlD-F  
mtlD-R 
GGCGTTCATTACGTTGCTGA 
TCGCTTCGTCAATGGTTTGAT 
qRT-PCR 
OG1RF_10298 
lacR-F 
lacR-R 
AGACGCCAATTTGTTAGAACG 
CACAACTAGCGGCTAAAGAAG 
qRT-PCR 
OG1RF_10456 
map-F 
map-R 
CAGAAGATGGCTTACACATTACCT  
GAGTAGGCTGTCCATGTCGCT 
qRT-PCR 
OG1RF_10683 
exp5-F 
exp5-R 
TAATGGTCGTTGTGGCAGTA AAT 
TGCCCAACCGATACTCT 
qRT-PCR 
OG1RF_10684 
11135-F 
11135-R 
CGTTCGTAGTTTTGCTGTCA 
GAAGGGACAAAGCCGATTTCT 
qRT-PCR 
OG1RF_11135 
gldA-F 
gldA-R 
GAGGGTGGCTTTAGTGGAGA  
TTCACCTTCTGCTACGACTT 
qRT-PCR 
OG1RF_11146 
glpK-F 
glpK-R 
AACAAGCCGCCTTATTTGGT 
GGTTCTTCGCCAGTGTTCAT 
qRT-PCR 
OG1RF_11592 
treB-F 
treB-R 
ATGCTTATTCAGTTGCGACGA 
CTAACATGGCTGGGATAACTTG 
qRT-PCR 
OG1RF_11753 
11763-F 
11763-R 
AACATCGGCGGTATCTTCAG 
ATGCCTACATCACCAGTAGC 
qRT-PCR 
OG1RF_11763 
selD-F 
selD-R 
CTTGTACTGATGTGACTGGGTT 
CCAACGCTCCTGTAATGGTT 
qRT-PCR 
OG1RF_11948 
uxuA-F 
uxuA-R 
CCCGACGAATGATTTGCCTA 
ATCTAACGAACCAGCGACACT 
qRT-PCR 
OG1RF_12398 
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Name Sequence (5’-3’) Applications 
gnd2-F 
gnd2-R 
GAAGCATTGCGTTTGGAGAT 
AGAAGCGACCACTTTGTTTG 
qRT-PCR 
OG1RF_12405 
citF-F 
citF-R 
ACTTGTTCGTGGACGGATTC 
TGCAATGCCAACTTCTGTTA 
qRT-PCR 
OG1RF_12564 
 
6. Buffers 
 
All buffers and solutions used in this work are listed in Table 4. 
 
Table 4. Buffers and solutions. 
Buffer Composition Application 
Anode buffer 200 mM Tris-HCl, pH 8.9 Protein electrophoresis: SDS-
PAGE (Tris-Tricine) 
 
AU 
 
 
50 mM Tris-HCl, pH 7.6 
1 mM EDTA 
0.1 mM DTT 
3% Glycerol 
200 mM NaCl 
Protein analysis by analytical 
ultracentrifugation 
 
BXF 
 
80% Deionised formamide 
10 mM NaOH 
0.1 % Bromophenol blue 
0.1% Xylene cyanol 
1 mM EDTA 
Loading-dye for DNA 
electrophoresis in denaturing PAA 
gels 
Buffer gel 
3 M Tris-HCl, pH 8.45 
0.3% SDS 
 
Protein electrophoresis: SDS-
PAGE 
(Tris-Tricine) 
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Buffer Composition Application 
 
BXGE 10X 
 
0.25% Bromophenol blue 
0.25% Xylene cyanol 
60% Glycerol 
10 mM EDTA 
Loading-dye for gel electrophoresis 
of DNA and DNA-protein 
complexes 
Cathode buffer 
100 mM Tris-HCl, pH 8.25 
100 mM Tricine 
0.1% SDS 
Protein electrophoresis: SDS-
PAGE (Tris-Tricine) 
Electroporation 
buffer 
500 mM Sucrose  
10% Glicerol 
Storage of electrocompetent cells 
of E. faecalis 
EB 
200 mM NaCl 
20 mM Tris-HCl, pH 8 
2 mM EDTA 
Elution of DNA from native PAA 
(5%) gels 
LB 
10 mM Tris pH 8.0 
1 mM EDTA pH 8.0 
1 mg/ml Lysozyme 
Lysis buffer for RNA extraction 
LBD 
50 mM Tris pH 8.0 
100 mM NaCl 
25% sucrose  
28 μg/ml RNase A  
10 mg/ml lysozyme 
Lysis buffer for genomic DNA 
extraction 
LBF 
25 mM Tris pH 7.6  
0.5 mM EDTA pH 8.0 
0.2 mg/ml Lysozyme 
260 U Mutanolysin  
Lysis buffer for total extract 
preparations from E.faecalis for 
Western blot 
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Buffer Composition Application 
LBP 
50 mM Tris-HCl, pH 7.6 
1 mM EDTA 
50 mM NaCl 
0.1% Deoxycholate 
Lysis buffer for total extract 
preparations from S. pneumoniae 
for Western blot  
OEB 
10 mM Magnesium acetate 
200 mM Sodium chloride 
0.1% SDS 
 
Elution of oligonucleotides from 
denaturing PAA gels. 
PBS 
10 mM Na2HPO4 
2 mM KH2PO4 
2.7 mM KCl 
137 mM NaCl 
pH 7.4 
Resuspension of cells for 
fluorescence measurements. 
Western blot: Washing buffer 
SB 
PBS  
0.05% Tween20 
0.2% Casein 
Western blot: Saturation Buffer 
SLB 5X 
250 mM Tris-HCl, pH 7.2 
10 % SDS 
3.5 M β-mercaptoethanol 
50% Glycerol 
0.5% Bromophenol blue 
Loading-dye for protein 
electrophoresis (SDS-PAGE) 
STOP  DNase I  
2 M Ammonium acetate 
0.8 mM Sodium acetate 
0.15 M EDTA 
Stop solution for DNase I digestion 
TAE 
40 mM Tris 
20 mM Acetic acid 
2 mM EDTA pH 8.1 
 
DNA electrophoresis in agarose 
gels 
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Buffer Composition Application 
TB 25 mM Tris Western blot:Transfer Buffer 
TBE 
89 mM Tris 
89 mM Boric acid 
2.5 mM EDTA 
pH 8.3 
DNA electrophoresis in 
polyacrylamide gel 
TE 
10 mM Tris pH 8.0 
1 mM EDTA pH 8.0 
Storage of DNA 
TG 
50 mM Tris-HCl, pH 8.3 
300 mM Glycine 
0.1 % SDS 
2 mM EDTA 
Protein electrophoresis: SDS-
PAGE 
(Tris-Glycine) 
S-His 
10 mM Tris-HCl, pH 7.6 
5% Glycerol 
300 mM NaCl 
1 mM DTT 
Purification of MAEfa-His protein. 
Buffer S-His was supplemented 
with imidazole (from 10 mM to 250 
mM) 
VL 
50 mM Tris-HCl, pH 7.6 
5% Glycerol 
1 mM DTT 
1 mM EDTA 
Purification and storage of MAEfa 
protein. Buffer VL was 
supplemented with different 
concentrations of NaCl 
WB 
PBS 
0.05% Tween 20 
 
Western blot, Washing Buffer 
 
 
7. Acrylamide solutions 
 
For protein electrophoresis, an acrylamide:bis-acrlylamide 40% solution (40:1) 
or 30% solution (37.5:1) was used. For nucleic acids, an acrylamide:bis-acrlylamide 
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30% solution (30:0.8) or 40% solution (29:1) for non-denaturing gels (native gels) and 
an acrylamide:bis-acrlylamide 38% solution (38:2) or 40% solution (19:1) for denaturing 
gels, were used. 
 
8. Software 
 
Table 5. Bioinformatic tools 
Application Program 
 
Company/webpage 
 
Analysis DNA 
sequences 
Chromas 
ApE 
mb.mahidol.ac.th/pub/chromas 
biology.utah.edu/jorgensen/wayned/ape 
Analysis 
oligonucleotides 
OligoAnalyzer 3.1 
Tm calculator 
eu.idtdna.com 
finnzymes.fi/tm_determination.html 
Analysis qRT-PCR iQ™5 Optical 
System Software 
Bio-Rad 
Bibliography 
manager 
EndNote X Thomson Reuters 
Data analysis, 
statistics and 
graphing 
SigmaPlot  
GraphPad Prism 5 
Microsoft Excel 
2007 
SigmaPlot 
GraphPad Software 
Microsoft 
Homologies finder BLAST blast.ncbi.nlm.nih.gov/Blast.cgi 
Image and figures 
processing 
Adobe Illustrator 
CS2 and CS3 
Adobe Photoshop 
CS2 and CS3 
Adobe Systems Inc. 
Non-labelled DNA 
visualization 
Quantity One Bio-Rad 
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Application Program 
 
Company/webpage 
 
Oligonucleotide 
design 
Primer_3 
Primer Blast 
frodo.wi.mit.edu 
ncbi.nlm.nih.gov/tools/primer-blast 
Operon prediction Biocyc  www.biocyc.org 
Prediction of intrinsic 
curvature 
Bend.it hydra.icgeb.trieste.it/dna/bend_it.html 
Prediction of 
functional domains 
CDD 
Pfam 
Phyre2 
ncbi.nlm.nih.gov/Structure/cdd/cdd.sht
ml 
pfam.sanger.ac.uk 
www.sbg.bio.ic.ac.uk/phyre2 
Primary protein 
structure analysis 
ProtParam web.expasy.org/protparam 
Promoter finder BPROM linux1.softberry.com/berry.phtml 
Radiolabelled DNA 
visualization 
Image-reader 
MultiGauge 
Quantity One 
Fuji 
Fuji 
Bio-Rad 
Restriction maps ApE  biology.utah.edu/jorgensen/wayned/ape 
Sequence 
alignments 
ClustalW 
Clustal Omega 
ebi.ac.uk/Tools/clustalw2 
ebi.ac.uk/Tools/msa/clustalo 
Sedimentation 
equilibrium 
HeteroAnalysis 
biotech.uconn.edu 
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Application Program 
 
Company/webpage 
 
Sedimentation 
velocity 
SEDFIT 
SEDNTERP 
analyticalultracentrifugation.com 
jphilo.mailway.com 
 
9. Autoradiography and radioactive material 
 
The radioactive DNA was visualized either by autoradiography using the X-
OmatS films (Kodak) or using a Phosphor screen scanned with a Fujifilm Image 
Analyzer FLA-3000 (Fuji). When autoradiography was used, the radioactive signal was 
amplified using the intensifying screens Cronex Lightning Plus (Dupon). 
 
METHODS 
 
1. Bacterial growth conditions 
 
E. faecalis and S. pneumoniae were grown in liquid medium under low aeration 
conditions at 37ºC, unless otherwise indicated. Bacteria were grown in flasks whose 
volume was twice the culture volume and incubated in a static bath. When enterococci 
were grown in M9YE medium, microtiter plates were used and 200 µl/well were 
applied. Microplates were incubated at 37ºC without shaking in a Thermo Scientific 
Varioskan Flash instrument. In solid medium, enterococcal cells were uniformly spread 
over TY agar, SR medium or BEA agar plates. In the case of pneumococci, cells and 
antibiotic (when required) were mixed with a basal layer (20 ml) of AGCH medium 
supplemented with sucrose (0.3%) and yeast extract (0.2%) plus 1% agar. Then, an 
over-layer (8 ml) of AGCH medium plus 0.75% agar was added covering the basal 
layer. Plates were incubated at 37ºC, except when specified. 
 
E. coli was grown in TY medium with rotary shaking using Erlenmeyer flasks. 
The flask volume was 5-times larger than the culture volume in order to maintain a 
constant aeration. In solid medium, bacteria were grown at the surface of TY plates. 
Cells were incubated at 37ºC. 
 
Bacterial growth in liquid medium was followed by turbidity at 650 nm for E. 
faecalis and S. pneumoniae or at 600 nm for E. coli, using a Bausch & Lomb 
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(Spectronic 20D+) spectrophotometer. When the Thermo Scientific Varioskan Flash 
instrument was used, growth of E. faecalis was measured at 600 nm. For preservation 
of all bacterial cultures, cells were grown to an optical density (OD) between 0.3 and 
0.4, which correspond with the exponential phase of growth. Then, sterile glycerol was 
added to 1 ml of culture to a final concentration of 10%. The culture was kept at 37°C 
for 10 min and then on ice for 10 min. Finally, cultures were stored at -80°C. 
 
2. Bacterial transformation 
 
2.1. Preparation of competent cells 
 
E. faecalis electrocompetent cells were prepared basically as reported by 
Shepard and Gilmore (1995). Cells were grown overnight in ESTY medium at 37ºC 
without aeration. Subsequently, the culture was 100-fold diluted into SG-ESTY 
medium(supplemented with antibiotic if required). The volume of the flask was 5-times 
larger than the culture volume, and the incubation continued as before. After 20-24 h, 
when the cultures reached an OD560 of 0.1-0.2, cells were collected by centrifugation at 
6,000 rpm in an Eppendorf F-34-6-38 rotor for 10 minutes at 4ºC. Then, cells were 
washed twice with ice-cold electroporation buffer and resuspended in a volume of ice-
cold electroporation buffer equal to 1/100 of the initial culture volume. Finally, aliquots 
of the cultures (40 µl) were stored at −80°C. 
 
S. pneumoniae competent cells were prepared as reported previously (Lacks, 
1966). Mainly, cells were grown in ACGH medium supplemented with sucrose (0.3%) 
and antibiotic (if required) at 37ºC to an OD650 of 0.3 (exponential phase). The culture 
was then diluted 1:40 with prewarmed medium and cells were grown under the same 
conditions to an OD650 of 0.3. This dilution step was repeated twice. Finally, glycerol 
was added to a final concentration of 10%, and aliquots of the culture (250 μl) were 
stored at -80°C. 
 
In the case of E. coli, electrocompetent cells were prepared from cultures grown 
with rotary shaking in SOC medium to an OD600 of 0.5 (exponential phase). Then, the 
culture was cooled on ice and centrifuged at 5,000 rpm in an Eppendorf F-34-6-38 rotor 
for 15 min at 4°C. Cell pellet was washed several times with ice-cold sterile water. 
Finally, cells were resuspended in 10% glycerol, and aliquots (50 μl) were stored at -
80°C. 
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2.2. Transformation 
 
2.2.1. Electroporation 
 
E. coli and E. faecalis electrocompetent cells were transformed as reported by 
(Dower et al., 1988; Shepard and Gilmore, 1995), respectively. DNA in water was 
mixed with electrocompetent cells in a 0.2 cm electroporation cuvette (CellProjects) 
pre-cooled on ice. The electric pulse was generated with a MicroPulser (Bio-Rad) (2.50 
kV and 3-5 ms). In the case of E. faecalis, after the electric pulse, 1 ml of ice-cold SG-
ESTY-MC medium was added to the cells. The cuvette was maintained at least 5 
minutes on ice and then the cells were incubated at 37ºC for 2 h without aeration. 
Finally, the enterococcal cells were spread over SR plates supplemented with the 
appropriate antibiotic for selection of transformants. E. coli cells, after the pulse, were 
transferred to 0.8 ml SOB medium containing glucose (0.4%) and incubated at 37ºC 
with rotary shaking for 1 h. In order to select transformants, TY-agar plates containing 
the appropriate antibiotic were used.  
 
2.2.2. Natural transformation 
 
Competent cultures of S. pneumoniae were transformed following the method 
described by Lacks (1966). Briefly, cells were inoculated in AGCH medium 
supplemented with sucrose (0.2%) and CaCl2 (70 μM) and incubated at 30°C for 20 
min before addition of DNA. After addition of DNA, cultures were incubated at 30°C for 
40 min. To enable the phenotypic expression (resistance to Tc), cultures were 
incubated at 37°C for 90 min. Transformants were selected in AGCH plates (described 
in Section 1) supplemented with Tc. 
 
3. Construction of bacterial strains 
 
3.1. Construction of strains OG1RFΔmaEfa and JH2-2ΔmaEfa 
 
Strain OG1RFmaEfa was constructed by deleting the chromosomal region that 
spans coordinates 2421575-2422640 (which corresponds to coordinates 2889057 and 
2890122 in V583 genome, see Results Section 5.1. and Fig. 13) using the plasmid 
pBVGh (Blancato and Magni, 2010), kindly provided by Dr. C. Magni. The pBVGh 
plasmid carries a thermosensitive replication origin and a constitutively expressed β-
galactosidase gene. This plasmid is suitable to delete specific chromosomal regions. It 
allows an easy modification of chromosomal genes and a rapid identification of 
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recombinant clones by colorimetric screenings. First, a 560-bp DNA region located 
upstream of the maEfa gene (locus_tag OG1RF_12293) was amplified by PCR using 
primers 12292Nco and maClaR, which introduced NcoI and ClaI restriction sites, 
respectively. Also, a 494-bp region that includes the 3´-end of maEfa was amplified 
using primers maClaF and 12294Nco, which introduced ClaI and NcoI sites, 
respectively. Both DNA fragments were digested with ClaI enzyme, mixed in 
equimolecular amounts and ligated with T4 DNA ligase. The ligation mixture was used 
as template for a PCR using primers 12292Nco and 12294Nco. The 1017-bp product 
was then digested with NcoI and ligated into the NcoI site of plasmid pBVGh. The 
ligation mixture was used to transform JH2-2 electrocompetent cells. After 
electroporation, cells were incubated for 150 min at 30ºC and plated on SR agar 
supplemented with X-Gal 100 µg/ml and Em 5 µg/ml. Plates were incubated at 30ºC for 
36 h (permissive temperature for plasmid DNA replication) and several blue 
transformant colonies were obtained. Subsequently, plasmid DNA from blue colonies 
was isolated and analysed by restriction. The inserted region in the recombinant 
plasmid (pBVGΔmaEfa, see Fig. 3) was verified by dye-terminator sequencing carried 
out at Secugen (Centro de Investigaciones Biológicas, Madrid). Then, plasmid 
pBVGΔmaEfa was introduced into OG1RF electrocompetent cells. 
 
To generate the maEfa deletion in E. faecalis (strains JH2-2 and OG1RF) a 
protocol based on the one described by Blancato and Magni (2010) was followed. First, 
cells carrying the recombinant plasmid (pBVGΔmaEfa) were grown overnight in TY 
medium supplemented with Em (5 µg/ml) at 42ºC. Then, they were plated in TY agar 
containing Em (5 µg/m)l and X-gal (100 µg/ml). Plates were incubated at 42ºC 
overnight. In this step, cells were grown under selective pressure (Em) and at the non-
permissive temperature for plasmid DNA replication. Thus, cells carrying the plasmid 
integrated into the chromosome were selected. The integration occurred by a single 
recombination event between homologous sequences present in the plasmid and the 
chromosome (Fig. 3). Integration was verified in several blue colonies by colony PCR 
(described in Section 4.3.2) using the oligonucleotides bga-R and Rv12294. One of the 
positive colonies was inoculated in TY medium supplemented with Em (5 µg/ml) and 
incubated overnight at 42ºC. Subsequently, the culture was 1500-fold diluted in TY 
medium without antibiotic. Cells were grown at 30ºC for 7 h to allow the excision of the 
integrated plasmid by a second recombination event (Fig. 3). Next, the culture was 
diluted 100-fold in fresh medium and incubated at 42ºC for 6 h, in order to lose the 
excised plasmid. After that, the culture was plated onto TY agar containing X-Gal (100 
µg/ml) and incubated overnight at 42ºC. White colonies (no plasmid DNA) selected in 
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this step had either the maEfa deletion or the parental chromosome (see Fig. 3). To 
discriminate between both possibilities, colony PCR (described in Section 4.3.2) was 
performed using the oligonucleotides Up12292 and Rv12294. When cells carried the 
maEfa deletion, a 594-bp PCR product was detected. When cells had the wild-type 
chromosome, a 1654-bp PCR product was detected. Then, we confirmed the sensitivity 
of the deletion mutant cells to Em at both temperatures, 30ºC and 42ºC. Finally, the 
chromosomal deletion was confirmed by DNA sequencing. Specifically, chromosomal 
DNA was isolated from the candidate strains, and a 2,500-bp region that includes the 
deletion was amplified by PCR using oligonucleotides Up12292 and Int12294. The 
PCR product was then sequenced at Secugen (Centro de Investigaciones Biológicas, 
Madrid). 
 
 
 
Figure 3. Deletion of the maEfa gene. First step: integration of pBVGΔmaEfa into the 
chromosome (selection at 42ºC with Em) ocurrs by a single recombination event through region 
A. Second step: the incubation at 30ºC stimulates a second recombination event between the 
duplicated homologous regions and leads to plasmid excision.  Excision through region A 
restores the parental chromosome, whereas excision through region B gives rise to the deletion 
of maEfa. Subsequently, cells are incubated at 42ºC in order to lose the excised plasmid. 
Alternatively, an initial integration through B and excision through A also result in maEfa gene 
deletion. Modified from (Biswas et al., 1993) 
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4. DNA preparations 
 
4.1. Plasmid DNA isolation 
 
Plasmid DNA was isolated using the High Pure Plasmid Isolation Kit (Roche 
Applied Science) with some modifications in the composition of specif buffers when 
enterococcal and pneumococcal cells were used. The Suspension Buffer was 
supplemented with 50 mM glucose, 1.2 mg/ml lysozyme and 240 units/ml mutanolysin 
for enterococcus, or 50 mM glucose and 0.1% deoxycholate in the case of S. 
pneumoniae. For both bacteria, the Lysis Buffer was freshly prepared. It contained 0.17 
M NaOH and 1% SDS. 
 
4.2. Genomic DNA isolation 
 
In order to isolate chromosomal DNA of E. faecalis, cells were grown in BHI 
medium containing 1.25% of glycine. Cells were incubated at 37ºC with rotary shaking 
in a flask whose volume was 5 times larger than the culture volume. When the cultures 
reached an OD650 of 1.2, cells were harvested and concentrated 10-fold in buffer LBD 
(Table 4) at 4ºC. Subsequently, 400 units of mutanolysin were added to 1 ml of the 
concentrated culture. After 20 min at 37ºC, SDS was added at a final concentration of 
1%. The lysate was treated with proteinase K (240 μg/ml) for 15 min. DNA was further 
purified by extraction with phenol/chloroform, dialyzed against buffer TE and recovered 
by precipitation with ethanol. For small-scale preparations of chromosomal DNA, 
bacteria were grown under routine growth conditions and the Bacterial Genomic 
Isolation Kit (Norgen Biotek Corporation) was used. 
 
4.3. Preparation of linear double-stranded DNA fragments 
 
Linear double-stranded DNA (dsDNA) fragments used in this Thesis were 
obtained by digestion with restriction enzymes, by polymerase chain reaction (PCR) or 
by annealing of complementary oligonucleotides. 
 
4.3.1. Digestion with restriction enzymes 
 
DNA digestions using restriction enzymes were performed following the 
indications specified by the suppliers. When needed, 10 μg/ml of BSA was included in 
the digestion reaction. In general, enzymes were inactivated at 65ºC for 10 min. 
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4.3.2. Polymerase chain reaction 
 
All PCR reactions were carried out in an iCycler Thermo Cycler (Bio-Rad). 
Analysis of transformants by PCR (colony PCR) was performed with Taq DNA 
polymerase (Roche). The transformant colonies were inoculated with a sterile toothpick 
in both growth medium (50 μl) and sterile water (50 μ)l. Then, 1 μl of the cells 
suspended in water was used as template for PCR. Reactions (25 μl) contained 10 mM 
Tris-HCl Ph 7.8, 50 mM KCl, 1.5 mM MgCl2, 12.5 pmol of each primer, 200 μM of each 
dNTP and 0.75 unit of Taq DNA polymerase. PCR conditions were: initial denaturation 
step at 94ºC for 3 min, followed by 30 cycles including the next steps: denaturation at 
94ºC for 45 s, annealing of the primers to the DNA template at around 55ºC (depending 
on the primer Tm) for 20-30 s followed by an extension at 72ºC for 20-40 s (depending 
on the amplicon length). A final extension step was performed at 72ºC for 10 min. 
 
Phusion High-Fidelity DNA polymerase (Finnzymes) was used when high 
fidelity PCR products were required. Reaction mixtures (50 μl) contained 5-30 ng of 
template DNA, 50 pmol of each primer, 200 μM of each dNTP and 1 unit of DNA 
polymerase. PCR conditions were as described with Taq DNA polymerase, but the 
denaturation steps were performed at 98ºC.  
 
4.3.3 Annealing of complementary oligonucleotides 
 
 Complementary oligonucleotides were annealed in buffer TE (2 mM Tris-HCl, 
pH 8, 0.2 mM EDTA) containing 50 mM NaCl. Equimolar amounts of the 
complementary oligonucleotides were used. Reaction mixtures (150 μl) were incubated 
at 95ºC for 10 min and then cooled down slowly to 37ºC. Then, they were kept at this 
temperature for 10 min and on ice for 10 min. 
 
4.4. DNA purification 
 
4.4.1 Linear double-stranded DNAs 
 
When it was required, linear dsDNA fragments (obtained either by digestion 
with restriction enzymes or by PCR) were purified with the QIAquick PCR purification 
kit (QIAGEN). The linear dsDNA fragments radioactively labelled at 5’-ends (obtained 
by PCR) were purified from non-denaturing polyacrylamide (5%) gels. After 
electrophoresis, DNA was visualized by autoradiography. The desired band was 
excised with a clean scalpel and the gel slice was incubated overnight in elution buffer 
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(see Table 4) with continuous shaking (450 rpm) at 42ºC using a Thermo-shaker (TS-
100, Biosan). The remains of the gel were removed using a Spin-X column (Costar). 
Finally, the eluted DNA was ethanol precipitated and dissolved in distilled water. 
 
4.4.2. Oligonucleotides 
 
Oligonucleotides used to obtain small dsDNA fragments (40-bp to 20-bp) were 
purified from denaturing (8 M urea) polyacrylamide (15-20%) gels (Maniatis et al., 
1982). The oligonucleotide solution was mixed with deionised formamide (50% final 
concentration) and heated at 55ºC for 5 min. The sample was cooled down on ice 
before being loaded onto the sequencing gel. After electrophoresis, the gel was placed 
on a piece of saran wrap and then on a Fluor-coated TLC plate (Ambion) and shined 
with a short wavelength UV light. The DNA absorbs the UV light and casts a shadow 
against the fluorescent background allowing the DNA to be visualized. The area of the 
gel containing the full-length oligonucleotide was excised. To elute the oligonucleotide, 
the gel slice was incubated in buffer OEB (see Table 4) overnight at 42ºC with 
continuous shaking. The remains of gel in the eluted DNA solution were removed using 
a Spin-X column (Costar). Finally, the eluted oligonucleotide was ethanol precipitated, 
dissolved in 50 μl of distilled water and loaded onto a MicroSpinTM G-25 column (GE 
Healthcare) to eliminate the remains of salt. 
 
4.5. Ligation 
 
In general, for ligation of linear DNA fragments, a vector to insert molar ratio of 
1:10 or 1:15. When the vectors were dephosphorylated, the vector to insert molar ratio 
was between 1:5 and 1:10. In all cases, 400 units of T4 DNA ligase (New England 
Biolabs) were added to a final reaction volume of 20-40 μl. Reaction mixtures were 
incubated overnight at room temperature.  
 
4.6. Construction of recombinant plasmids 
 
All the constructions described below were confirmed by dye-terminator 
sequencing at Secugen (Centro de Investigaciones Biológicas, Madrid). 
 
4.6.1. Construction of plasmids pET24b-maEfa and pET24b-maEfa-His  
 
To overproduce and purify the MAEfa and MAEfa-His proteins, plasmids 
pET24b-maEfa and pET24b-MaEfa-His were constructed (see Section 7). In both 
cases, the pET24b expression vector (Novagen) was used. To obtain pET24b-maEfa 
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plasmid, a 1,502-bp region of the V583 chromosme containing the maEfa gene was 
amplified by PCR using the UpmaEfa and DwmaEfa primers. These primers contained 
a single restriction site for NdeI and XhoI, respectively. The amplified product was 
digested with both enzymes, and the 1,470-bp digestion product was inserted into the 
pET24b expression vector. To overproduce the MAEfa-His protein, the maEfa gene 
was engineered to encode a MAEfa protein fused to a C-terminal His6-tag. Specifically, 
a 1,481-bp region of the V583 genome was amplified by PCR using the UpmaEfa and 
DwmaEfaHis primers. DwmaEfaHis oligonucleotide was designed to change the stop 
codon of maEfa gene by a restriction site for XhoI. Subsequently, the PCR product was 
digested with NdeI and XhoI and the 1,448-bp digestion product was cloned into the 
pET24b expression vector. 
 
4.6.2 Construction of the pAS terminator-probe vector and the pAST promoter-
probe vector  
 
To construct the terminator-probe vector, pAS, an 833-bp DNA region of the 
pGreenTIR plasmid (Miller and Lindow, 1997), which contains the gfp reporter 
cassette, was amplified by PCR using the oligonucleotides F-gfp and R-gfp. Both 
oligonucleotides include a HindIII restriction site. The PCR-synthesized DNA fragment 
was digested with HindIII and the 802-bp digestion product was inserted into HindIII-
linearized plasmid pLS1 (Lacks et al., 1986). The promoter-probe vector, pAST, was 
constructed introducing the transcriptional termination sites T1T2 of the E.coli rrnB 
ribososomal RNA operon (Brosius, 1981) into the multicloning site of pAS plasmid. For 
PCR amplification of a DNA region containing such terminators we used the pPR54 
plasmid as template (Serrano-Heras et al., 2005) and the oligonucleotides F-T1T2rrnB 
and R-T1T2rrnB as primers. The 286-bp DNA fragment was further digested with SalI, 
and the 246-bp digestion product was cloned into the SalI site of plasmid pAS in both 
orientations, obtaining plasmid pAST (orientation T1T2rrnB; promoter-probe vector) 
and plasmid pAS-T2T1rrnB (opposite orientation). 
 
4.6.3. Construction of pAS and pAST derivatives 
 
To assess whether pAS functions as a terminator-probe vector, several 
derivatives were constructed, including pAST, whose construction was described in the 
previous section. To generate pAS-TrsiV, a 305-bp region of the enterococcal genomic 
DNA that contains the putative terminator of the sigV–rsiV operon (Benachour et al., 
2005) was amplified with the F-TrsiV and R-TrsiV primers. Then, the PCR-amplified 
DNA was digested with SalI, and the 265-bp restricted fragment was inserted into the 
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SalI site of the pAS vector. For the construction of plasmid pAS-TpolA, a 278-bp region 
of the pneumococcal genome containing the terminator of the polA gene (López et al., 
1989) was amplified with the F-TpolA and R-TpolA primers. After SalI digestion, the 
resulting 238-bp fragment was cloned into the SalI site of the pAS vector.   
 
To analyse whether pAST is suitable as a promoter-probe vector, various DNA 
regions containing defined or predicted promoters were inserted into the multicloning 
site of the plasmid. From the enterococcal genome, two regions of 192-bp and 190-bp 
containing the promoter of the uppS and EF2493 genes (Hancock et al., 2003), 
respectively, were amplified with the F-PuppS and R-PuppS primers or the F-P2493 
and R-P2493 primers. After SacI digestion, the 164-bp (PuppS promoter) and 160-bp 
(P2493 promoter) restriction fragments were cloned into the SacI site of the pAST 
vector, generating plasmids pAST-PuppS and pAST-P2493, respectively. Moreover, to 
construct plasmid pAST-P2962, a 191-bp region of the enterococcal genome that 
contains the putative promoter of the EF2962 gene was amplified with the F-P2962 and 
R-P2962 primers. After BamHI digestion, the 158-bp restriction fragment (P2962 
promoter) was inserted into the BamHI site of the pAST vector. Using pneumococcal 
genomic DNA as template, two regions of 199-bp and 195-bp containing the promoter 
of the sulA (Lacks et al., 1995; López et al., 1987) and ung (Méjean et al., 1990) genes, 
respectively, were amplified with the F-PsulA and R-PsulA primers or the F-Pung and 
R-Pung primers. The PCR-synthesized DNAs were further digested with BamHI. The 
166-bp (PsulA promoter) and 159-bp (Pung promoter) digestion products were inserted 
into the BamHI site of the pAST vector, generating plasmids pAST-PsulA and pAST-
Pung, correspondingly. Regarding the inducible pneumococcal PfcsK promoter (Chan 
et al., 2003), a 150-bp region was amplified using pneumococcal genomic DNA as 
template and the oligonucleotides F-PfcsK and R-PfcsK as primers. After XbaI 
digestion, the 117-bp restriction fragment (PfcsK promoter) was cloned into the XbaI 
site of the pAST vector in both orientations: plasmid pAST-PfcsK (gene gfp under the 
control of the PfcsK promoter) and plasmid pAST-oPfcsK (opposite orientation). 
 
4.6.4. Construction of plasmids pAST-Pma, pAST-PmaΔ19 and pAS-PmaΔ19  
 
The pAST-Pma recombinant plasmid was used to identify the transcription start 
site of the maEfa gene. To construct pAST-Pma, a 242-bp region of the V583 
enterococcal genome was amplified by PCR using the UpPma and DwPma primers. 
Both oligonucleotides contained a restriction site for SacI. The amplified DNA was 
digested with SacI, and the 214-bp digestion product (coordinates 288864-2889078) 
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was inserted into the SacI site of pAST. In pAST-Pma, gfp expression is under the 
control of the Pma promoter. To construct pAST-PmaΔ19 and pAS-PmaΔ19, a 228-bp 
region of the V583 genome was amplified with the UpPma and DwPma2 primers. After 
SacI digestion, the 197-bp restriction fragment (coordinates 2888864-2889059) was 
cloned into the SacI site of both pAST (pAST-PmaΔ19) and pAS (pAS-PmaΔ19).  
 
4.6.5. Construction of pDL287 derivatives plasmids 
 
Several plasmids were constructed to provide the maEfa gene in trans. They 
are based on the pDL287 plasmid (LeBlanc et al., 1993), a derivative of pVA380-1, that 
carries a Km resistance gene. First, two expression vectors for E. faecalis were 
developed, pDLF and pDLS. These plasmids contain an engineered unique restriction 
site for SphI downstream of the P2493 and PsulA promoters, respectively. For the 
construction of pDLF, a 194-bp region of the V583 enterococcal genome, which 
contains the P2493 promoter, was amplified using the oligonucleotides P2493Cla-F 
and P2493Cla-R. Both oligonucleotides carry a restriction site for ClaI. The P2493Cla-
R carries also a SphI restriction site. The PCR product was digested with ClaI 
generating a 171-bp fragment which was inserted into ClaI-linearized pDL287. For the 
construction of pDLS, a 202-bp fragment that carries the PsulA promoter was amplified 
using pneumococcal chromosomic DNA and the primers PsulCla-F and PsulCla-R. 
Both primers contained a restriction site for ClaI. In addition, PsulCla-R includes a 
restriction site for SphI. After ClaI digestion, the 181-bp DNA fragment was cloned into 
the ClaI site of pDL287. The next step was to introduce a promoterless maEfa gene 
from V583 strain (maEfaV583) in the expression vectors. To this end, a 1,546-bp region 
of the V583 enterococcal genome was amplified using the oligonucleotides maSph-F 
and maSph-R. After SphI digestion, the 1,514-bp restriction fragment was inserted into 
the SphI site of pDLF and pDLS, obtaining pDLFmaEfaV583 and pDLSmaEfaV583, 
respectively. In addition, the maEfa gene of strain OG1RF (maEfaOG1RF), which was 
amplified by PCR with the same primers, was introduced into pDLF, obtaining 
pDLFmaEfaOG1RF.  
 
4.7. Radioactive labelling of DNA  
 
Radiolabelled DNA was visualized either by autoradiography or using a Fujifilm 
Image Analyzer FLA-3000 (Phosphorimager). The intensity of the labelled DNA bands 
was quantified using the Quantity One software (Bio-Rad) 
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4.7.1. 5´-end labelling 
 
Radioactive labelling of the oligonucleotides at their 5’ ends was performed 
using [γ-32P]-ATP and the T4 Polynucleotide Kinase (PNK) (New England Biolabs). 
Reactions mixtures (25 μl) contained 25 pmol of oligonucleotide, 2.5 μl of 10x kinase 
buffer (provided by the supplier), 41.5 pmol of [γ-32P]-ATP (3,000 Ci/mmol; 10 μCi/μl) 
and 10 units of T4 PNK. After incubation at 37ºC for 30 min, additional T4 PNK (10 
units) was added and the reaction mixtures were incubated at 37ºC for 30 min. Finally, 
to inactivate the enzyme, reaction mixtures were incubated at 65ºC for 20 min. Non 
incorporated nucleotide was removed using MicroSpinTM G-25 columns (GE 
Healthcare). The 5´-labelled oligonucleotides were used to obtain labelled-dsDNA by 
PCR amplification (labelling at the 5´ end of one DNA strand). 
 
4.7.2. Internal labelling 
 
The incorporation of a radiolabelled nucleotide ([α-32P]-dATP, 3,000 Ci/mmol, 
10 µCi/µL, Hartmann) was used for primer extension experiments and manual 
sequencing (using the Sequenase v2.0 kit, according to the indications of the supplier).  
 
5. Analysis of DNA 
 
5.1. DNA quantification 
 
To quantify non-radiolabelled DNA, agarose gels were stained either with EtBr 
(1 μg/ml) or GelRed 1x (Biotium). DNA bands were visualized using a Gel Doc system 
(Bio-Rad) and quantified using a molecular weight marker (NZYDNA Ladder III) with 
the Quantity One program. In addition, the concentration of DNA samples was 
determined using a NanoDrop ND-2000 Spectrophotometer (Bio-Rad). For 5´-labelled 
DNA, the ionizing radiation was measured with a scintillation counter (Wallac1450 
MicroBeta, TriLux). Knowing that 125 μCi of [γ-32P]-ATP (41.5 pmol) are equivalent to 
1.37x108 cpm, we estimated the incorporation of [γ-32P]-ATP in the labelling reaction 
and then the DNA concentration using the total cpm obtained. 
 
5.2. DNA electrophoresis 
 
5.2.1. Agarose gels 
 
In general, DNA was analysed by horizontal agarose gel electrophoresis in TAE 
buffer. The agarose concentration used (generally 0.8-1.2 %) depended on the size of 
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the DNA analysed. DNA samples were mixed with BXGE buffer (see Table 4) and 
loaded onto the gel. After electrophoresis, gels were stained in a solution of EtBr (1 
μg/ml in TAE buffer) or GelRed (1x in water supplemented with 0.1 M NaCl) for 15-30 
min at room temperature. DNA was visualized using a short wavelength UV light (254 
nm) with a Gel Doc XR system (Bio-Rad). The image obtained was captured with the 
Quantity One software and quantified when it was necessary. 
 
5.2.2. Native polyacrylamide gels 
 
Vertical polyacrylamide gels were run in TBE buffer (see Table 4) using a Mini 
Protean-III system (Bio-Rad). The concentration of acrylamide used (5-8%) depended 
on the size of the DNA analysed. DNA samples were mixed with BXGE buffer and 
loaded onto the gels. Gels were run at 100 V at room temperature or 4ºC. After 
electrophoresis, gels were soaked in GelRed 1x and visualized as described before. 
When radioactively labelled DNA was used, after electrophoresis, gels were fixed with 
acetic acid (10%), dried using a gel dryer (model 583, Bio-Rad) and the DNA was 
visualized by autoradiography or using a Fujifilm Image Analyzer FLA-3000. 
 
5.2.3. Denaturing polyacrylamide gels 
 
Oligonucleotides were purified (when needed) from denaturing polyacrylamide 
gels in TBE buffer and 8 M urea. The concentration of acrylamide used depended on 
the size of the oligonucleotide: 19% for 15-25 nt and 15% for 25-40 nt. After 
electrophoresis, oligonucleotides were purified as described before (see Section 4.4). 
Sequencing reactions, primer extension products, as well as footprinting reactions were 
run in vertical denaturing urea (8 M) polyacrylamide (6%) gels. A Sequi-Gen GT 
sequencing system and 21x50 cm gels (Bio-Rad) were used. Previous to load the DNA 
samples, gels were prerun to heat the gel up (50ºC). Then, gels were run at 50 W to 
maintain the gel temperature. After electrophoresis, gels were allowed to cool down. 
Siliconized glass plate was carefully removed from the gel assembly and, immediately, 
a large piece of WhatmanTM 3MM paper filter was employed to cover the exposed gel. 
Gel was peeled off along the paper and covered with plastic SaranTM wrap, then 
vacuum-dried, and exposed to Phosphor screen. Bands were visualized using a 
Fujifilm Image Analyzer FLA-3000. 
 
 
 
 
 
MATERIALS AND METHODS 
 
 
60 
 
5.3. DNA sequencing 
 
5.3.1 Manual DNA sequencing: Dideoxy chain-termination sequencing method 
(Sanger method)  
 
Manual DNA sequencing was performed following the dideoxy chain-
termination method (Sanger et al., 1977). The Sequenase v2.0 DNA Sequencing kit 
(USB Corporation) was used following the supplier indications. When linear dsDNA 
was used some modifications were performed. The sequencing reactions which were 
run alongside the primer extension products were carried out using DNA from 
M13mp18 (Yanisch-Perron et al., 1985) and the −40 M13 primer provided by the kit. In 
the annealing step, 1 µg of DNA was mixed with 1 pmol of the primer and the reaction 
mixture was incubated at 65ºC for 5 min and then cooled down slowly to 37ºC. Then, 
Sequenase DNA polymerase (3.25 units) and [α-32P]-dATP (3,000 Ci/mmol; Hartmann) 
were added to the mixture. After 2-5 min at room temperature, the mixture was 
distributed into four tubes. Each tube contained one of the four ddNTPs (ddATP, 
ddCTP, ddGTP or ddTTP) pre-warmed at 37ºC. Mixtures were then incubated at 37ºC 
for 5 min and finally, the reactions were stopped by adding the Stop Solution of the kit 
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol). For 
linear dsDNA sequencing, 2.5 pmol of a 5´ radiolabelled primer were mixed with 0.25 
pmol of dsDNA (obtained by PCR). The mixture was heated at 95ºC for 3 min and 
placed on ice. Thereafter, the Sequenase was added and the reaction proceeded as 
described above. 
 
5.3.2. Automated DNA sequencing 
 
All the plasmid constructions as well as the chromosomal modifications were 
confirmed by dye-terminator sequencing at Secugen (Automated DNA Sequencing 
Service, CIB). 
 
5.4. In silico prediction of intrinsic DNA curvature 
 
The intrinsic curvature of the C and NC DNA fragments was predicted with the 
bend.it server (http://hydra.icgeb.trieste.it/dna/bend_it.html). It was calculated as 
degrees per helical turn (10.5º/helical turn = 1º/basepair). The curvature propensity plot 
was calculated using the consensus scale algorithm (DNase I + nucleosome 
positioning data) with a windows size of 20-bp. 
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6. RNA techniques 
 
6.1. Total RNA isolation from E. faecalis 
 
To extract total RNA from enterococcal cells either Aurum Total RNA mini Kit 
(Bio-Rad) or RNeasy mini Kit (QIAGEN) were used. For microarrays and qRT-PCR 
studies, cells were grown to an OD650 of 0.4 (exponential phase) and 2 ml of culture 
were centrifuged at 4°C. Then, cells were resuspended in 100 µl of LB buffer (Table 4) 
and 160 units of mutanolysin were added. The samples were incubated at 37°C for 10 
min (cell lysis). After this step, the RNeasy mini Kit (QIAGEN) was used following the 
manufacturer’s recommendations. To remove any residual DNA in the RNA 
preparations, the samples were treated with DNase I recombinant RNase free (Roche). 
After DNase I digestion, the RNA preparations were cleaned up using the kit columns. 
In the case of primer extension assays and RT-PCR experiments, cells were grown 
under the same conditions described for genomic DNA isolation (see Section 4.2) to an 
OD650 of 0.5. Then, 4 ml of culture were concentrated (40X) in LB buffer, followed by 
the addition of 160 units of mutanolysin. After incubation at 37ºC for 10 min, Aurum 
Total RNA mini Kit (Bio-Rad) was used. Finally, an additional DNase I digestion and 
the subsequent RNA purification (kit columns) were performed. In all the RNA 
preparations, the integrity and yield of rRNAs was checked by agarose gel 
electrophoresis and the RNA concentration was determined using a NanoDrop ND-
1000 Spectrophotometer.  
 
6.2. Primer extension  
 
Primer extension analyses were carried out using total RNA isolated from the 
enterococcal strain JH2-2/pAST-Pma. The ThermoScript Reverse Transcriptase kit 
(Invitrogen) and [α-32P]-dATP (3000 Ci/mmol, Perkin Elmer) were used. First, 4.5 μg of 
total RNA were mixed with 20 pmol of the corresponding primer and the dNTPs (100 
μM of dCTP, dGTP and dTTP; 9.75 μM of dATP and 0.25 μM of [α-32P]-dATP). The 
reaction mixture (12 µl) was incubated at 65º C for 5 min. Then, additional components 
of the kit and 15 units of ThermoScript Reverse Transcriptase were added. Extension 
reactions were carried out at 55ºC for 45 min. Reactions were stopped by heating at 
85ºC for 5 min, and the non-incorporated nucleotides were removed using Illustra 
MicroSpinTM G-25 columns (GE Healthcare). Finally, samples were ethanol precipitated 
and dissolved in BXF buffer (see Table 4). cDNA products were subjected to 
electrophoresis in a 8 M urea/ 6% polyacrylamide sequencing gel. To estimate the 
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length of the extension products, sequencing reactions obtained by the Sanger method 
were run in the same gel. Labelled products were visualized using a FUJIFILM Image 
Analyzer FLA-3000.  
 
6.3. Reverse transcription polymerase chain reaction 
 
For first-strand cDNA synthesis, the ThermoScript Reverse Transcriptase kit 
was used as recommended by the supplier. Specifically, 20 pmol of the specific primer 
were mixed with 175 ng of total RNA and 100 µM of each dNTP. The reaction mixture 
(12 µl) was incubated at 65ºC for 5 min. Then, 5 mM DTT, and cDNA Synthesis buffer 
(provided by the supplier) and the Thermoscript Reverse Transcriptase (15 units) were 
added. Reaction mixtures (20 μl) were incubated at 55ºC for 45 min. After the 
extension step, the enzyme was inactivated (incubation at 85ºC for 5 minutes). PCRs 
were then carried out as described in Section 4.3.2 using the cDNA as template (10% 
of the first-strand reaction) and Phusion High-Fidelity DNA Polymerase (Finnzymes). 
To rule out the presence of genomic DNA in the RNA preparations, the same reactions 
were performed in the absence of ThermoScript Reverse Transcriptase (negative 
control). As a positive control, PCRs were performed with genomic DNA. PCR products 
were analysed by agarose (0.8%) gel electrophoresis. 
 
6.4. Quantitative reverse transcription polymerase chain reaction 
 
Quantitative reverse polymerase chain reaction (qRT- PCR) was performed in 
two steps. First, we carried out the reverse transcription of RNA into cDNA. Then, the 
cDNA was used as template in a quantitative PCR based on SYBR® Green I detection. 
The synthesis of cDNA was performed either with ThermoScript Reverse Transcriptase 
kit or iScript Select cDNA Synthesis kit (Bio-Rad). In each case, total RNA from three 
biological replicates was used. ThermoScript Reverse Transcriptase was used for 
cDNA synthesis using specific primers (validation of microarray data) as described in 
Section 6.3 with some modifications. Specifically, 20 pmol of the specific primer and 
250 ng of total RNA were used. In addition, the final reaction mixtures contained 40 
units of RNasin® Plus RNase Inhibitor (Promega). Thereafter, samples were 2-fold 
diluted with sterile water and stored in aliquots at -80ºC. For cDNA synthesis with 
random primers (complementation assays), the iScript Select cDNA Synthesis kit was 
used according to manufacturer’s instructions. The mixture reactions (20 µl) contained 
1 µg of total RNA, 4 µl of iScript Select reaction mix, 2 µl of random primers and 1 µl of 
iScript Reverse Transcriptase. The reactions were incubated at 25 ºC for 5 min, then at 
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42 ºC for 30 min, and finally at 85ºC for 5 min. The cDNA samples were 3-fold diluted 
with sterile water and stored at -80ºC. Negative controls (the same reactions without 
adding Reverse Transcriptase) were performed with to ensure the absence of DNA 
  
The primers for quantitative PCR (qPCR) were designed using the published 
genome sequence of the strain OG1RF (Bourgogne et al., 2008) and the Primer3 
software (Rozen and Skaletsky, 2000) or Primer-BLAST (Ye et al., 2012) to produce 
amplicons of similar lengths (100-150 bp). The analysis of each primer was performed 
with the OligoAnalizer 3.1 tool available at www.idtdna.com and its specificity was 
verified using the Basic Local Alignment Search Tool BLAST NCBI tool (Johnson et al., 
2008).  
 
qPCRs were carried out using iQ SYBR Green Supermix (Bio-Rad), on a 
iCycler Thermal Cycler (Bio-Rad). PCR reactions were performed using as template 1 
µl of cDNA obtained with specific primers or 3 µl of cDNA synthesized with random 
primers. In addition, PCR reactions were carried out using as template the negative 
controls of the reverse transcription reactions. The reaction mixtures (20 µl) also 
contained 10 µl of iQ SYBR Green Supermix 2x and 500 nM of each primer. The 
protocol consisted of an initial step of denaturation at 95ºC for 5 min followed by 40 
cycles that included the next steps: (i) denaturation at 95ºC for 30 s; (ii) annealing at 
55ºC or 60ºC for 30 s; and (iii) extension at 72ºC for 20 s. The final step was a melt 
curve analysis to confirm the specificity of the selected primers. Data was analysed 
with the software iQ™5 Optical System Software. Relative quantification of gene 
expression was performed using the comparative Ct method (Livak and Schmittgen, 
2001; Schmittgen and Livak, 2008). The internal control gene employed was recA. The 
threshold cycles values (Ct) of the genes of interest and the control gene were used to 
calculate 2-ΔCt, where ΔCt = (Ct gene of interest - Ct internal control). For a particular 
gene, the fold change in expression (FC) between two strains was obtained dividing 
the corresponding 2 ΔCt values.  
 
6.5. Microarrays 
 
For each strain under study, total RNA was isolated as described in Section 6.1 
from four biological replicates. Microarrays experiments were performed at Bioarray S. 
L. Company (Alicante, Spain). The microarrays were specifically designed for 
Enterococcus faecalis OG1RF using eArray (Agilent) (ID 0 49739). The quality of the 
RNA was assessed using Tape Station and the kit R6K ScreenTape (Agilent). The 
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Two-Color Microarray-Based Prokaryote Analysis Fair Play III Labeling protocol (v. 1.3) 
(Agilent) was followed to label the samples. Bioinformatics analysis of microarray data 
were done using Bioconductor (www.bioconductor.org), with the following packages: 
Limma, Marray, affy, pcaMethods and EMA, in the R computing environment. 
Significant fold changes (FC) were considered when the log2FC of the wild-type strain 
versus the mutant strain was higher than 3.  
 
7. Protein purification 
 
The pET24b expression vector (Novagen) and the E. coli BL21 (DE3) strain 
were used for overproduction and purification of proteins. In pET24b, the gene of 
interest is expressed under control of the φ10 promoter of phage T7. E. coli BL21 
(DE3) strain was used as host since it contains the T7 RNA polymerase (RNAP) 
encoding gene (T7 gene) under the control of the lacUV5 promoter and a chromosomal 
copy of the lacI gene. In the absence of IPTG, the LacI repressor binds to the operator 
region of the lacUV5 promoter and represses the transcription of the T7 gene. In the 
presence of IPTG, LacI is blocked and, therefore, there is synthesis of the T7 RNAP, 
which transcribes the gene of interest from the φ10 promoter. 
 
7.1. Purification of MAEfa 
 
E. coli BL21 (DE3) cells carrying the pET24b-maEfa plasmid were grown at 
37ºC with rotary shaking in TY broth containing Km (30 μg/ml). When the culture 
reached an OD600 of 0.45, 1 mM IPTG was added to induce the expression of the 
maEfa gene. After 25 min under the same growth conditions, the culture was treated 
with rifampicin (200 μg/ml) for 60 min, which specifically inhibits bacterial RNAP. Cells 
were collected by centrifugation (8,000 rpm in an SLA-3000 rotor for 15 min at 4ºC), 
washed twice with buffer VL containing 200 mM NaCl and stored at -80ºC. The cell 
pellet was concentrated (40X) in buffer VL containing 200 mM NaCl and a protease 
inhibitor cocktail (Roche). Cells were lysed by two passages through a pre-chilled 
French pressure cell, and the whole-cell extract was centrifuged (10,000 rpm in an 
Eppendorf F-34-6-38 rotor for 40 min at 4ºC) to remove cell debris. The clarified extract 
was mixed with 0.2% polyethyleneimine (PEI), kept on ice for 30 min, and centrifuged 
at 9,000 rpm in an Eppendorf F-34-6-38 rotor for 20 min at 4ºC. Under these 
conditions, nucleic acids and some proteins, including MAEfa, precipitated. The pellet 
was washed twice with buffer VL containing 200 mM NaCl to remove any trapped 
protein. Then, the pellet was washed with buffer VL containing 400 mM NaCl to elute 
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the MAEfa protein. Subsequently, proteins present in the supernatant were precipitated 
with 70% (w/v) saturated ammonium sulphate, which was added slowly. The mixture 
was kept on ice with constant stirring for 60 min, followed by a centrifugation step 
(9,000 rpm in an Eppendorf F-34-6-38 rotor for 20 min at 4ºC). The precipitate was 
dissolved in buffer VL containing 200 mM NaCl and then dialyzed at 4ºC against the 
same buffer to remove the ammonium sulphate. The sample was loaded onto a 
heparin affinity column (HiPrep Heparin, GE Healthcare) equilibrated with buffer VL 
containing 200 mM NaCl. After washing the bound proteins with 5-column volumes of 
the same buffer, a linear gradient (200-600 mM NaCl) was applied to elute MAEfa. 
Protein fractions were analysed using Coomassie-stained SDS-polyacrylamide (12%) 
gels. Fractions containing MAEfa were pooled and dialyzed at 4ºC against VL buffer 
containing 200 mM NaCl. The protein preparation was concentrated by filtering through 
a 10-kDa-cutoff membrane (Macrosep; Pall). Then, the protein preparation was applied 
to a HiLoad Superdex 200 gel-filtration column (120 ml; 16 x 600 mm) (Amersham 
Biosciences) and subjected to fast-pressure liquid chromatography (FPLC) (Biologic 
DuoFlow; Bio-Rad) at 4ºC. The column was equilibrated with buffer VL containing 200 
mM NaCl at a constant flow rate of 1 ml/min. Buffer VL containing 200 mM NaCl was 
used also as running buffer. Protein fractions were analysed as described above, and 
fractions containing pure MAEfa were pooled, concentrated and stored at -80ºC. 
 
7.2. Purification of MAEfa-His 
 
E. coli BL21 (DE3) cells harbouring the pET24b-maEfa-His plasmid were used 
to overproduce the MAEfa-His protein. Induction of the expression of maEfa-His was 
performed as described above (see Section 7.1). After the incubation with rifampicin, 
cells were sedimented by centrifugation, and washed twice with buffer S-His. The cell 
pellet was concentrated (30X) in buffer S-His supplemented with an EDTA-free 
protease inhibitor cocktail (Roche). Cells were disrupted by two passages through a 
prechilled cell-pressure French Press, and the cell lysate was clarified by centrifugation 
(8,000 rpm in an Eppendorf RF-34-6-38 rotor for 30 min at 4ºC). Then, imidazole was 
added to the clarified extract at a final concentration of 10 mM. This extract was loaded 
onto a nickel affinity column (HisTrap HP column, GE Healthcare) pre-equilibrated with 
buffer S-His containing 10 mM imidazole. After washing with the same buffer, MAEfa-
His was eluted using a linear gradient of buffer S-His containing from 10mM to 250 mM 
imidazole. Fractions were analysed by electrophoresis on SDS polyacrylamide gels 
(10%) gels followed by staining with Coomassie Brilliant. Blue. Fractions containing 
MAEfa-His were pooled, dialyzed against buffer VL containing 200 mM NaCl and 
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concentrated by filtration through a 10-kDa-cutoff membrane (Macrosep; Pall). Then, 
the protein sample was loaded onto a Bio-Silect SEC 125-5 column (Bio-Rad) pre-
equilibrated with buffer VL containing 200 mM NaCl, and subjected to fast-pressure 
liquid chromatography (FPLC; Biologic DuoFlow; Bio-Rad). Fractions were analysed as 
indicated above, and those containing MAEfa-His were pooled, concentrated, and 
stored at -80ºC. 
 
8. Protein analysis 
 
8.1. Determination of protein concentration 
 
The theoretical molecular weight (Da) and the molar extinction coefficient (M-1 
cm-1) were calculated from the amino acid sequence of a protein. These values were 
used for measuring the concentration of a particular protein in solution using a 
Nanodrop (ND-1000) Spectrophotometer (Bio-Rad).  
 
8.2. N-terminal sequencing 
 
The purified MAEfa protein (in buffer VL containing 200 mM NaCl) was 
subjected to amino terminal sequencing by Edman degradation using a Procise 494 
Sequencer (Perkin Elmer) (Protein Chemistry Facility; CIB).  
 
8.3. Protein electrophoresis 
 
8.3.1. Tris-Glycine SDS-PAGE 
 
Protein samples were analysed by SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). The stacking gel contained 4% polyacrylamide in 0.125 M Tris-HCl, pH 
6.8, and 0.1% SDS. The resolving gel contained 10-12% polyacrylamide in 0.374 M 
Tris-HCl, pH 8.8, and 0.1% SDS. TEMED and ammonium persulfate (APS) were used 
to catalyze polyacrylamide gel polymerization. Protein samples were mixed with SLB 
(see Table 4) and heated at 95ºC for 5 min prior to electrophoresis. Gels were run in a 
Mini-Protean III Electrophoresis System (Bio-Rad) using TG buffer (see Table 4). 
Electrophoresis was carried out at 80 V until the dye (bromophenol blue) migrated 
down to the bottom of the stacking gel. Then, the voltage was increased to 180 V. Gels 
were stained with Coomassie Brilliant Blue R-250 (Bio-Rad). 
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8.3.2. Tris-Tricine SDS-PAGE 
 
Proteins smaller than 30 kDa were resolved by Tris-Tricine SDS-PAGE 
(Schägger and von Jagow, 1987). The stacking gel contained 4% polyacrylamide and 1 
ml of Buffer gel (see Table 4). The resolving gel (5 ml) contained 16% polyacrylamide, 
1.65 ml of Buffer gel and glycerol (13%). APS and TEMED were used to catalyze the 
polyacrylamide polymerization. Two different electrophoresis buffers were used, the 
cathode buffer and the anode buffer (see Table 4). Electrophoresis conditions were the 
same as described in the previous Section.  
 
8.4. Gel filtration chromatography 
 
Gel filtration chromatography was used to determine the size (Stokes radius) of 
the MAEfa protein. The protein preparation was subjected to gel filtration 
chromatography as described in Section 7.2, but the column was previously calibrated 
with a set of proteins of known Stokes radius. The standard proteins used were alcohol 
dehydrogenase (ADH; 45 Ǻ), albumin (A; 35.5); ovalbumin (O; 30.5 Ǻ) and carbonic 
anhydrase (CA; 20.1 Ǻ). They were dissolved in buffer VL containing 200 mM NaCl at 
a final concentration of 4 mg/ml. The chromatographic runs were performed under the 
conditions described in Section 7.2. The elution volume of each protein was 
determined monitoring the absorbance at 280 nm. The Kav, an elution volume 
parameter, was calculated for each one as follows: 
Kav = (Ve-V0)/(Vt-V0) 
where Ve is the elution volume, V0 is the void volume (equal to blue dextran elution 
volume) and Vt is the total volume of the packed bed. 
 
8.5. Analytical ultracentrifugation 
 
Analytical ultracentrifugation experiments were performed at the Analytical 
Ultracentrifugation and Macromolecular Interactions Facility of CIB. These experiments 
provided information about the molecular mass of MAEfa as well as the hydrodynamic 
behaviour of the protein. An Optima XL-I analytical ultracentrifuge (Beckman-Coulter) 
equipped with an UV-visible optical detection system was used to perform the 
experiments, using an An50Ti rotor and Epon-charcoal standard double sector 
centerpieces (12 mm optical path).  
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8.5.1. Sedimentation velocity 
 
MAEfa was equilibrated in buffer AU (see Table 4) and two protein 
concentrations (5 and 10 μM; 350 μl) were analysed. Sedimentation velocity 
experiments were performed at 48,000 rpm and 12ºC. The sedimentation coefficient for 
MAEfa was estimated applying a direct linear least-squares boundary modelling of the 
sedimentation velocity data using the SEDFIT program (version 12.0) (Schuck and 
Rossmanith, 2000). The sedimentation coefficient was corrected to standard conditions 
to obtain the corresponding S20,w value using the SEDNTERP program (Laue et al., 
1992) The translational frictional coefficient (f) of MAEfa was determined from the 
molecular mass and sedimentation coefficient of the protein (van Holde, 1985), 
whereas the frictional coefficient of the equivalent hydrated sphere (f0) was estimated 
using a hydration of 0.37 g H2O/g protein (Pessen and Kumosinski, 1985). With these 
parameters the translational frictional ratio (f/f0) was calculated, which allows an 
estimation of the hydrodynamic shape of MAEfa. 
 
8.5.2. Sedimentation equilibrium 
 
Sedimentation equilibrium experiments were performed at 12ºC. Two protein 
concentrations (5 and 10 μM) were analysed. Samples (90 µl) were centrifuged at two 
successive speeds (8,000 and 10,000 rpm) and absorbance readings were done after 
the sedimentation equilibrium was reached. The absorbance scans were taken at 280 
and 291 nm, depending on MAEfa concentration. In all cases, the baseline signals 
were measured after high-speed centrifugation (40,000 rpm). Apparent average 
molecular masses of MAEfa protein were determined using the HETEROANALYSIS 
program (Cole and Michael, 2004). The partial specific volume of MAEfa was 0.742 
ml/g, calculated from the amino acid composition with the SEDNTERP program (Laue 
et al., 1992). 
 
8.6. Western blots 
 
E. faecalis cells were grown to an OD650 of 0.3 (exponential phase) and 2 ml of 
culture were centrifuged to prepare whole-cell extracts. Bacteria were resuspended in 
50 μl of LBW buffer and incubated at 37ºC for 10 min. Then, 13 μl of SLB buffer (5x) 
were added, and the samples were heated at 95ºC for 5 min. Subsequently, 6 µl of 
10% SDS were added to the cell extracts and were heated as before. Equivalent 
amounts of the cell extracts (12 µl samples) were loaded onto a SDS-polyacrylamide 
(10%) gel to separate total proteins. Pre-stained proteins (SeeBlue Plus Invitrogen) 
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were run in the same gel as molecular weight markers. After electrophoresis, the gel 
was equilibrated with TB buffer (see Table 4). Immun-Blot PVDF membranes (Bio-Rad) 
were used for protein blotting. Prior to the transfer, the membrane was soaked in 
methanol followed by equilibration in TB buffer. Proteins were transferred 
electrophoretically to Immun-blot PVDF membranes in TB buffer using a Mini Trans 
Blot (Bio-Rad) at 100 mA and 4ºC for 120 min. Thereafter, the membrane was dried by 
immersion in methanol for 2 min. Membranes were probed with polyclonal antibodies 
against MAEfa raised in rabbits, which were diluted 1:1,000 in SB buffer (see Table 4). 
After 1 h of incubation, the membrane was rinsed five times with WB buffer. 
Subsequently, it was incubated with the secondary antibody for 1 h. The secondary 
antibody, anti rabbit IgG conjugated with horseradish peroxidase (HRP), was diluted 
1:30,000 in SB buffer. The unbound secondary antibody was removed washing the 
membrane with PBS buffer (see Table 4) five times. Antigen-antibody complexes were 
detected using the Immun-StarTM HRP substrate kit (Bio-Rad). The peroxidase linked 
to the secondary antibody catalyzes the oxidation of the substrate (luminol) leading to 
light emission. The light signal was detected with a Luminescent Image Analyzer LAS-
3000 (Fujifilm Life Science) or by autoradiography. 
 
The pneumococcal whole-cell extracts were prepared from cultures grown to 
late logarithmic phase (OD650 of 0.6). Media containing 0.3% sucrose and different 
concentrations of fucose (0.1% to 1%) as carbon source were used. Bacteria were 
concentrated 40-fold in buffer LBP and incubated at 30ºC for 10 min. Then, samples (8 
μl) were mixed with 2 μl of SLB buffer (5x) and heated at 95ºC for 5 min before being 
loaded onto SDS-polyacrylamide (14%) gels. Thus, equivalent amounts of the cell 
extracts (similar number of cells) were loaded onto the gel. The SeeBlue Plus 2 pre-
stained protein standard (Invitrogen) was run in the same gel as a molecular weight 
marker. Protein transfer to the membrane was performed as described above 
(enterococcal whole cell-extracts). Then, primary and secondary antibody incubation 
were carried out as specified by the supplier. The primary antibody was Anti-GFP 
(Roche Applied Science), a mixture of two mouse monoclonal antibodies against the 
green fluorescent protein; and the secondary antibody was Peroxidase-conjugated 
AffiniPure Goat Anti-Mouse IgG (H+L) (Jackson ImmunoResearch).  
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9. DNA-protein interactions 
 
9.1. Electrophoretic mobility shift assays 
 
In general, standard binding reactions (10-20 µl) were performed mixing 10 nM 
of unlabelled DNA or 0.1-5 nM of 5´-labelled DNA with different amounts of purified 
MAEfa or MAEfa-His. The binding buffer contained 30 mM Tris-HCl, pH 7.6; 1 mM 
DTT; 0.2 mM EDTA; 1 % glicerol; 50 mM NaCl, and 0.5 mg/ml BSA. When indicated, 
non-labelled competitor calf thymus DNA was added simultaneously with the 32P-
labelled DNA to the binding reaction. The reaction mixture was incubated at room 
temperature for 20 min. Then, BXGE buffer was added and free and bound DNA forms 
were separated by electrophoresis on native polyacrylamide gels (5-8% PAA, 
depending on the DNA length) using TBE buffer. Gels and running buffer were 
maintained at 4ºC until the pre-electrophoresis was started. Then, gels were pre-run 
(20 min) and run at 100 V (room temperature or 4ºC). Labelled DNA was visualized by 
a Fujifilm Image Analyzer FLA-3000 and quantified with the Quantity One software 
(Bio-Rad).  
 
9.2. DNase I footprinting assays 
 
Binding reactions (50 μl) contained 2 nM of the 5’-labelled DNA fragment; 30 
mM Tris-HCl, pH 7.6; 1 mM DTT; 0.2 mM EDTA; 1 % glicerol; 50 mM NaCl, 0.5 mg/ml 
BSA, 1 mM CaCl2, 10 mM MgCl2 and different concentrations of the MAEfa protein. 
The reactions mixtures were incubated at room temperature for 20 min. DNase I (stock 
solution) was diluted in 50% glycerol to 1:500. DNA was digested by adding 0.04 units 
of DNase I. After incubation for 5 min at room temperature, reactions were stopped by 
adding 25 μl of STOP DNase I buffer. DNA was precipitated with 187 μl of absolute 
ethanol, dried and dissolved in 5 µl of BXF buffer. Then samples were heated at 95ºC 
for 5 min and loaded onto sequencing gels (6% PAA, 8 M urea).   
 
10. Fluorescence measurements 
 
Enterococcal and pneumococcal cells harbouring plasmid (gfp reporter gene) 
were grown to an OD650 of 0.3, except pneumococcal cells carrying pAST-PfcsK or 
pAST-oPfcsK, which were grown to an OD650 of 0.6. Then, different volumes of the 
culture (from 25 μl to 1 ml) were centrifuged at 4ºC, and cells were resuspended in 200 
μl of PBS buffer. Fluorescence was measured either on a LS-50B espectrophotometer 
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(Perkin-Elmer) or on a Thermo Scientific Varioskan Flash instrument (Perkin-Elmer) by 
excitation at 488 nm and detection of emission at 515 nm. The LS-50B 
espectrophotometer (Perkin-Elmer) was used for the experiments shown in Chapter 1. 
The Thermo Scientific Varioskan Flash instrument (Perkin-Elmer) was used for the 
experiments shown in Chapters 2 and 4. In all cases, three independent cultures were 
analysed. The fluorescence corresponding to 200 μl of PBS buffer without cells was 
also measured in each case. 
 
11. Infection models 
 
11.1. Bacterial adhesion to HEp-2 cells  
 
The human epithelial cell line HEp-2 (ATCC CCL23) was cultured in DMEM 
medium (Gibco-ThermoFisher) supplemented with 2 mM glutamine, heat-inactivated 
5% fetal bovine serum (Gibco-ThermoFisher), streptomycin 100 U/ml and penicillin 100 
µg/ml. Cells were incubated at 37°C in an atmosphere containing 7% CO2. Cells were 
passaged every 5 days. Prior to the infections, cells were seeded onto glass cover slips 
placed on the bottom of 4-well culture plates at a density of 2-5 x 105 cell/ well and 
cultivated for 24 h at 37ºC and 7% CO2. To infect the cells, bacteria (strains 
OG1RF/pMV158GFP and OG1RFΔmaEfa/pMV158GFP) were grown to mid-
exponential phase, centrifuged and resuspended into the cell medium to achieve a 
multiplicity of infection of 5:1. Then, bacteria suspensions were added to the epithelial 
cells and were incubated for 2 h at 37ºC and 7% CO2. After that, the cells were washed 
twice with PBS to remove unbound bacteria and further incubated with fresh medium 
supplemented with gentamicin 100 µg/ml, streptomycin 100 U/ml and penicillin 100 
µg/ml. After 2, 3 and 24 h of incubation, cells were fixed in PBS with 2.5% 
paraformaldehyde for 15 min and kept at 4ºC for 24 h. Then, cover slips were washed 
with PBS, mounted on glass slides with Moviol containing 4′,6′-diamidino-2-
phenylindole (DAPI) and analysed by fluorescence microscopy. At each time point, five 
microscopic fields were randomly chosen and photographs were taken. The number of 
cells with bacteria attached was counted. Three independent experiments were 
performed. 
 
11.2. Mice infection 
 
The animal experiments were approved by the appropriate national ethics board 
(Niedersächsisches Landesamt für Verbraucherschutz und Lebensmittelsicherheit, 
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Oldenburg, Germany). Mice were infected intraperitoneal with 5 x 107 CFU of live E. 
faecalis (strains OG1RF and OG1RFΔmaEfa) and euthanized by CO2 inhalation at 24 h 
after bacterial inoculation. The infiltrating inflammatory cells were isolated from the side 
of infection by extensively rinsing with 2 ml of warm DMEM medium. The resulting cell 
suspension was counted using a Neubauer chamber and levels of inflammatory 
neutrophils were determined by flow cytometry analysis using anti-mouse Ly6G/C 
antibody (BD Pharmingen, San Diego, USA). The cell suspension was also used to 
determine the amount of viable bacteria by plating serial dilutions on bile esculin azide 
agar (Fluka) plates and the levels of inflammatory cytokines.  
 
11.2.1 Cytokine determination 
 
The determination of IL-6 levels in the peritoneal lavage was performed by 
specific enzyme-linked immunosorbent assay (ELISA), using matched antibody pairs 
and recombinant cytokines as standards. Briefly, 96-well microtiter plates were coated 
with the corresponding purified anti-murine capture monoclonal anti-IL-6 (Pharmingen, 
San Jose, CA) at a concentration of 2 µg/ml in sodium bicarbonate buffer overnight at 
4°C. The wells were washed and then blocked with 1% bovine serum albumin-PBS 
before the serum samples and the appropriate standard were added to each well. 
Biotinylated rat monoclonal anti-IL-6 (BD Pharmingen) at 2 µg/ml was added as the 
second antibody. Detection was performed with streptavidin-peroxidase, and the plates 
were developed by use of TMB (3,3’,5,5’-tetramethylbiphenyl-4,4’-diamine). 
 
11.2.2. Statistical analysis  
 
Data were analysed using Prism 5 (GraphPad). Statistical significance was 
determined by using the unpaired Student’s t-test for the comparison of two groups. In all 
analyses, P<0.05 was considered statistically significant. 
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Despite the increasing interest in a deeper understanding of the molecular 
biology of E. faecalis, the availability of plasmid-based genetic tools is still limited. We 
have developed several plasmid-based genetic tools which have been very useful to 
address essential questions in the study of the enterococcal maEfa gene. In this 
chapter, we describe the construction of these genetic tools and their validation in E. 
faecalis. Moreover, we show that they are also suitable for S. pneumoniae. The results 
concerning the utility of the pAS terminator-probe vector and the pAST promoter-probe 
vector in E. faecalis and S. pneumoniae were published in 2010 (Ruiz-Cruz et al., 
2010). 
 
1.1. The pAS terminator-probe vector 
 
We have constructed a terminator-probe vector, pAS, based on the pMV158 
replicon. The streptococcal plasmid pMV158 (5540 bp), which is the prototype of a 
family of rolling-circle replicating plasmids (del Solar et al., 1998), is able to replicate 
and confer resistance to tetracycline (gene tetL) in a broad variety of bacterial hosts 
(del Solar et al., 1998; Lacks et al., 1986), including E. faecalis (Nieto and Espinosa, 
2003). Sequence analysis of the region located just downstream of the tetL gene 
revealed the existence of a putative Rho-independent transcriptional terminator (Fig. 
4). It consists of an inverted-repeat followed by a short stretch of thymine residues 
(Lacks et al., 1986). This sequence element is also present in plasmid pLS1, a 
pMV158-derivative that lacks the 1132-bp EcoRI restriction fragment (Lacks et al., 
1986). The efficiency of the tetL inverted-repeat as transcriptional terminator was first 
investigated in our group by primer extension assays (Ruiz-Cruz et al., 2010). Such 
experiments were performed using total RNA isolated from pLS1-carrying S. 
pneumoniae cells. The results obtained suggested that the pneumococcal RNA 
polymerase (RNAP) does not recognize efficiently the tetL inverted-repeat as a stop 
signal (not shown).  
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Figure 4. The transcriptional terminator of the tetL gene. Relevant features of pLS1 are 
indicated. copG and repB genes are involved in plasmid DNA replication. The location of the 
replication origins dso (double-strand origin) and ssoA (single-strand origin) is indicated. The 
tetL gene confers resistance to tetracycline. The nucleotide sequence of the region spanning 
the translation stop codon (TAA) of the tetL gene and the HindIII site (H) is shown. IR: inverted-
repeat, E: EcoRI site. 
 
To confirm this result, we cloned a gfp reporter cassette into the HindIII site of 
plasmid pLS1 (Fig. 5A). The HindIII site is located downstream of the tetL inverted-
repeat. The gfp reporter cassette contains a multiple cloning site (MCS) upstream of a 
promoter-less gfp allele, which encodes a green fluorescent protein (GFP) that carries 
the F64L and S65T mutations (Cormack, 1996; Heim, 1995). The F64L mutation 
increases GFP solubility, while the S65T mutation increases GFP fluorescence and 
causes a red shift in the excitation spectrum. In addition, the gfp allele carries 
translation initiation signals (SD in Fig. 5) which are optimal for its expression in 
prokaryotes (Miller and Lindow, 1997). The gfp cassette was inserted into pLS1 in both 
orientations (plasmids pAS and pSA). In plasmid pAS, the tetL and gfp genes are 
located on the same DNA strand (Fig. 5A). Both plasmids were introduced into S. 
pneumoniae 708 and E. faecalis JH2-2. We analysed gfp expression in cells carrying 
pAS or pAS by measuring the intensity of fluorescence at 515 nm (excitation at 
488 nm) (Fig. 5B). Expression of gfp was detected in pneumococcal and enterococcal 
cells carrying pAS. The fluorescence increased as a function of the culture volume in 
both cases. No gfp gene expression was observed in cells harbouring pSA, which 
confirmed the absence of promoter signals within the gfp reporter cassette. The 
fluorescence corresponding to 0.8 ml culture (OD650 = 0.3; pAS-containing cells) was 3-
fold and 4.5-fold higher than the background level in S. pneumoniae and E. faecalis, 
respectively. Therefore, RNAP read through the tetL inverted repeat not only in S. 
pneumoniae but also in E. faecalis. As a consquence, there is transcription of the gfp 
reporter cassette. This fact and the presence of a MCS between the HindIII site and the 
promoter-less gfp gene suggested that plasmid pAS could be used as a terminator-
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probe vector. This type of vectors makes possible to rapidly test whether a particular 
sequence functions as a transcriptional terminator.  
 
 
 
Figure 5. The pAS terminator-probe vector. (A) The gfp reporter cassette was inserted into 
the HindIII site (H) of the pLS1 plasmid. This cassette contains a multiple cloning site (MCS), 
translation initiation signals optimized for prokaryotes (SD) and a promoter-less gfp allele (Miller 
and Lindow, 1997). Plasmid pSA (control plasmid, not shown) carries the gfp reporter cassette 
inserted in the opposite orientation. S: SalI, H: HindIII, X: XbaI, B: BamHI, Sm: SmaI, Sa: SacI. 
(B) gfp gene expression in plasmid-harbouring cells. S. pneumoniae carrying plasmid pAS (dark 
green) or pSA (dark red). E. faecalis carrying plasmid pAS (light green) or pSA (light red). The 
graph is the mean of three experiments. 
 
To test this hypothesis we selected some predicted or experimentally 
determined Rho-independent terminators from different bacterial genomes. 
Specifically, we inserted independently the following DNA sequences (Fig. 6) into the 
SalI site of the pAS plasmid (see Fig. 5A): 
 
(i) A 246-bp region containing the tandem terminators T1 and T2 of the E. coli 
rrnB ribosomal RNA operon (Brosius, 1981). Such a fragment was inserted 
in both orientations (herein named T1T2rrnB and T2T1rrnB fragments, 
respectively). These terminators have been used frequently in the 
construction of plasmids (Brosius, 1984; Serrano-Heras et al., 2005; 
Simons, 1987). 
 
(ii) A 238-bp DNA fragment containing the transcriptional terminator of the S. 
pneumoniae polA gene (fragment TpolA). By mapping with S1 nuclease, it 
was shown that transcription of the polA gene terminates at the palindrome 
shown in Fig. 6 (López et al., 1989). 
 
(iii) A 265-bp SalI region containing the putative Rho-independent terminator of 
the E. faecalis sigV–rsiV operon (fragment TrsiV). The sigV and rsiV genes 
encode members of the extracytoplasmic function subfamily of eubacterial 
RNAP sigma and anti-sigma factors, respectively (Benachour et al., 2005). 
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Figure 6. Palindromic sequences at the terminator regions analysed in this work. Arrows 
indicate nucleotide sequences corresponding to potential RNA hairpin structures. 
Complementary bases of the hairpin structures are shown in bold. 
 
The recombinant plasmids pAST (fragment T1T2rrnB), pAS-T2T1rrnB, pAS-
TpolA and pAS-TrsiV were introduced into E. faecalis JH2-2 and S. pneumoniae 708. 
The efficiency of the inserted fragments as transcriptional terminators was evaluated by 
monitoring gfp gene expression (Fig. 7). The fluorescence in enterococcal and 
pneumococcal cells carrying the pAS plasmid was 259.54 ± 24.49 and 139.54 ± 13.22, 
respectively. Compared to pAS-carrying cells, the T1T2rrnB and TrsiV fragments 
reduced the intensity of fluorescence to background values in both bacteria. In the case 
of the T2T1rrnB fragment, the fluorescence decreased 1.5-fold and 1.8-fold in 
enterococcus and pneumococcus, respectively. However, the TpolA fragment reduced 
the fluorescence in E. faecalis (3-fold) but not in S. pneumoniae. A further analysis of 
the TpolA fragment using the BPROM prediction program (Softberry, Inc.) revealed a 
near-consensus −10 hexamer (TAgAAT) located 5 nucleotides downstream of the 
TpolA palindrome, as well as a near-consensus extended −10 element (TGTa) (see 
Fig. 6). Thus, activity of this predicted promoter in S. pneumoniae but not in E. faecalis 
might explain why the terminator activity of the TpolA palindrome was only detected in 
E. faecalis. These results demonstrate that plasmid pAS can be used to assess 
whether particular sequences (homologous or heterologous) function as transcriptional 
terminators in E. faecalis and S. pneumoniae. Moreover, we have shown that the 
predicted TrsiV terminator of E. faecalis is active in both bacteria. In our system, it is as 
efficient as the tandem terminators T1 and T2 of E. coli.  
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Figure 7. Use of plasmid pAS as a terminator-probe vector. The intensity of fluorescence in 
enterococcal (A) and pneumococcal cells (B) harbouring the indicated recombinant plasmids 
was measured. Cells were exponentially grown to an OD650=0.3 and the fluorescence (arbitrary 
units) corresponds to 0.8 ml of culture. Each bar represents the mean ± SD of three 
independent experiments. The intensity of fluorescence in cells carrying the control plasmid 
pSA was 58.08 ± 0.64 and 46.32 ± 2.24, respectively.  
 
1.2. The pAST promoter-probe vector 
The bacterial RNAP holoenzyme is a complex of six subunits (α2ββ´ωσ). During 
initiation of transcription, most of the sequence-specific contacts of the RNAP with the 
promoter region are made by the σ subunit. In general, bacterial genomes encode 
diverse forms of the σ factor, which confers promoter specificity to the RNAP (Gruber 
and Gross, 2003; Wigneshweraraj et al., 2008). Most transcription in exponentially 
growing bacterial cells is initiated by RNAP carrying a housekeeping σ factor similar to 
E. coli σ70. This holoenzyme recognizes promoters characterized by two main 
sequence elements, the –35 and –10 hexamers, whose consensus sequence is 5´-
TTGACA-3´ and 5´-TATAAT-3´, respectively. The optimum spacer length between 
these elements is 17 nucleotides. Additionally, some of these promoters contain the 
extended –10 element, which is located one nucleotide upstream of the –10 hexamer. 
This element is more conserved in Gram-positive bacteria (5´-TRTG-3´ motif) than in E. 
coli (5´-TG-3´ motif) (Mitchell et al., 2003; Sabelnikov et al., 1995; Voskuil and 
Chambliss, 1998). Since the sequence elements at numerous promoters have evolved 
to diverge from the consensus, definitive identification of a promoter target for RNAP 
requires the use of diverse experimental strategies, such as the use of promoter-probe 
plasmid vectors (Minchin and Busby, 2009; Ross and Gourse, 2009).  
 
Cloning of the E. coli T1T2rrnB terminator region into the SalI site of the pAS 
terminator-probe vector generated plasmid pAST (5456 bp; see above). This derivative 
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conserves unique restriction sites for XbaI, BamHI, SmaI and SacI between the 
T1T2rrnB region (transcriptional terminator) and the promoter-less gfp gene (see Fig. 
8). To examine whether plasmid pAST is suitable as a promoter-probe vector, we 
selected several DNA fragments containing a predicted or experimentally tested 
promoter from E. faecalis or S. pneumoniae. These regions were independently 
inserted into the BamHI or SacI site of pAST (Figs. 8 and 9). The recombinant plasmids 
were then introduced into E. faecalis JH2-2 and S. pneumoniae 708, and promoter 
activity was evaluated by monitoring gfp expression (Fig. 10).  
 
 
 
Figure 8. Relevant features of the pAST promoter-probe vector. The tetL gene confers 
resistance to tetracycline. T1T2: tandem terminators T1 and T2 of the E. coli rrnB rRNA operon. 
The translation initiation signals (SD) optimized for the expression of the gfp gene in 
prokaryotes are followed by a promoter-less gfp allele. X: XbaI, B: BamHI, Sm: SmaI, S: SacI. 
 
Regarding the enterococcal promoters, we analysed the promoter region of 
three genes from E. faecalis V583: uppS (or cpsA; undecaprenyl diphosphate 
synthase) (Hancock and Gilmore, 2002; Thurlow et al., 2009b), EF2493 (or cpsC; 
putative teichoic acid biosynthesis protein) (Hancock and Gilmore, 2002) and EF2962 
(putative LacI family transcriptional regulator) (Fig. 9). The PuppS and P2493 
promoters were identified by primer extension (Hancock et al., 2003). Promoter PuppS 
promoter has a consensus –10 hexamer and shows a 4/6 match at the –35 element, 
whereas P2493 promoter has near-consensus –10 and –35 hexamers. In the case of 
the EF2962 gene, the BPROM program (Softberry, Inc.) predicted a –10 hexamer (four 
consensus bases) located 56 nucleotides upstream of the initiation codon. This 
promoter has a near-consensus –10 extension and shows a 3/6 match at the –35 
element. Compared to pAST-carrying cells, the P2493 promoter was the strongest 
enterococcal promoter in both E. faecalis and S. pneumoniae (Fig. 10). The activity of 
such a promoter was higher than the PuppS and P2962 promoters. It was 5.2 and 3.2-
fold higher in enterococcus, and 1.6 and 2.3-fold higher in pneumococcus, respectively.  
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Figure 9. Main sequence elements at the promoter regions analysed in this work. The −35 
and −10 hexamers are indicated. The position of the extended −10 element (5′-TRTG-3′ motif) 
is shown. Conserved nucleotides are indicated in bold. 
 
We further analysed the promoter region of the pneumococcal sulA 
(dihydropteroate synthase) and ung (uracil-DNA glycosylase) genes. The PsulA 
promoter, which was identified by primer extension (Lacks et al., 1995; López et al., 
1987), has a near-consensus –10 hexamer and a consensus –10 extension. In the 
case of the ung gene (Méjean et al., 1990), the BPROM prediction program (Softberry, 
Inc.) revealed a consensus –10 hexamer located 28 nucleotides upstream of the 
translation initiation codon and a near-consensus –10 extension (see Fig. 9). In 
enterococcus, the intensity of fluorescence increased only 2-fold when the PsulA 
promoter region was cloned into pAST (plasmid pAST-PsulA) (Fig 10). The activity of 
the PsulA promoter was slightly higher than that of the Pung promoter. Different results 
were obtained in pneumococcus. In this case, the fluorescence increased 10-fold in 
cells harbouring the pAST-Pung recombinant plasmid. The activity of the Pung 
promoter was 1.9-fold higher than that of the PsulA promoter. In conjunction, our 
results demonstrate that plasmid pAST is useful to assess whether particular 
sequences (both homologous and heterologous) function as promoter signals in E. 
faecalis and S. pneumoniae. Among the analysed promoters, we have shown that two 
predicted promoters, Pung and P2962, are active in both bacteria. Furthermore, we 
have demonstrated that, under our experimental conditions, the strongest promoters 
(10-fold increase in fluorescence) are the P2493 promoter in enterococcus and the 
Pung promoter in pneumococcus.  
 
 
 
CHAPTER 1 
 
 
86 
 
 
 
Figure 10. Use of plasmid pAST as a promoter-probe vector. The intensity of fluorescence 
in enterococcal (A) and pneumococcal cells (B) harbouring the indicated recombinant plasmids 
was measured. The fluorescence (arbitrary units) corresponds to 0.8 ml of culture. Each bar 
represents the mean ± SD of three independent experiments.  
 
Next, we analysed whether plasmid pAST can be used for the study of 
regulated promoters. For this purpose, we selected the promoter of the pneumococcal 
fuculose kinase gene (fcsK), the first gene of the fucose operon, which is induced by 
fucose (Chan et al., 2003). This promoter (PfcsK) has a canonical −10 hexamer and a 
near-consensus −35 sequence (TTGAaA). Both sequence elements are separated by 
17 nucleotides. According to primer extension experiments, transcription of the fcsK 
gene starts at an adenine residue located 24 nucleotides upstream of the initiation 
codon (Chan et al., 2003). A 117-bp DNA fragment containing the PfcsK promoter was 
inserted into the XbaI site of the pAST vector, generating plasmids pAST-PfcsK (gene 
gfp under the control of the PfcsK promoter) (Fig. 11A)  and pAST-oPfcsK (fragment in 
the opposite orientation). Both recombinant plasmids were introduced into S. 
pneumoniae 708. Then, we examined whether fucose induces gfp expression in cells 
carrying the pAST-PfcsK plasmid. Cells harbouring pAST-oPfcsK were used as control. 
Since S. pneumoniae is unable to grow in media containing fucose as the sole carbon 
source (Chan et al., 2003) bacteria were grown in media containing 0.3% sucrose and 
different concentrations of fucose to late logarithmic phase (OD650=0.6). The bacterial 
growth rate was similar under the various conditions assayed (not shown). In a first 
approach, gfp expression was analysed by Western blotting using monoclonal GFP 
antibodies (Fig. 11B). A protein band was detected in cells carrying pAST-PfcsK but 
not in control cells (plasmid pAST-oPfcsK). Since pre-stained proteins were run in the 
same gel, exposition of the blot to X-ray films allowed us to determine that such a band 
had the mobility expected for GFP (~28 kDa) (not shown). The Western blot analysis 
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revealed a basal level of gfp expression in cells grown without fucose. However, 
compared to cells grown without fucose, the intensity of the GFP band was 4.5-fold 
higher in cells grown with 1% fucose. Hence, the PfcsK promoter cloned into the pAST 
vector is activated by fucose. 
 
 
 
Figure 11. Fucose-induction of gfp expression in pneumococcal cells carrying plasmid 
pAST-PfcsK. Cells were grown in media containing 0.3% sucrose and the indicated amount of 
fucose to an OD650=0.6. Cells harbouring plasmid pAST-oPfcsK were used as control. (A) 
Relevant features of the pAST-PfcsK plasmid. T1T2: tandem terminators T1 and T2 of the E. 
coli rrnB rRNA operon. The translation initiation signals (SD) are followed by a promoter-less gfp 
allele. B: BamHI, Sm: SmaI, S: SacI. (B) Western blot analysis using antibodies against GFP. 
Total proteins from cell extracts were separated by SDS-PAGE (14% polyacrylamide). Pre-
stained proteins (Invitrogen) were run in the same gel as molecular weight markers (not shown). 
(C) Intensity of fluorescence in cultures (400 μl) of pneumococcal cells carrying the pAST-PfcsK 
plasmid. The intensity of fluorescence in cultures of cells carrying the pAST-oPfcsK plasmid was 
43.22 ± 2.30 in the absence of fucose and 41.15 ± 1.81 in the presence of 1% fucose. In each 
case, three independent cultures were analysed. 
 
These results were further confirmed by fluorescence assays (Fig. 11C). In the 
absence of fucose, the fluorescence in cells carrying pAST-PfcsK (64.66 ± 5.95 units) 
was slightly higher than in cells harbouring pAST-oPfcsK (43.22 ± 2.30; control cells). 
Thus, there is a low basal level of gfp expression. Moreover, the fluorescence in cells 
carrying pAST-PfcsK increased as a function of the fucose concentration (from 0.1% to 
1%). Specifically, a 5-fold increase in fluorescence was observed when the medium 
was supplemented with 1% fucose (Fig. 11C). Therefore, we conclude that plasmid 
pAST is a useful vector for in vivo studies of regulated promoters. 
 
1.3. The pDLF and pDLS expression vectors 
 
To date, the availability of plasmid-based expression vectors to clone 
homologous and heterologous genes in E. faecalis is very scarce. Since such a tool 
was essential for in vivo studies of the maEfa gene, we constructed two expression 
vectors named pDLF and pDLS. They are based on the pDL287 plasmid, a pVA380-1 
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derivative which carries a kanamycin resistance gene and replicates via the rolling 
circle mode (LeBlanc et al., 1993). Vector pDLF (Fig. 12) was constructed by cloning a 
194-bp that contains the enterococcal P2493 promoter (Hancock et al., 2003) into the 
ClaI site of pDL287. To construct the pDLS vector (Fig. 12), a 202-bp region that 
contains the pneumococcal PsulA promoter (Lacks et al., 1995; López et al., 1987) was 
inserted into the ClaI site of pDL287. As shown in Figure 10, unlike in pneumococcal 
cells, the P2493 promoter was stronger than the PsulA promoter in enterococcal cells. 
Both expression vectors contain an engineered restriction site for SphI downstream of 
the inserted promoters (see Fig. 12). Promoter-less genes inserted into SphI can be 
expressed not only in E. faecalis (see Results, Section 4.4) but also in S. pneumoniae 
(unpublished results).  
 
 
 
Figure 12. Expression vectors pDLF and pDLS. Promoters P2493 (yellow) and PsulA (pink) 
were inserted into the ClaI site of the pDL287 plasmid (LeBlanc et al., 1993). Both plasmids 
carry an engineered restriction site for SphI downstream of the promoter. Relevant features of 
pDL287 are indicated: rep gene is involved in plasmid DNA replication; mob gene encodes a 
mobilization protein; and kan gene confers kanamycin resistance. The location of the replication 
origin (ori) is indicated.  
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In this chapter, we show that the maEfa gene is transcribed in different E. 
faecalis strains under standard bacterial growth conditions. We have identified the 
promoter of the maEfa gene (promoter Pma) using several in vivo approaches: RT-
PCR assays, promoter-reporter fusions (vector pAST) and primer extension 
experiments. Moreover, using the pAS terminator-probe vector, we have found that 
there is a functional transcriptional terminator upstream of the Pma promoter. 
 
2.1. Genetic organization of the maEfa region  
 
The complete genome sequence of the enterococcal V583 strain was published 
in 2003 (Paulsen et al., 2003) (GenBank AE016830.1). The EF3013 gene (here named 
maEfa) encodes a potential transcriptional regulator of the Mga/AtxA family. The ATG 
codon at coordinate 2889087 is likely the translation start site of the maEfa gene 
(locus_tag EF3013) (Fig.13). Translation from this ATG codon would generate a 
protein of 482 residues (MAEfa) as there is a stop codon (TAA) at coordinate 2890535. 
Downstream of the stop codon, there is a putative Rho-independent transcriptional 
terminator (coordinates 2890541- 2890576). The maEfa gene is flanked by two 
uncharacterized genes, the EF3012 (coordinates 2887814-2888395) and EF3014 
genes (coordinates 2890541-2893093), which are predicted to encode a membrane 
protein and a cation transporter E1-E2 family ATPase, respectively. The maEfa and 
EF3014 genes are located on different strands. According to the BioCyc database 
(www.biocyc.org), the three genes would be transcribed as monocistronic mRNAs. In 
the enterococcal OG1RF strain, whose genome sequence was published in 2008 
(Bourgogne et al., 2008) (GenBank CP002621.1), the maEfa gene (locus_tag 
OG1RF_12293; coordinates 2421605 to 2423053) is conserved. It encodes a protein 
that differs from the MAEfa protein of V583 strain in five amino acid residues (A37T, 
Q131L, M145T, S193N, I388S). Genes flanking the maEfa gene are also conserved in 
strain OG1RF. Regarding the enterococcal JH2-2 strain, we determined the nucleotide 
sequence of a chromosomal region (3383 nucleotides) that includes the corresponding 
EF3012 and maEfa genes. It also contains part of the corresponding EF3014 gene (the 
last 612 nucleotides). Compared to strain V583, MAEfa from strain JH2-2 has five 
amino acid changes (K133N, T139M, M145T, A152E, I388S). 
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Figure 13. Genetic organization of the maEfa region (locus_tag EF3013) in the E. faecalis 
V583 genome. The coordinates of the predicted start and stop codons are shown. The 
nucleotide sequence of the region spanning coordinates 2889098 to 2888965 is shown. The 
stop codon (TAG) of EF3012 and the start codon (ATG) of maEfa are indicated in boldface 
letters. The transcription start site (+1 position) of the maEfa gene, and the main sequence 
elements (-35 box and -10 box) of the Pma promoter identified in this work are indicated. IR: 
inverted-repeat. 
 
2.2. Identification of the Pma promoter 
 
To examine whether the maEfa gene is transcribed in strains V583, OG1RF 
and JH2-2 under standard bacterial growth conditions, RT-PCR experiments were 
performed. Total RNA was isolated from the three strains. The oligonucleotide A (Fig. 
14), which anneals to an internal region of the maEfa gene, was used for cDNA 
synthesis. The cDNA products were further amplified by PCR (Fig. 14). With 
oligonucleotides A and B, a PCR product that migrated at the position expected for a 
439-bp DNA was synthesized. No PCR products were detected using oligonucleotides 
A and C, although they were able to amplify a fragment of 498-bp when chromosomal 
DNA was used as template (positive control). Results shown in Figure 14 correspond 
to strain V583. Similar results were obtained using total RNA from strains OG1RF and 
JH2-2. Moreover, we performed RT-PCR assays using oligonucleotide D for cDNA 
synthesis. Further amplification of the cDNA molecules with oligonucleotides D and B 
generated a product of 1427-bp (not shown). These results demonstrated that maEfa is 
transcribed in the three strains studied under standard laboratory conditions. In 
addition, we delimited that maEfa transcription starts between coordinates 2889039 
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and 2889098 of the V583 genome (Fig. 14). The nucleotide sequence of such a 60-bp 
region is identical in strains OG1RF and JH2-2. 
 
 
 
Figure 14. Transcription of maEfa in vivo. RT-PCR assays using total RNA from V583 cells. 
The position of the four primers (A, B, C and D) used in the experiment is shown. RT-PCRs 
samples (lanes R) were analysed by agarose (0.8%) gel electrophoresis. The sizes (in bp) of 
the DNA regions amplified by PCR using chromosomal DNA and the corresponding pair of 
primers (lanes P; positive control) are indicated. RT-PCRs without adding the reverse 
transcriptase were also performed (lanes N; negative control). The sizes (in bp) of DNA 
fragments (lane M) used as molecular weight markers (HyperLadder I, Bioline) are indicated on 
the right of the gel. 
 
To determine the transcription initiation site of the maEfa gene, we performed 
primer extension assays using total RNA from V583 cells and different primers. 
Nevertheless, we failed to identify such a site suggesting that the amount of maEfa 
transcripts in the RNA preparations was small. To amplify the signal, a 214-bp region of 
the V583 genome (Pma region; coordinates 2888864 to 2889078) was inserted into the 
SacI site of the pAST promoter-probe vector (Fig. 15). The pAST-Pma recombinant 
plasmid was then introduced into the enterococcal JH2-2 strain. The intensity of 
fluorescence in cells harbouring plasmid pAST-Pma was 2.2-fold higher than in pAST-
containing cells (Fig. 15), indicating that the Pma region contained a promoter signal. 
Sequence analysis of the 214-bp Pma region revealed the existence of a putative 
promoter (Pma) (Fig. 13), which shows a 4/6 match at the -10 hexamer (5´-TATTCT-
3´) and a 5/6 match at the -35 hexamer (5´-TTGACC-3´) (consensus residues are 
shown in bold). The -35 and -10 elements are separated by 17 nucleotides. Additional 
experiments confirmed that promoter Pma drives transcription of the gfp gene in 
plasmid pAST-Pma. Firstly, a deletion of 19 nucleotides in the Pma region (Pma19 
region, coordinates 2888864 to 2889059) reduced the intensity of fluorescence to 
background levels (cells harbouring plasmid pAST-Pma19 versus cells harbouring 
pAST) (Figs. 13 and 15). Such a deletion removes the -10 element of the Pma 
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promoter (Fig. 15). Secondly, two cDNA extension products of 108 and 109 nucleotides 
were detected using total RNA from cells harbouring plasmid pAST-Pma and the 
INTgfp primer (it anneals to gfp transcripts) (Fig. 16). Thus, transcription of the gfp 
gene starts at the proper distance of 6-7 nucleotides from the -10 element of the Pma 
promoter. These results demonstrate that the Pma promoter is functional in vivo under 
our bacterial growth conditions.  
 
 
 
Figure 15. Fluorescence assays. (A) Activity of the Pma promoter. The promoter-probe vector 
pAST is described in this work (Fig. 8). Genes tetL (tetracycline resistance determinant) and gfp 
(green fluorescence protein) are indicated. The T1T2 box represents the tandem terminators T1 
and T2 of the E. coli rrnB rRNA operon. The coordinates of the V583 DNA regions are indicated. 
The stem-loop structure represents the inverted-repeat (IR) identified upstream of the Pma 
promoter (this work). (B) Role of the IR element. The terminator-probe vector pAS is described 
in this work (Fig. 5). The intensity of fluorescence (arbitrary units) corresponds to 0.8 ml of 
culture (OD650=0.3). In each case, three independent cultures were analysed. 
 
Sequence analysis of the region located between the TAG stop codon of the 
locus_tag EF3012 (coordinate 2888995) and the Pma promoter revealed the existence 
of an inverted-repeat followed by a short stretch of thymine residues (IR element) (Fig. 
13). This sequence element has the features of a Rho-independent transcriptional 
terminator. To examine the efficiency of this IR element as transcriptional terminator, 
we inserted the Pma19 region (196-bp; coordinates 2888864 to 2889059) into the 
pAS terminator-probe vector. The recombinant plasmid pAS-Pma19 (Fig. 15) was 
introduced into strain JH2-2. Compared to pAS-carrying cells, the intensity of 
fluorescence was 6.4-fold lower in cells harbouring plasmid pAS-Pma19 (Fig. 15). 
Thus, there is a functional transcriptional terminator signal upstream of the Pma 
promoter. 
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Figure 16. Initiation of transcription at the Pma promoter. Primer extension reactions were 
carried out using total RNA from JH2-2 cells harbouring plasmid pAST-Pma. The main 
sequence elements of the Pma promoter (-35 and -10 boxes), and the ATG initiation codon of 
the gfp gene are indicated. The SacI site is underlined. The asterisks indicate the 3´-end of the 
cDNA products synthesized using the INTgfp primer. The sizes of the cDNA products (lane R) 
are indicated in nucleotides on the right of the gel. Dideoxy-mediated chain-termination 
sequencing reactions (M13mp18 DNA and primer -40 M13) were used as DNA size markers 
(lanes A, C, G, T). 
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In this chapter, we show that the organization of predicted functional domains in 
MAEfa is similar to that found in the members of the Mga/AtxA family of global 
transcriptional regulators. We also describe a protocol to overproduce and purify an 
untagged form of the MAEfa protein. The purity grade of the protein preparations has 
allowed us to study the oligomerization state of MAEfa by gel filtration chromatography 
and analytical ultracentrifugation (sedimentation velocity and sedimentation equilibrium 
assays).  
 
3.1. MAEfa is a potential member of the Mga/AtxA family of global 
transcriptional regulators  
 
The organization of predicted functional domains in MAEfa resembles that 
found in the members of the Mga/AtxA family of transcriptional regulators (Mga, AtxA 
and MgaSpn). According to the conserved domain database of the National Center for 
Biotechnology Information (NCBI) (Marchler-Bauer et al., 2015), MAEfa has two 
putative DNA-binding domains within the N-terminal region, the HTH_Mga (Family 
PF08280, residues 11 to 69) and Mga (Family PF05043, residues 76 to 164) domains, 
and an EIIB-like motif at the C-terminal region (residues 407 to 476) (Fig. 17). Two 
DNA-binding domains and an EIIB-like motif are also present in Mga, AtxA and 
MgaSpn (Hammerstrom et al., 2015; Hondorp et al., 2013; Solano-Collado, 2014; 
Solano-Collado et al., 2013). In Mga, the two DNA-binding domains were shown to be 
required for DNA binding and transcriptional activation (McIver and Myles, 2002; 
Vahling and McIver, 2006). Analysis of MAEfa with the protein structure prediction 
server Phyre2 (Kelley and Sternberg, 2009) revealed that the central region of MAEfa 
has structural homology to PTS regulatory domains (PRDs) (residues 171 to 389) (Fig. 
17). The Mga, AtxA and MgaSpn proteins are also PRD-containing global regulators 
(Hammerstrom et al., 2015; Hondorp et al., 2013; McIver and Myles, 2002; Solano-
Collado, 2014; Vahling and McIver, 2006). It has been shown that the activity of AtxA is 
modulated by phosphorylation of histidine residues within the PRDs (Hammerstrom et 
al., 2015; Tsvetanova et al., 2007), and this is likely a general feature of the Mga/AtxA 
family of regulators. In fact, Mga can be phosphorylated in vitro by components of the 
PTS (Hondorp et al., 2013). 
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Figure 17. Predicted functional domains in MAEfa. Predicted domains according to in silico 
analysis using Conserved Domain Database (CDD) and Phyre2 programs (Kelley and 
Sternberg, 2009; Marchler-Bauer et al., 2015). MAEfa contains at the N-terminal region two 
putative DNA binding domains: the HTH-Mga and Mga motifs. The central region is predicted to 
have structural homology to PTS regulatory domains (PRD). The C-terminal region has a 
putative EIIB-like motif. 
 
The three-dimensional structures of MAEfa (EF3013; PDB 3SQN) ((Osipiuk, 
2011), unpublished results) and AtxA (PDB 4R6I) (Hammerstrom et al., 2015) have 
been solved. Both proteins crystallize as dimers. The closest structural homolog for the 
AtxA C-terminal region (EIIB-like motif) is the C-terminal region of MAEfa 
(Hammerstrom et al., 2015). Moreover, it has been reported that the closest overall 
protein structure identified with similarity to Mga was the crystal structure of MAEfa 
(Hondorp et al., 2013). In conjunction, these observations suggest that MAEfa is a 
potential member of the Mga/AtxA family of transcriptional regulators.  
 
3.2. Purification of an untagged form of MAEfa  
 
The protocol used to overproduce and purify an untagged form of MAEfa is 
essentially based on the one described previously for MgaSpn (Solano-Collado et al., 
2013). This protocol is explained in detail in Methods (Section 7.1). The maEfa gene 
from the enterococcal strain V583 was cloned into the inducible expression vector 
pET24b, and the recombinant plasmid (pET-maEfa) was introduced into the E. coli 
BL21 (DE3) strain. The maEfa gene is under the control of a promoter that is 
recognized by the T7 RNAP. The BL21 (DE3) strain carries the T7 RNAP-encoding 
gene fused to the lacUV5 promoter, which is an IPTG-inducible promoter. Thus, 
expression of the maEfa gene is induced when IPTG is added to the bacterial cultures 
(Fig. 18, lanes 1 and 2). Various bacterial growth conditions and IPTG concentrations 
were assayed to define the optimal conditions (TY medium, 37ºC and 1 mM IPTG) for 
maEfa gene expression. The large-scale purification of the MAEfa protein (Fig. 18) 
involved essentially four steps: (i) nucleic acids and some DNA-binding proteins, 
including MAEfa, were precipitated with PEI at a low ionic strength; (ii) the MAEfa 
protein was eluted from the PEI pellet using a higher ionic strength buffer; (iii) the 
sample was subjected to heparin affinity chromatography and (iv) the protein 
preparation was loaded onto a gel-filtration column. Protein fractions were analysed in 
each step of the purification process using Coomassie-stained SDS-Tris-Glycine 
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polyacrylamide (12%) gels (Fig. 18). Under these conditions, MAEfa migrated between 
the 45 and 66 kDa bands of the molecular weight marker (Fig. 18), which agrees with 
the theoretical molecular weight of the MAEfa monomer (56,247 Da; 482 residues). 
The final protein preparation was more than 95% pure as it was shown using 
Coomassie-stained overloaded gels. Additionally, SDS-Tricine-PAGE (16%) was 
performed to rule out the presence of proteins smaller than 30 kDa. Determination of 
the N-terminal amino acid sequence of MAEfa by Edman degradation showed that the 
first Met residue was not removed in the purified protein. 
 
 
 
Figure 18. Purification of MAEfa. Fractions of the different purification steps were analysed by 
electrophoresis on SDS-Tris-Glycine polyacrilamide (12%) gels. From lane 1 to 3: induction of 
maEfa gene expression; (1) uninduced cultures; (2) maEfa expresion induced with IPTG for 30 
min; (3) after treatment with rifampicine for 1 h. From lanes 4 to 11: purification steps: (4) 
supernatant of a clear lysate (5) supernatant after PEI precipitation at low ionic strength; (6-7) 
proteins eluted from the PEI pellet using the same low ionic strength buffer; (8) proteins eluted 
from the PEI pellet using a higher ionic strength buffer; (lanes group 9) heparin affinity 
chromatography: proteins retained in the column were eluted with a salt gradient (0.2-0.6 M 
NaCl); (lanes group 10) gel filtration chromatography, (11) final protein preparation after 
concentration. M indicates the molecular weight standards (in kDa). 
 
3.3. MAEfa forms dimers in solution 
To study the oligomerization state of MAEfa in solution and its hydrodynamic 
properties, we performed gel filtration chromatography and analytical ultracentrifugation 
experiments. First, to determine the molecular size (Stokes radius) of MAEfa, we 
carried out gel filtration chromatography using a running buffer that contained 200 mM 
of NaCl. The elution profile is shown in Figure 19. MAEfa eluted from the column as a 
single peak, and the elution volume was used to calculate the Kav value, (see Methods 
Section 8.4). To calibrate the column, several standard proteins of known Stokes 
radius were loaded and their corresponding values of Kav was calculated. The Stokes 
radius of MAEfa determined from the calibration curve, ((-logKav)
1/2 versus the Stokes 
radius) (Fig. 19B) was 43 Å, which is slightly lower than the Stokes radius of the 
alcohol dehydrogenase protein (45 Å), with a molecular weight of 150 kDa. Since the 
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molecular weight of the MAEfa monomer calculated from its amino acid sequence is 
56,247 Da, the protein appears to be a dimer under our experimental conditions  
 
 
 
Figure 19. Determination of the Stokes radius of MAEfa. (A) Elution profile of MAEfa on the 
gel filtration column HiLoad Superdex 200 (Amersham) at a flow rate of 1 ml/min. The inset 
shows an analysis of the eluted protein by SDS-polyacrilamide (12%) gel electrophoresis. The 
molecular weight (in kDa) of proteins used as markers. (B) Calibration plot using proteins of 
known Stokes radii: alcohol dehydrogenase (ADH; 45 Å), albumin (A; 35 Å), ovalbumin (O; 30.5 
Å) and carbonic anhydrase (CA; 20.1 Å). Stokes radius of MAEfa was determined by 
interpolation. 
 
 To corroborate the previous result, analytical ultracentrifugation experiments 
(sedimentation velocity and sedimentation equilibrium) were carried out at 5 and 10 μM 
(Fig. 20). In both cases, sedimentation velocity profiles showed a major peak (92-98%, 
respectively), with an S20,w value of 6 S. Samples were also analysed by sedimentation 
equilibrium. At 5 µM, the experimental data are best fit to an average molecular mass 
(Mw,a) of 118,000 ± 1,000 Da, a value that corresponds with the theoretical mass of a 
MAEfa dimer (112,495 Da). A similar average molecular mass was determined at 10 
μM (121,000 ± 1,000 Da). The frictional ratio (f/f0) calculated was 1.34, indicating that 
the dimer of MAEfa deviates from the behaviour expected for a rigid spherical particle 
(f/f0=1). From these results, we conclude that, under the conditions tested, MAEfa 
forms dimers in solution. 
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Figure 20. Analytical ultracentrifugation analysis of MAEfa. Sedimentation equilibrium 
profile of MAEfa (5 µM) at 10,000 rpm and 12ºC. The lower part shows the experimental data 
(circles) and the best fit (solid line) to a single species with a Mw,a=118,000. The upper part 
shows the residuals to the fit. The inset shows the sedimentation coefficient distribution 
determined for the same MAEfa protein sample at 48,000 rpm and 12ºC.  
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In this chapter, we analyse the interaction of MAEfa with DNA by gel retardation 
and footprinting experiments. We demonstrate that MAEfa binds to linear double-
stranded DNA generating multimeric complexes. MAEfa does not seem to recognize a 
specific nucleotide sequence. Moreover, we show that MAEfa binds preferentially to a 
site located upstream of the promoter of its own gene (promoter Pma). This site 
contains a potential intrinsic curvature. 
  
4.1. MAEfa generates multimeric complexes on linear double-stranded 
DNA 
 
The Mga global transcriptional regulator from S. pyogenes was shown to 
activate the transcription of its own gene by binding to a region located upstream of the 
major promoter (McIver et al., 1999). In addition, the MgaSpn protein of S. pneumoniae 
is able to bind to the promoter of its own gene as primary binding site (Solano-Collado 
et al., 2013), although it has not yet been determined whether binding of MgaSpn to 
such a site influences the expression of its own gene in vivo. For these reasons to 
investigate the DNA binding properties of the untagged MAEfa protein, we performed 
electrophoretic mobility shift assays (EMSA) using, firstly, a linear double-stranded 
DNA (dsDNA) fragment that contains the promoter of the maEfa gene (Pma) (see 
Fig.13 in Chapter 2). This DNA fragment (217-bp; coordinates 2888932-2889148) was 
radioactively labelled at the 5’-end of the non-coding strand. The labelled DNA (2 nM) 
was incubated with increasing concentrations of MAEfa (20 to 360 nM) in the presence 
of non-labelled competitor calf thymus DNA (5 μg/ml) (Fig. 21A). The binding 
conditions were those described in Methods, Section 9.1. Free and bound DNAs were 
separated by electrophoresis on a native polyacrylamide (6%) gel. Labelled DNA 
bands were visualized using a Fujifilm Image Analyzer (FLA‐3000). At the lower 
concentration of MAEfa, a DNA-protein complex was observed. When the protein 
concentration was raised, higher-order complexes appeared gradually, while 
complexes moving more rapidly disappeared. This result suggests that multimeric 
DNA-protein complexes are generated by sequential binding of several MAEfa units to 
the DNA molecule.  
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Figure 21. Detection of MAEfa‐DNA complexes by EMSA. The 217-bp DNA fragment 
(coordinates 2888932- 2889148) was radiolabelled at the 5’-end of the non-coding strand. Free 
and bound DNAs were resolved on a native polyacrilamide gel (6%). Labelled bands were 
visualized with a Fujifilm Image Analyzer (FLA- 3000). (A) Formation of multimeric MAEfa-DNA 
complexes: the labelled DNA fragment (2 nM) was incubated with increasing amounts of MAEfa 
in the presence of non-labelled calf thymus DNA (5 µg/ml); (B) Dissociation experiments: the 
labelled DNA (2 nM) was mixed with 260 nM of MAEfa (formation of higher-order complexes), 
and then competed with the indicated amount of non-labelled calf thymus DNA.  
 
Furthermore, we performed dissociation experiments using the 32P-labelled 
217-bp DNA fragment and non-labelled competitor calf thymus DNA (Fig. 21B). In this 
assay, the 217-bp DNA (2 nM) was mixed with MAEfa (260 nM) and incubated for 20 
min at room temperature (formation of higher-order complexes). Then, increasing 
amounts of the competitor DNA were added to the reaction mixtures and they were 
incubated for 5 minutes at the same temperature. As the concentration of the 
competitor was increased, higher-order complexes disappeared, whereas complexes 
moving faster and free DNA appeared progressively. Thus, the dissociation of the 
protein units from the higher-order complexes was sequential. The appearance of free 
217-bp DNA molecules indicated that the competitor DNA was able to displace all the 
protein units bound to the DNA molecule. We have also performed dissociation 
experiments using supercoiled plasmid DNA (pMV158) as competitor DNA (not 
shown). Our results show that MAEfa binds not only to linear dsDNA but also to 
supercoiled DNA.  
 
To further analyse the DNA-binding properties of MAEfa, we determined the 
time required for the reaction mixture to reach the equilibrium (Fig. 22A). In this 
experiment, MAEfa (100 nM) was mixed with the non-labelled 217-bp DNA fragment 
(10 nM) under standard conditions (50 mM NaCl). After different incubation times (2.5–
8.5 min), the reactions mixtures were loaded onto running gels (200 V). When the last 
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sample entered the gel, the voltage was reduced to 100 V. Under these conditions, the 
loading process itself acts to quench the association reaction, since the free DNA 
begins to be separated from complexes as soon as the sample is loaded onto the 
running gel (Carey, 1991). A faint band of free DNA and six protein-DNA complexes 
were detected at 2.5 min. The amount of the different complexes did not change at 
longer incubation times, indicating that the reactions had already reached the 
equilibrium at 2.5 min. A similar experiment was performed using a higher 
concentration of NaCl (200 mM). In this assay, the incubation time varied from 2 min to 
10 min (not shown). Free DNA and six complexes were detected at 2 min. Their 
amount was similar at 10 min, confirming that the protein-DNA binding reaction 
reaches the equilibrium very fast.  
 
 
 
Figure 22. Binding of MAEfa to DNA under different conditions. The non-labelled 217-bp 
DNA fragment was used in both experiments. Free and bound DNAs were separated by native 
polyacrylamide (6%) gel electrophoresis. Bands were stained with GelRed (Biotium) and 
visualized using a Gel Doc system (Bio-Rad). (A) Time course formation of the DNA-protein 
complexes: the DNA fragment (10 nM) was mixed with 100 nM of MAEfa. Then, samples were 
incubated for the indicated time (from 2.5 to 8.5 min) and loaded onto the running gel (200 V). 
(B) Effect of NaCl concentration on the formation of MAEfa-DNA complexes: MAEfa (200 nM) 
was incubated with DNA (10 nM) in the presence of the indicated concentration of NaCl.  
 
The DNA-binding ability of some proteins is highly dependent on the salt 
concentration of the reaction mixture (Laniel et al., 2001). We have analysed the effect 
of NaCl concentration on the MAEfa-DNA binding reaction. The non-labelled 217-bp 
DNA fragment (10 nM) was mixed with MAEfa (200 nM). The reaction mixtures 
contained different concentrations of NaCl (20-300 mM). As shown in Figure 22B, at 
high salt concentrations (150-300 mM), a slight increase in the amount of free DNA and 
a small decrease in the amount of higher order-complexes was observed. Thus, high 
concentrations of NaCl affect slightly the binding of MAEfa to DNA. The results were 
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similar when the experiment was performed at a lower concentration of MAEfa (100 
nM) (not shown).  
 
4.2. MAEfa does not appear to recognize a specific nucleotide sequence  
 
MAEfa is thought to be a member of the Mga/AtxA family of global response 
regulators. A general feature of these regulators seems to be their ability to bind to 
DNA with little or no sequence specificity (Hause and McIver, 2012; Solano-Collado et 
al., 2013). Therefore, we analysed the binding of MAEfa to additional dsDNA fragments 
by EMSA (Fig. 23). Specifically, we used a 321-bp DNA from the enterococcal V583 
chromosome (coordinates 94488–94808) and a 322-bp DNA from the pneumococcal 
R6 chromosome (coordinates 1598010–1598331). Although these fragments have a 
similar A+T content (72.3% and 71.1%, respectively), sequence similarities are not 
apparent. Both DNA fragments were radioactively labelled. The labelled DNAs (1 nM) 
were incubated with increasing concentrations of MAEfa in the presence of non-
labelled competitor calf thymus DNA (1 μg/ml). In both cases, MAEfa generated a 
pattern of DNA-protein complexes similar to that generated on the 217-bp DNA (Fig. 
21A). Thus, MAEfa does not appear to recognize a specific nucleotide sequence. 
Moreover, these results support that MAEfa is able to form multimeric complexes on 
linear dsDNA. 
 
 
 
Figure 23. MAEfa binds to linear dsDNAs with low sequence specificity. EMSAs were 
carried out using a 321-bp DNA fragment from the enterococcal V583 chromosome and a 322-
bp DNA fragment from the pneumococcal R6 chromosome. Both DNA fragments (1 nM) were 
radiolabelled and incubated with increasing amounts of MAEfa in the presence of non-labelled 
calf thymus DNA (1 μg/ml). Bands corresponding to free DNA (F) and MAEfa-DNA complexes 
(C1 to C4) are indicated.  
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4.3. MAEfa-His also generates multimeric complexes 
 
We have also overproduced and purified a His-tagged MAEfa protein (MAEfa-
His). It carries the Leu-Glu-6xHis tag fused to its C-terminus. To investigate whether 
this variant of the MAEfa protein binds to linear dsDNA, we performed EMSA 
experiments using two different DNA fragments from the enterococcal V583 
chromosome: a 260-bp DNA fragment (coordinates 2888858-2889117), which includes 
the Pma promoter, and a 321-bp DNA fragment (coordinates 94488–94808) from a 
region unrelated to the maEfa gene. Apparently, these fragments do not have 
sequence identity. As shown in Figure 24, MAEfa-His binds to both DNA fragments 
forming a pattern of complexes which is similar to that formed by MAEfa protein on 
such DNAs (not shown). This result indicates that the eight amino acid peptide fused to 
the C-terminal end of MAEfa does not affect its ability to generate multiple DNA-protein 
complexes.  
 
 
 
 
 
Figure 24. MAEfa-His binds to linear dsDNA 
forming multiple complexes. EMSA analysis 
of the interaction of MAEfa-His with two DNA 
fragments of the V583 chromosome. The non-
labelled 321-bp and 260-bp DNAs were mixed 
with the indicated amounts of MAEfa-His. DNA 
was stained with GelRed (Biotium) and 
visualized using a Gel Doc system (Bio-Rad). 
 
 
 
 
 
4.4. Binding of MAEfa to small DNA fragments 
 
Next, we analysed the minimum DNA size required for MAEfa binding by EMSA 
experiments. We used DNA fragments of 20, 26, 32 and 40 bp. These fragments, 
which were obtained by annealing of complementary oligonucleotides, had been 
previously used in our laboratory to determine the minimum DNA size required for 
MgaSpn binding (Solano-Collado, 2014; Solano-Collado et al., 2013). The 
oligonucleotides carry sequences from the pneumococcal R6 chromosome. The non-
labelled DNA fragments were incubated with increasing concentrations of MAEfa. In 
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the case of the 20-bp DNA fragment, a faint band was observed at 0.3 µM of MAEfa 
(Fig 25A). However, its intensity did not change significantly as the protein 
concentration was increased. Most of the DNA molecules moved as free DNA even at 
high concentrations (4.8-9 µM). A similar result was obtained with the 26-bp DNA 
fragment. As shown in Figure 25B, most of the 26-bp DNA moved as free DNA at 4 µM 
of MAEfa. Different results were obtained with the 32-bp and 40-bp DNA fragments 
(Fig. 25B and C). In both cases, as the protein concentration was increased, the 
amount of free DNA decreased. Furthermore, a MAEfa-DNA complex was detected at 
0.2 µM of MAEfa, and the amount of such a complex increased at high protein 
concentrations (4-5 µM). From these results we conclude that the minimum DNA size 
required for MAEfa binding is between 26 and 32 bp.  
 
 
 
Figure 25. Binding of MAEfa to small DNA fragments. EMSA experiments were performed 
with DNA fragments of 20-bp (A), 32-bp and 26-bp (B) and 40-bp (C). The indicated 
concentration of MAEfa was mixed with 300 nM of DNA (20-bp and 26-bp DNA fragments) or 
with 200 nM of DNA (32 bp and 40 bp DNA fragments). Binding reactions were analysed by 
native polyacrilamide (8%)gels electrophoresis DNA was stained with GelRed (Biotium) and 
visualized using a Gel Doc system (Bio-Rad). 
 
4.5. MAEfa recognizes a site located upstream of the Pma promoter  
 To further investigate the interaction of MAEfa with the promoter region of its 
own gene, we carried out DNase I footprinting experiments. We used a 227-bp DNA 
fragment (coordinates 2888932-2889158) and a 217-bp DNA fragment coordinates 
(2888932-2889148). Both fragments contain the promoter (Pma) promoter and the 
transcription initiation site of maEfa (Fig. 26). The 227-bp DNA fragment was 
radioactively labelled at the 5´-end of the coding strand, while the 217-bp DNA 
fragment was radioactively labelled at the 5´-end of the non-coding strand. We used 
the 217-bp DNA because we had technical problems to label the non-coding strand of 
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the 227-bp DNA. Binding reactions contained 2 nM of the labelled DNA fragment and 
different concentrations of MAEfa. On the coding strand and at 80 nM of MAEfa, two 
regions were protected against DNase I digestion (Fig. 27). They were located between 
the positions -74 to -80 and -88 to -110 with respect to the transcription initiation site of 
the maEfa gene. At higher protein concentrations, changes in the DNase I sensitivity 
(diminished cleavages) were observed along the DNA fragment. On the non-coding 
strand and at 120 nM, diminished cleavages were observed from -73 to -80 and from -
88 to -101. When the protein concentration was increased, a slight protection against 
DNase I cleavage was observed in the regions flanking such positions. These results 
indicate that MAEfa recognizes preferentially a site on the linear DNA fragments that 
contain the Pma promoter. Such a primary binding site is located upstream of the Pma 
promoter, between the positions -73 and -110 relative to the transcription start site. 
Moreover, the protections observed at higher concentrations of MAEfa, together with 
the pattern of DNA-protein complexes observed by EMSA (Fig. 21), suggest that 
MAEfa might be able to spread along the DNA fragment subsequent to its initial 
binding.  
 
 
Figure 26. Relevant features of the two DNA fragments used for DNase I footprinting 
assays. The DNAs fragments were radiolabelled at the 5´-end of either the coding (227-bp DNA 
fragment, coordinates 2888932-2889158) or the non-coding strand (217-bp DNA fragment, 
coordinates 2888932-2889148) relative to the maEfa gene. The nucleotide sequence of the 
region spanning coordinates 2888932-2889103 of the V583 genome is shown. It includes the 
predicted stop codon (TAG) of EF3012, the start codon (ATG) of maEfa, the transcriptional 
terminator (TT), the Pma promoter (-35 and -10 elements) and the transcription initiation site of 
maEfa. The site recognized by MAEfa is indicated with brackets. 
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Figure 27. DNase I footprints of complexes formed by MAEfa on linear DNA. Coding and 
non-coding strands relative to the Pma promoter were 
32
P-labelled at the 5’-end. Dideoxy-
mediated chain termination sequencing reactions were run in the same gel (lanes A, C, G, T). 
All the lanes displayed came from the same gel. Densitometer scans corresponding to DNA 
without protein (black line) and DNA with the indicated concentration of protein (grey line) is 
shown. In this assay, the concentration of DNA was 2 nM. Brackets show the regions protected 
at the indicated concentration. The indicated positions are relative to the transcription start site 
of maEfa. 
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In vitro studies showed that the pneumococcal MgaSpn regulator interacts with 
DNA sites that contain a potential intrinsic curvature (Solano-Collado et al., 2013). 
Moreover, the promoter regions of several target genes of AtxA are intrinsically curved 
(Hadjifrangiskou and Koehler, 2008). Therefore, we calculated the curvature propensity 
plot of the 227-bp DNA fragment using the bend.it program (Vlahovicek et al., 2003). 
The profile of the DNA fragment contains one peak of potential sequence-dependent 
curvature at position -104 (Fig. 28), which is within the primary binding site of MAEfa 
(positions -110 to -73). The magnitude of the curvature propensity (14.13) is within the 
range calculated for experimentally tested curved motifs (Gabrielian et al., 1997). Thus, 
the site recognized by MAEfa contains a potential intrinsic curvature. 
 
 
 
Figure 28. Curvature propensity plot of 
the 227-bp DNA fragment according to 
the bend.it program (Vlahovicek et al., 
2003). The primary binding site of MAEfa 
is indicated (positions -110 to -73). The 
Pma promoter and the transcription 
initiation site are also indicated. 
 
 
 
 
 
Since MAEfa is able to recognize a site located upstream of the Pma promoter, 
we decided to analyse whether MAEfa influences the expression of its own gene in 
vivo. To this end, we constructed two plasmids to overproduce MAEfa. We inserted the 
maEfa gene from the V583 strain (maEfaV583) (coordinates 2889087-2890535) into the 
expression vectors pDLF (Fig. 29A) and pDLS (this work, see Results 1.3.). In the 
pDLFmaEfaV583 and pDLSmaEfaV583 recombinant plasmids, the maEfa gene is under 
the control of the P2493 and PsulA promoters, respectively. In E. faecalis, the P2493 
promoter is stronger than the PsulA promoter (see Chapter 1, Section 1.2). Both 
plasmids were introduced into JH2-2 cells. To confirm that MAEfa is synthesized in 
cells carrying the recombinant plasmids, we carried out Western blot assays using 
polyclonal antibodies against MAEfa (Fig. 29B). As expected, the amount of MAEfa in 
cells harbouring pDLFmaEfaV583 was higher than in those cells carrying 
pDLSmaEfaV583. In JH2-2 cells harbouring the pDLF vector, MAEfa was not detected. 
This was expected as we were not able to detect MAEfa in JH2-2 cells without plasmid 
CHAPTER 4 
 
 
116 
 
(not shown). Then, to analyse the effect of the MAEfa overproduction on the activity of 
the Pma promoter, we tried to introduce pDLF, pDLSmaEfav583 and pDLFmaEfav583 into 
JH2-2 cells harbouring plasmid pAST-Pma. However, we failed to obtain strain JH2-
2/pAST-Pma/pDLSmaEfa transformants. Thus, we continued our study with strains 
JH2-2/pAST-Pma/pDLF (negative control) and JH2-2/pAST-Pma/pDLFmaEfa. Plasmid 
pAST-Pma carries the Pma::gfp fusion gene (see Results, Section 2.2). Fluorescence 
assays were carried out to evaluate the activity of the Pma promoter (gfp expression). 
As shown in Fig. 29C, the intensity of fluorescence was similar in both strains. 
Moreover, it was similar to the fluorescence of JH2-2 cells harbouring only plasmid 
pAST-Pma. Hence, the activity of the Pma promoter was not affected by the 
overproduction of MAEfa. 
 
 
 
Figure 29. Overproduction of MAEfa in E. faecalis JH2-2 cells and its effect on the activity 
of the Pma promoter. (A) Construction of the pDLFmaEfaV583 plasmid. The promoter-less 
maEfa gene was inserted into the SphI site of the expression vector pDLF (see Results, Section 
1.3), generating pDLFmaEfa. (B) Detection of MAEfa by Western blotting using polyclonal 
antibodies against MAEfa. Equivalent amounts of total proteins from JH2-2 cells carrying pDLF, 
pDLFmaEfa and pDLSmaEfa were separated by SDS-PAGE (12%). MAEfa and pre-stained 
proteins (Invitrogen) were run in the same gel (C) The intensity of fluorescence in JH2-2 cells 
harbouring pAST (black); pAST-Pma (blue); pAST-Pma and pDLF (pink); or pAST-Pma and 
pDLFmaEfa (green). Cells were exponentially grown to an OD650=0.3 and the fluorescence 
(arbitrary units) corresponds to 0.8 ml of culture. Each bar represents the mean ± SD of three 
independent experiments. 
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In this chapter, we show that MAEfa influences positively the transcription of 
many genes by genome-wide microarrays, quantitative RT-PCR assays, and 
complementation studies. The most significant target genes encode components of 
PTS-type membrane transporters, components of ABC-type membrane transporters, 
and proteins involved in the metabolism of carbon sources. Furthermore, we show that 
a MAEfa-lacking strain induces a significant lower degree of inflammation in the 
peritoneal cavity of mice, indicating that enterococcal cells deficient in MAEfa are less 
virulent. 
5.1. Deletion of the maEfa gene in strain OG1RF 
The Mga protein of S. pyogenes regulates, directly or indirectly, the expression 
of about 10% of the genome during exponential growth (Ribardo and McIver, 2006). 
The Mga-regulated genes are mainly involved in virulence, carbohydrate metabolism 
and other metabolic processes (Ribardo and McIver, 2006). The B. anthracis AtxA 
protein controls the expression of more than a hundred genes, including the anthrax 
toxin genes, the capsule synthesis genes and genes implicated in transcriptional 
regulation and signaling (Fouet, 2010). To investigate whether MAEfa functions as a 
global transcriptional regulator, we constructed an OG1RF derivative, named 
OG1RFmaEfa, which is not able to synthesize MAEfa. We selected the OG1RF strain 
for this study because (i) its genome has been totally sequenced (Bourgogne et al., 
2008); (ii) it does not carry plasmids, (iii) it is readily transformable by electroporation, 
and (iv) it is sensitive to common antibiotics. These features facilitate its genetic 
manipulation. For the construction of the OG1RFΔmaEfa strain (see details in 
Methods, Section 3.1), the chromosomal region between coordinates 2421575 and 
2422640 was deleted (coordinates 2889057 and 2890122 in the V583 genome) (see 
Fig. 30). This deletion removes the -10 element of the Pma promoter and the first 344 
codons of the maEfa gene but not the IR element located upstream of Pma 
(transcriptional terminator signal), as it was confirmed by DNA sequencing. Moreover, 
by RT-PCR assays, we confirmed the presence of maEfa transcripts in strain OG1RF 
but not in OG1RFmaEfa under standard bacterial growth conditions.  
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Figure 30. Strain OG1RFmaEfa. It lacks the chromosomal between coordinates 2421575 an 
2422640. The -10 hexamer of the Pma promoter and the first 344 codons of the maEfa gene 
have been removed, but not the transcriptional terminator of OG1RF_12292. OG1RFmaEfa is 
not able to synthesize MAEfa. 
 
5.2. MAEfa influences transcription of numerous enterococcal genes  
By genome-wide microarrays, we obtained the transcriptional profiles of strains 
OG1RF and OG1RFmaEfa. The OG1RF genome has 2,658 predicted genes 
(Bourgogne et al., 2008) and the total number of genes represented in the array was 
2,629. Bacteria were grown to mid-log phase under standard laboratory conditions. In 
MAEfa-lacking cells, 90 genes were significantly differentially expressed (P value < 
0.05): 87 genes were down-regulated (log2FC of mutant strain versus wild-type strain 
was lower than -3) (Annexes, Table 1) and three genes were up-regulated (log2FC of 
mutant strain versus wild-type strain was about 4). The latter genes were 
OG1RF_10454 (fruA, PTS family fructose porter, IIABC component), OG1RF_10455 
(fruk2, 1-phosphofructokinase) and OG1RF_10456 (lacR, lactose PTS family porter 
repressor), which constitute an operon (lacR-fruk2-fruA). Thus, MAEfa influences 
negatively the transcription of such an operon. Among the 87 down-regulated genes, 
15 genes encode components of PTS-type membrane transporters and nine genes 
encode components of ABC-type membrane transporters (Annexes, Table 1). 
Moreover, and according to KEGG (Kyoto Encyclopedia of Genes and Genomes) 
annotations, 18 genes encode enzymes involved in carbon source metabolism. 
 
Our microarray analysis showed that MAEfa influences positively the 
expression of numerous PTS genes. In the absence of MAEfa, the highest reduction in 
gene expression corresponded to mtlA2, mltF2 and mtlD (OG1RF_10296-98) (log2FC 
about -6). These three genes constitute an operon involved in mannitol utilization 
(Table 6). Bacteria usually take up mannitol via the mannitol PTS transporter (mtlA2 
and mltF2), which phosphorylates mannitol to mannitol-1-phosphate during the 
transport process. Mannitol-1-phosphate dehydrogenase (mtlD) converts intracellular 
mannitol-1-phosphate into fructose-6-phosphate, which is then metabolized via 
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glycolysis. A high reduction in gene expression (log2FC about -5) was also observed in 
a gene that encodes the EIIBC component of a trehalose PTS transporter 
(OG1RF_11753; treB). Among the mannose family of PTS transporters, E. faecalis 
encodes a gluconate specific EII system, which consists of four components (Zúñiga et 
al., 2005). It is part of a predicted metabolic pathway that consists of two operons, 
(OG1RF_12399-97 and OG1RF_12405-00). Such a pathway facilitates gluconate 
uptake and catabolism via the mannonate route. Both operons (nine genes in total) 
were down-regulated in MAEfa-lacking cells (log2FC values between -4.8 and -3.7) 
(Table 6). The putative operon OG1RF_11616-11, which encodes four components of 
another mannose-class PTS transporter, was also down-regulated in the absence of 
MAEfa. (log2FC values between -4.8 and -3.3).  Thus, MAEfa has a positive effect on 
the expression of several PTS transporters. 
 
TABLE 6 Operons down-regulated in MAEfa-lacking cells 
 
Operon Description Gene validated by qRT-PCR 
OG1RF_10296-98  Mannitol utilization  
(PTS transporter) 
OG1RF_10298 (mtlD), mannitol-1-
phosphate 5-dehydrogenase 
 
OG1RF_10683-80  
 
Maltose metabolism 
 
OG1RF_10683 (malP), maltose 
phosphorylase 
 
OG1RF_11003-05  
 
ABC transporter  
(unknown substrate) 
 
ND 
 
OG1RF_11135-33  
 
Sugar ABC transporter 
 
OG1RF_11135, sugar-binding 
protein 
 
OG1RF_11146-49  
 
Glycerol metabolism 
 
OG1RF_11146 (gldA), NAD
+
-
dependent glycerol dehydrogenase 
 
OG1RF_11181-88  
 
Molybdenum cofactor 
biosynthesis 
(ABC transporter) 
 
ND 
 
OG1RF_11592-90  
 
Glycerol metabolism 
 
OG1RF_11592 (glpK), glycerol 
kinase 
 
OG1RF_11616-11  
 
Mannose-class PTS 
transporter 
 
ND 
 
OG1RF_11763-61  
 
Carbohydrate ABC transporter 
 
 
OG1RF_11763, membrane protein 
 
OG1RF_11951-44  
 
Selenocompound metabolism 
 
OG1RF_11948 (selD), selenide 
water dikinase 
 
OG1RF_12399-97  
 
Gluconate utilization 
(PTS transporter) 
 
OG1RF_12398 (uxuA), mannonate 
dehydratase 
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Operon Description Gene validated by qRT-PCR 
OG1RF_12405-00  
 
Gluconate utilization OG1RF_12405 (gnd2),  
6-phosphogluconate dehydrogenase 
 
OG1RF_12571-60  
 
Citrate utilization OG1RF_12564 (citF), citrate lyase 
 
OG1RF_12572-73  
 
Citrate utilization  ND 
ND: no determined 
 
MAEfa influences positively the expression of some ABC transporters (Table 6). 
Transcription of genes OG1RF_11763-61, which encode components of a 
carbohydrate ABC transporter, and transcription of the putative operon OG1RF_11135-
33 (sugar ABC transporter) were highly reduced in MAEfa-lacking cells (log2FC about -
5 and -4, respectively). Furthermore, the OG1RF_11003-05 operon (ABC transporter of 
unknown substrate; log2FC about -3) and genes OG1RF_11186-88 (molybdenum 
substrate) were also down-regulated. The latter genes are part of an eight-gene operon 
(OG1RF_11181-88) that includes genes involved in molybdenum cofactor 
biosynthesis. Seven genes of such an operon were differentially expressed in the 
absence of MAEfa (log2FC between -2.5 and -3.7). 
 
Numerous genes involved in carbon source utilization were found to be down-
regulated in MAEfa-lacking cells. Among them, genes implicated in the utilization of 
maltose, citrate and glycerol were found. The malPBMR operon (OG1RF_10683-80) 
and its neighbouring OG1RF_10684 gene (malT, PTS transporter) are divergently 
transcribed and were shown to be involved in maltose utilization (Le Breton et al., 
2005). In the absence of the MAEfa regulator, malP (OG1RF_10683), malB 
(OG1RF_10682) and malT (OG1RF_10684) were down-regulated (log2FC about -4). 
The malPBMR operon was originally designated bopABCD (biofilm on plastic surfaces) 
because it was found to influence biofilm formation (Hufnagel et al., 2004b). Genes 
OG1RF_11951 (selenium-dependent molybdenum hydroxylase) and OG1RF_11948 
(selD; selenide, water dikinase) were also down-regulated in the absence of MAEfa 
(log2FC about -3). The latter genes form part of a putative eight-gene operon 
(OG1RF_11951-44 operon) also reported to contribute positively to biofilm formation 
(Ballering et al., 2009; Srivastava et al., 2011).  
 
E. faecalis is able to use citrate as the sole source of carbon and energy. Citrate 
metabolism has been extensively investigated in this bacterium (Blancato et al., 2008; 
Repizo et al., 2013; Suárez et al., 2011). The cit locus is constituted by two divergent 
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operons: citHO and oadHDB-citCDEFX-oadA-citMG. Our microarray analysis revealed 
that the cit locus (OG1RF_12572-73 and OG1RF_12571-60) was down-regulated in 
the absence of the MAEfa regulator. With the exception of citO (OG1RF_12573; log2FC 
-1.66) and citG (OG1RF_12560; log2FC -2.46), the log2FC value of such genes was 
between -5.38 (oadH, OG1RF_12571) and -3.07 (citM, OG1RF_12561) (Annexes, 
Table 1). Therefore, MAEfa has a positive effect on the transcription of the two operons 
involved in citrate utilization. 
 
In E. faecalis, as in many Gram-positive bacteria, glycerol is an essential 
precursor for the synthesis of lipids and (lipo)teichoic acids. Glycerol can also be a 
carbon/energy source for several pathogenic bacteria (Ramsey et al., 2014). Two 
pathways for glycerol catabolism are present in E. faecalis. In the GlpO/GlpK pathway, 
glycerol is first phosphorylated by glycerol kinase (glpK) and then oxidized by glycerol-
3-phosphate oxidase (glpO). In the GldA/DhaK pathway, glycerol is first oxidized by a 
NAD+-dependent glycerol dehydrogenase (gldA1) and then phosphorylated by 
dihydroxyacetone kinase (dhaK). The final product in both pathways is 
dihydroxyacetone phosphate. The glpK, glpO and glpF genes constitute an operon 
(OG1RF_11592-90). Gene glpF encodes a membrane protein involved in glycerol 
transport. Our microarray analysis showed that expression of the glpKOF operon was 
down-regulated in MAEfa-lacking cells (log2FC about -3). A higher reduction in gene 
expression was also  observed in the OG1RF_11146-49 operon, which includes genes 
gldA and dhaK (log2FC about -5).  
 
E. faecalis encodes several putative glycosidases but little is known about their 
biological function. The endo--N-acetylglucosaminidase EndoE (OG1RF_10107) was 
shown to cleave the N-linked glycans of both the human immunoglobulin G (Giard et 
al., 2006) and the human glycoprotein lactoferrin (Riboulet-Bisson et al., 2009), which 
is considered to be a component of innate immunity. Gene OG1RF_12167 also 
encodes an endo--N-acetylglucosaminidase activity (Ballering et al., 2009). Our 
microarray analysis revealed that transcription of both genes (OG1RF_10107 and 
OG1RF_12167) was highly reduced in the absence of MAEfa (log2FC about -4) 
 
5.3. Validation of the microarray results by qRT-PCR.  
To validate the microarray results, we performed qRT-PCR assays using the 
comparative CT method (Schmittgen and Livak, 2008). Specifically, we selected 12 
potential MAEfa target genes involved in metabolism (mtlD, malP, gldA, glpK, selD, 
uxuA, gnd2 and citF), regulation (lacR) or transport (malT, OG1RF_11135, 
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OG1RF_11763) (Table 6). These genes are transcribed from different promoters. We 
determined their relative expression in OG1RF and OG1RFmaEfa using recA as 
internal control gene (Fig. 31). Except for lacR, gene expression was reduced in strain 
OG1RFmaEfa compared to OG1RF. In all the cases, the fold change in gene 
expression (log2FC) due to the lack of MAEfa (OG1RFmaEfa versus OG1RF) was 
comparable to the value obtained in the microarray experiments (Fig. 31). Additionally, 
we performed qRT-PCR assays using total RNA isolated from strains JH2-2 and JH2-
2maEfa. In this case, we determined the relative expression of genes lacR, mtlD, gldA 
and citF. The results obtained confirmed that MAEfa has a negative effect on the 
transcription of lacR but a positive effect on the transcription of mtlD, gldA and citF (not 
shown). 
 
 
 
Figure 31. Effect of MAEfa on gene expression. Log2 fold change in the expression of the 
indicated genes due to the lack of MAEfa (OG1RFmaEfa vs OG1RF) determined by 
microarray analysis and by qRT-PCR. Log2 fold change in gene expression due to the presence 
of the MAEfa-encoding plasmid (OG1RFmaEfa/pDLFmaEfaOG1RF vs OG1RFmaEfa/pDLF). 
 
5.4. Genetic complementation studies in strain OG1RFmaEfa  
 For genetic complementation of the maEfa deletion, we inserted the maEfa 
gene of OG1RF (maEfaOG1RF) into the pDLF expression vector (see Results Section 
1.3), and introduced the pDLFmaEfaOG1RF recombinant plasmid into strain 
OG1RFmaEfa. By qRT-PCR, we determined the relative expression of the 12 genes 
mentioned above in strain OG1RFmaEfa harbouring either pDLFmaEfaOG1RF 
(plasmid-encoded MAEfa) or pDLF (absence of MAEfa). The fold change in gene 
expression (log2FC) due to the plasmid-encoded MAEfa is shown in Figure 31. 
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Compared to cells harbouring pDLF, the relative expression of lacR was reduced in 
cells harbouring pDLFmaEfaOG1RF. On the contrary, the relative expression of the other 
11 genes was increased to a different extent. Hence, plasmid-encoded MAEfa 
influences positively the transcription of the 11 genes in the maEfa deletion mutant 
strain. 
 
5.5. Potential curvatures in promoter regions of MAEfa-regulated operons 
 
MAEfa is thought to be a member of the Mga/AtxA family of global response 
regulators. These regulators appear to bind DNA with low sequence specificity. In vitro 
studies showed that Mga binds to regions located upstream of the target promoters. 
Sequence alignments of all established Mga-binding regions revealed that they exhibit 
only 13.4% identity (Hause and McIver, 2012). In the case of AtxA, in silico and in vitro 
analyses revealed that the promoter regions of several target genes are intrinsically 
curved (Hadjifrangiskou and Koehler, 2008). Furthermore, in vitro studies showed that 
MgaSpn interacts with DNA sites that contain a potential intrinsic curvature. (Solano-
Collado et al., 2012). Recently, Innocenti et al. (2015) mapped numerous transcription 
start sites on the V583 genome using a modified RNA-seq approach. Their study 
allowed us to locate the transcription star sites of six MAEfa-regulated operons on the 
OG1RF genome. The first gene of each operon and its transcription start site are listed 
in Table 7. We calculated the curvature propensity plots of the corresponding promoter 
regions (positions -1 to -200) using the bend.it program (Vlahovicek et al., 2003). 
Compared with the global A+T content (62.2%) of the OG1RF genome, five out of the 
six promoter regions display a high A+T content (74-77%). Moreover, they contain one 
peak of potential sequence-dependent curvature with a magnitude higher than 
14º/helical turn. The peak of such a curvature is located at position -171 in gene glpK, 
and between positions -63 and -86 in genes gldA, OG1RF_11763, gnd2 and 
OG1RF_12571 (Table 7). Further work is required to elucidate whether MAEfa is able 
to bind to DNA containing such potential intrinsic curvatures.  
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TABLE 7. Potential intrinsic curvatures within promoter regions 
 
Locus tag (gene)  
 
 
OG1RF_10296 (mtlA2) 
 
OG1RF_11146 (gldA) 
 
 
OG1RF_11592 (glpK) 
 
OG1RF_11763  
 
 
OG1RF_12405 (gnd2) 
 
 
OG1RF_12571 
 
 
TSS position 
a
 
 
 
310152 
 
1197479 
 
 
1660384 
 
1846229 
 
 
2542744 
 
 
2733071 
 
A+T 
b
 
(%) 
 
64.5 
 
75.5 
 
 
77 
 
74.5 
 
 
74 
 
 
76.5 
 
Curvature 
c
 
(º/helical turn) 
 
12.02 
 
13.16 
16.16 
 
17.35 
 
14.64 
15.01 
 
12.92 
14.27 
 
14.83 
13.71 
 
Location 
d 
 
 
-40 
 
-179 
-63 
 
-171 
 
-86 
-78 
 
-136 
-76 
 
-85 
-24 
 
a
 Position of the transcription start site on the OG1RF genome
 
b
 A+T content of the promoter region (from position -1 to position -200) 
c
 Predicted curvatures with a magnitude 12 degrees/10.5 bp helical turn 
d
 Location of peaks of potential curvatures within the promoter regions (relative to the TSS)      
 
5.6. MAEfa plays a positive role in the utilization of different carbon 
sources 
 
Two operons for glycerol metabolism are present in E. faecalis. Both of them 
were down-regulated in MAEfa-lacking cells (Table 6, Fig. 31). To evaluate the effect of 
MAEfa on the utilization of glycerol, we analysed the growth of strains OG1RF and 
OG1RFmaEfa in M9YE medium supplemented or not with glycerol (Fig. 32A). In the 
absence of glycerol, both cultures reached a similar OD600 (about 0.2). However, in 
glycerol-supplemented medium, the final OD600 in cultures of the mutant strain was 
lower than in cultures of the wild-type strain. Furthermore, compared to the wild-type 
strain, the MAEfa-lacking strain showed a diminished growth in M9YE medium 
supplemented with maltose (Fig. 32B), which correlates with the lower expression 
found in genes malP, malB and malT (maltose utilization) (Table 6, Fig. 31). The 
growth of the mutant strain was also reduced in M9YE medium supplemented with 
mannitol (Fig. 32C), which is linked to the reduction in expression of the 
OG1RF_10296-98 operon (mannitol utilization) (Table 6, Fig. 31). Therefore, MAEfa 
has a positive effect on the utilization of glycerol, maltose and mannitol. 
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Figure 32. Effect of MAEfa on the utilization of different carbon sources. Bacteria were 
grown in M9YE medium supplemented (circles) or not (squares) with glycerol (A), maltose (B) 
or mannitol (C). White symbols correspond to strain OG1RF. Black symbols correspond to 
strain OG1RFmaEfa. Data correspond to the mean values of three independent experiments. 
Error bars indicate standard error. 
 
5.7. Contribution of MAEfa to the virulence of E. faecalis 
 
In order to study whether the MAEfa protein contributes to the virulence of E. 
faecalis, we used first an in vitro infection model. We compared the adhesion capacity 
of strains OG1RF/pMV158GFP (wild-type) and OG1RFΔmaEfa/pMV158GFP (mutant) 
to the human epithelial cell line HEp-2. Both strains carry the gfp gene inserted into 
plasmid pMV158GFP and, therefore, they synthesize constitutively the green 
fluorescent protein (Nieto and Espinosa, 2003). Epithelial cells were infected with 
bacteria and, after different incubation times, the number of cells with bacteria attached 
was determined (fluorescence microscopy). No significant differences were observed 
between both bacterial strains. Representative images taken after 2 and 24 h of 
infection are shown in Figure 33.  
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Figure 33. Attachment of enterococcal bacteria to human epithelial cells in vitro 
(fluorescence microscopy). The epithelial cells were infected with OG1RF/pMV158GFP or 
OG1RFΔmaEfa/pMV158GFP for 2 h (A) and 24 h (B). Bacteria synthesize constitutively the 
green fluorescent protein. The epithelial cells nuclei are stained by DAPI (blue). The number of 
cells with bacteria attached was determined in each case.  
  
To investigate the influence of the MAEfa regulator in vivo, a peritonitis infection 
model was used comparing the maEfa deletion mutant strain (OG1RFmaEfa) and the 
corresponding isogenic wild-type strain (OG1RF). Our results indicate a role of the 
MAEfa regulator in bacterial virulence. A significant higher degree of inflammation 
could be obtained in the peritoneal cavity of mice infected with the wild-type bacteria 
compared to the maEfa deletion mutant. This finding was indicated on the cytokine 
level by a higher release of IL-6 (Fig. 34A) an important systemic inflammatory 
cytokine, and on the cellular basis by higher numbers of infiltrating neutrophils (Fig. 
34B) to the side of infection. It is important to state that even though the number of 
infiltrating neutrophils was 2.5 times higher when mice were infected with the wild-type 
bacteria compared to the mutant strain, no significant reduction in the bacterial loads 
within the peritoneal cavity could be observed (data not shown); this also highlights the 
role of the MAEfa regulator in bacterial virulence. Taken together, our observations 
clearly demonstrate an in vivo role of the MAEfa regulator in the course of infections 
caused by E. faecalis.  
RESULTS 
 
 
129 
 
 
 
Figure 34. Determination of IL-6 levels and number of infiltrating neutrophils. Levels of IL-
6 (A) and number of infiltrating LyG6C positive cells (B) in the peritoneal cavity of BALB/c mice 
after intraperitoneal infection with E. faecalis OG1RF wild type and OG1RFmaEfa mutant 
strain. PBS treated animals served as negative controls. Each bar represents the mean ± SD of 
three independent experiments. **,p < 0.05. 
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New plasmid-based genetic tools in E. faecalis 
 
Identification of promoters on the bacterial genomes is essential to understand 
the regulation of gene expression. In bacteria, many genes are organized in operons 
and, therefore, they are transcribed from the same promoter into a single polycistronic 
mRNA molecule. Promoters can be located at intergenic regions or within the coding 
region of adjacent genes. Although many algorithms have been developed for the 
prediction of promoter sequences in genomic DNAs (de Jong et al., 2012; Lin et al., 
2014; Song, 2012), definitive identification of promoters requires the use of several 
experimental approaches, both in vivo and in vitro (Ross and Gourse, 2009). Among 
the in vivo approaches, the use of promoter-probe plasmid vectors facilitates the 
identification of sequence elements that are essential for promoter activity. Moreover, 
they make possible to rapidly examine whether a particular promoter is active in 
different genetic backgrounds and under diverse environmental stimuli. Promoter-probe 
plasmid vectors are particularly necessary when dealing with bacterial genomes that 
have a high A+T content, as it is the case of E. faecalis and S. pneumoniae, whose 
genomes have about 60% of A+T content. Sequences resembling the consensus 
sequence of the promoter element -10 (5´-TATAAT-3´) are frequent in both genomes. 
Such an element is present in promoters recognized by RNAPs that carry a 
housekeeping σ factor similar to the E. coli σ70 factor. Despite this fact, plasmid-based 
genetic tools are still very scarce in E. faecalis and S. pneumoniae. In this Thesis, we 
have constructed the pAST promoter-probe vector, and we have demonstrated that it 
can be used to assess the activity of specific promoter sequences (homologous and 
heterologous) not only in E. faecalis but also in S. pneumoniae. Among the promoters 
tested, we have shown that two predicted promoters, the pneumococcal Pung 
promoter and the enterococcal P2962 promoter, are functional in both bacteria. In 
addition, the pAST promoter-probe vector has allowed us to identify the transcription 
start site of the maEfa regulatory gene. This site was not identified in the study 
performed by Innocenti et al. (2015) using a modified RNA-seq approach (tagRNA-
seq), which highlights the usefulness of pAST for the identification of promoters. Up to 
now, plasmid pAST has been successfully used in the characterization of promoters 
activated by the pneumococcal MgaSpn regulator (Solano-Collado et al., 2012), and in 
studies of the pneumococcal yefM-yoeB toxin-antitoxin system (Chan et al., 2014). The 
pAST promoter-probe vector is based on the S. agalactiae pMV158 plasmid, which is 
one of the most promiscuous replicons reported so far. It has been established in 
nearly 30 different bacterial species (M. Espinosa, unpublished observations). Hence, it 
is very likely that pAST can be used in a number of different Gram-positive bacteria.  
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Plasmid pAST is also a valuable tool for the study of regulated promoters, and 
for the identification of bacterial growth conditions that influence the activity of a 
particular promoter. This conclusion is supported by our results concerning the study of 
the pneumococcal PfcsK promoter, which is induced by fucose (Chan et al., 2003). 
Specifically, we constructed plasmid pAST-PfcsK and demonstrated that the activity of 
the PfcsK promoter depends on the concentration of fucose added to the bacterial 
growth medium. These experiments were performed with the S. pneumoniae strain 
708, and we found that the PfcsK promoter was not totally repressed in the absence of 
fucose. This finding indicates that a single chromosomal copy of the putative fucose 
regulator gene (fcsR) is not sufficient for total repression of the PfcsK promoter placed 
on a pLS1 derivative (pLS1 has ~22 copies per genome equivalent) (del Solar et al., 
1993). Nevertheless, since gene fcsR is widely conserved in S. pneumoniae (Chan et 
al., 2003), we believe that plasmid pAST-PfcsK could be used as an inducible 
expression vector in pneumococcus. The promoter-less gene of interest would be 
inserted into the multiple cloning site located between the PfcsK promoter and the gfp 
reporter gene. Compared to bacteria grown without fucose, we found that the activity of 
the PfcsK promoter increases about 5-fold (fluorescence assays) when the bacterial 
medium contains 1% fucose. Therefore, this expression system would be useful when 
cells expressing different levels of a particular gene are needed. 
 
The studies performed with the pAST promoter-probe vector allowed us to 
design new plasmid-based expression vectors suitable for E. faecalis. Expression 
vectors are useful to carry out genetic complementation studies or to assess the effect 
of transcriptional regulators on specific promoters. In order to develop new plasmid-
based expression vectors, we selected the pneumococcal PsulA promoter and the 
enterococcal P2493 promoter, which are functional not only in E. faecalis but also in S. 
pneumoniae (this work). In E. faecalis, promoter P2493 is stronger than promoter 
PsulA. Both promoters were inserted into plasmid pDL287 (replicon pVA380-1), which 
is compatible with the pAST promoter probe vector (replicon pMV158). Thus, vector 
pDLF (based on promoter P2493) and vector pDLS (based on promoter PsulA) make 
possible to analyse the effect of particular regulatory genes on promoters cloned into 
pAST. In our case, the maEfa gene was cloned into both expression vectors, and 
enterococcal cells producing different levels of the MAEfa protein were obtained. It is 
likely that both pDLF and pDLS could be used in other Gram-positive bacteria, since 
they are based on plasmid pDL287, which is a broad host-range plasmid (LeBlanc et 
al., 1993). In fact, the mgaSpn regulatory gene was fused to the PsulA promoter, and 
the fusion gene was inserted into pDL287. Pneumococcal cells carrying the 
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recombinant plasmid were shown to overproduce MgaSpn (Solano-Collado et al., 
2012). In S. pneumoniae, promoter PsulA is stronger than promoter P2493 (this work). 
The pDLF and pDLS expression vectors have only a single restriction site (SphI) 
downstream of P2493 and PsulA, respectively. Insertion of a multiple cloning site into 
the SphI would give more versatility to both expression vectors. 
 
Bacterial gene expression can be controlled at the transcription termination 
process. The RNAP can terminate transcription efficiently at Rho-independent signals, 
which are active in the nascent transcript. The Rho-independent terminators (also 
known as intrinsic terminators) typically consist of a G:C rich stem–loop structure, 
followed by a short stretch of U residues. The stem–loop structure halts the RNAP and 
leads to its release. Thus, transcription termination occurs near the end of the poly(U) 
region. Transcription attenuation is a highly conserved regulatory mechanism used by 
bacteria. Attenuators are usually located at the 5′ untranslated regions of genes or 
operons and combine an intrinsic terminator with an RNA element that senses specific 
environmental stimuli (Merino and Yanofsky, 2005; Naville and Gautheret, 2009). 
Several algorithms are able to detect intrinsic terminators in genomic DNAs (Mitra et 
al., 2010; Naville et al., 2011). Nevertheless, some intrinsic terminating sequences 
deviate from the common motif and, consequently, the availability of terminator-probe 
plasmid vectors makes possible to rapidly test whether a particular sequence functions 
as a terminator. Such genetic tools are still very scarce in E. faecalis. In this work, we 
have constructed the pAS terminator-probe vector, and demonstrated that it can be 
used to examine whether particular sequences (homologous or heterologous) function 
as transcriptional terminators in E. faecalis and S. pneumoniae. Moreover, we have 
shown that the predicted TrsiV terminator of E. faecalis is active in both bacteria. In our 
system, such terminator is as efficient as the tandem terminators T1 and T2 of E. coli, 
which have been used frequently in the construction of plasmid vectors (Brosius, 1984; 
Serrano-Heras et al., 2005; Simons, 1987). The TrsiV transcriptional terminator has 
been used recently in our laboratory to improve the features of the pAST promoter-
probe vector. Specifically, the TrsiV terminator has been inserted downstream of the 
gfp reporter gene, and the new pAST derivative has been shown to be useful to study 
strong promoters (unpublished results). 
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Expression of the maEfa gene in E. faecalis 
 
By RT-PCR, we have demonstrated that maEfa is transcribed in three different 
strains of E. faecalis (V583, OG1RF and JH2-2) under standard laboratory conditions 
(BHI medium, 37ºC, without aeration). Moreover, we have shown that genes EF3012 
and maEfa (EF3013) are not cotranscribed. The maEfa gene is also transcribed in E. 
faecalis OG1RF cells grown in the laboratory under aeration conditions, and during in 
vitro macrophage infection (not shown). Under standard conditions, we found that the 
amount of maEfa transcripts in V583 cells is low, as we were unable to detect a primer 
extension cDNA product using total RNA preparations. In agreement with this, we 
could not detect MAEfa in whole-cell extracts by Western blotting using polyclonal 
antibodies. These observations suggest that maEfa expression might be activated 
under specific external signals. 
 
In order to identify the transcription start site of the maEfa gene, we cloned a 
region that contained a predicted promoter into the pAST promoter-probe vector. Using 
total RNA from strain JH2-2 harbouring the recombinant plasmid (pAST-Pma), we 
demonstrated that the predicted promoter (promoter Pma) is functional under standard 
laboratory conditions (primer extension assays). This conclusion was supported by 
fluorescence assays, as plasmid pAST-Pma carries the gfp gene under control of the 
Pma promoter. We believe that plasmid pAST-Pma could be useful to identify 
environmental signals that influence the activity of the Pma promoter and, therefore, 
the expression of the maEfa gene. Sequence analysis of the intergenic region (91 
nucleotides) between EF3012 and maEfa revealed the existence of a putative Rho-
independent transcriptional terminator upstream of the Pma promoter. Using the pAS 
terminator-probe vector, we have demonstrated that such a terminator sequence is 
functional, although it is not as efficient as the tandem terminators T1 and T2 of E. coli. 
In addition, Merino and Yanofski (2005) predicted that an alternative RNA secondary 
structure might function as an anti-terminator signal of maEfa. If this were the case, 
transcription initiated upstream of the anti-terminator signal might continue through the 
transcriptional terminator sequence. This finding suggests that transcriptional 
attenuation might control the expression of maEfa from a promoter located upstream of 
the Pma promoter. According to the BPROM prediction program (Softberry, Inc.), there 
is a putative promoter sequence upstream of the EF3012 gene. Therefore, under 
certain conditions, genes EF3012 and maEfa might be cotranscribed. In the case of the 
regulatory genes mga (S. pyogenes) and atxA (B. anthracis), two promoters have been 
identified. The major promoter (P2) of mga is located close to the coding sequence, 
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whereas the secondary promoter (P1) is located about 300-bp upstream of the P2 
promoter (Okada et al., 1993). Regarding atxA, two transcription start sites have been 
identified. They are separated by 650-bp. Moreover, the distal promoter is located 
within the coding region of a divergently transcribed gene (Bongiorni et al., 2008). 
 
The Mga regulator activates the transcription of its own gene during exponential 
growth (McIver et al., 1999). Mga fused to the maltose binding protein was shown to 
bind to two sites located upstream of the P2 promoter. Such sites are centred around 
the -104 and -185 positions, respectively (McIver et al., 1999). By DNase I footprinting 
analysis, we have shown that an untagged form of MAEfa recognizes a site located 
upstream of the Pma promoter. This site is centred at the position -90. The DNA 
fragment used included from the position -140 to the position +87. This finding 
suggested that binding of MAEfa to such a site might control the expression of its own 
gene. To test this hypothesis, we used plasmid pAST-Pma, in which the gfp gene is 
under control of the Pma promoter. In this transcriptional fusion, the Pma promoter 
region includes from the position –207 to the position +7. We determined the activity of 
the Pma promoter in JH2-2 cells overproducing MAEfa, and found that its activity was 
independent on the intracellular amount of MAEfa. Thus, either MAEfa does not 
influence the activity of the Pma promoter in vivo or sequence elements that are not 
present in the Pma::gfp transcriptional fusion are required for a MAEfa-mediated 
regulation. Moreover, MAEfa could require a factor that is not at the amount needed 
when MAEfa is overproduced. It will be also interesting to investigate the putative role 
of MAEfa in self-regulation using different E. faecalis strains. For instance, Mga does 
not activate the transcription of its own gene in the serotype M4 of GAS (Hondorp et 
al., 2012; Vahling and McIver, 2006). In addition, the global regulator Ers of E. faecalis 
was shown to repress the expression of one of its target genes in strain JH2-2 but not 
in strain OG1RF (Cohen et al., 2013). Regarding other regulators of the Mga/AtxA 
family, AtxA does not seem to control the expression of its own gene (Bongiorni et al., 
2008), and MgaSpn was shown to bind to the promoter of its own gene (positions -23 
to +21) (Solano-Collado et al., 2013), but it has not yet been determined whether this 
binding influences the expression of mgaSpn in vivo. 
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MAEfa is a new member of the Mga/AtxA family of global regulators 
 
AtxA controls the expression of numerous genes on the B. anthracis plasmids 
and chromosome (Bourgogne et al., 2008). Sequence similarities in the promoter 
regions of AtxA-regulated genes are not apparent, but in silico modeling and in vitro 
experiments revealed that the promoter regions of several target genes are intrinsically 
curved. Thus, intrinsic curvature might play a role in recognition of the promoters by 
AtxA (Hadjifrangiskou and Koehler, 2008). The crystal structure of AtxA has revealed 
two structures indicatives of DNA-binding: a winged helix-turn-helix motif and an 
adjacent helix-turn-helix motif. Despite the fact that possible models of AtxA-DNA 
complexes have been suggested (Hammerstrom et al., 2015), the molecular basis for 
AtxA function as a transcriptional regulator has not been established, since there are 
no reports on DNA binding activity. In the case of the Mga global regulator of S. 
pyogenes, several DNA-binding sites have been identified using fusion proteins 
(Hondorp and McIver, 2007). Three categories of Mga-regulated promoters were 
proposed based on the number of binding sites and their position relative to the 
initiation transcription site (Almengor and McIver, 2004). Nevertheless, comparing the 
nucleotide sequence of the different Mga binding sites, it was found that they exhibit 
only 13.4% identity with no discernible symmetry. A further mutagenesis analysis 
established that Mga binds to DNA in a promoter-specific manner (Hause and McIver, 
2012). Regarding the pneumococcal MgaSpn regulator, its interaction with linear 
dsDNA was studied, and two MgaSpn binding sites have been identified (sites I and II) 
(Solano-Collado et al., 2013). Site I is located upstream of a target promoter (positions 
-60 to -90 of the P1623B promoter), whereas site II overlaps the promoter of the 
mgaSpn gene (positions -23 to +21). These sites were shown to have a low sequence 
identity and a potential intrinsic curvature. Moreover, MgaSpn showed a high affinity for 
a naturally occurring curved DNA. It has been suggested that MgaSpn might recognize 
particular DNA conformations to achieve DNA-binding specificity. On binding to the 
primary site (site I or II), multiple MgaSpn units bind orderly along the DNA molecule 
generating multimeric complexes (Solano-Collado et al., 2013). 
  
In this Thesis, we have purified an untagged form of the MAEfa protein and 
shown that it interacts with linear dsDNAs. To our knowledge, neither Mga nor AtxA 
have been purified without tags. By DNase I footprinting assays and using DNA 
fragments that contain the Pma promoter (promoter of the maEfa gene), we have 
shown that MAEfa recognizes preferentially a site that is located upstream of the Pma 
promoter, between the positions -73 and -110. According to the bend.it program 
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(Vlahovicek et al., 2003), this site contains a potential intrinsic curvature, suggesting 
that MAEfa, like other regulators of the Mga/Atxa family, might recognize structural 
features of the DNA rather than a specific nucleotide sequence. In fact, by EMSA, we 
found that MAEfa binds to various DNA fragments that do not have sequence identity. 
Furthermore, using the bend.it program, we analysed the promoter region of six 
operons whose transcription increases in the presence of MAEfa (microarray results). 
Five out of the six promoter regions contain a potential intrinsic curvature located 
upstream of the -35 element (between positions -63 and -171). The magnitude of such 
curvatures (14 degrees/helical turn) is within the range calculated for experimentally 
tested curved motifs (Gabrielian et al., 1997). It will be interesting to analyse whether 
MAEfa recognizes such curvatures to influence the expression of the target genes. For 
some proteins, recognition of DNA shape is the mechanism used to achieve DNA-
binding specificity. This mechanism called shape readout is less known than the base 
readout mechanism (when the protein recognizes the unique chemical signatures of 
the DNA bases), but it has been described for numerous transcription factors (Rohs et 
al., 2010). For instance, the Fis nucleoid-associated protein, which functions as a 
global regulator and is conserved in most Gram-negative bacteria, was shown to 
recognize the shape of the minor groove in some DNA targets (Stella et al., 2009). With 
a preference for intrinsically curved AT-rich regions, H-NS is known to function as a 
global modulator of gene expression (Gruber, 2014). In the Gram-positive bacterium 
Staphylococcus aureus, the global regulator SarA was shown to have a preference for 
AT-rich binding sites (Sterba et al., 2003) and SarA was proposed to recognize 
topological features of the DNA (Fujimoto et al., 2000). Nevertheless, Rohs et al. 
(2010) pointed out that any one DNA-binding protein is likely to use a combination of 
readout mechanisms to achieve DNA-binding specificity.  
 
By EMSA and using increasing amounts of protein, we found that MAEfa is able 
to generate multimeric complexes on linear double-stranded DNAs. Higher-order 
MAEfa-DNA complexes appeared gradually before the total disappearance of unbound 
DNA. The pattern of complexes detected in those experiments is compatible with a 
sequential binding of several MAEfa units on the same DNA molecule. This 
interpretation has been supported by DNase I footprinting assays. Specifically, using 
DNA fragments that contain the Pma promoter, we observed binding of MAEfa to a 
specific site and then, when protein concentration was increased, binding of MAEfa to 
the regions flanking such a site. These results indicate that the DNA-binding properties 
of MAEfa are similar to those described for the pneumococcal MgaSpn regulator 
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(Solano-Collado et al., 2012). MgaSpn recognizes a specific site on particular linear 
DNAs and, on binding to such a site, it is able to spread (presumably through 
oligomerization) along the adjacent DNA regions(Solano-Collado et al., 2012). In 
solution (without DNA), proteins MgaSpn (Solano-Collado et al., 2012) and MAEfa (this 
work) form dimers. Formation of multimeric protein-DNA complexes has not been 
shown for other regulators of the Mga/AtxA family. Nevertheless, AtxA has been 
reported to form homo-multimers by co-affinity purification, non-denaturing PAGE and 
cross-linking experiments. In these experiments, several strains producing native and 
epitope-tagged AtxA were used. In addition, AtxA dimerization was shown to enhance 
under conditions that promote expression of AtxA-regulated genes (cells grown with 
elevated CO2/bicarbonate) (Hammerstrom et al., 2011). Later, it was shown that AtxA 
mutants affected in dimerization are also impaired in transcriptional activity 
(Hammerstrom et al., 2015). Similar to MAEfa (PDB 3SQN), AtxA crystallizes as a 
dimer in the absence of DNA (Hammerstrom et al., 2015). Regarding the Mga 
regulator, it was shown to form oligomers in solution (Hondorp et al., 2012). Its ability to 
oligomerize was found to correlate with transcriptional activation, thus DNA binding is 
necessary but not sufficient for full Mga activity (Hondorp et al., 2013; Hondorp et al., 
2012). Hause et al. (2012) suggested that Mga interacts with DNA as a dimer. They 
supported their hypothesis, in addition to their results, with the crystal structure of 
MAEfa (PDB 3SQN). These authors compared the main DNA binding domain of Mga 
(wHTH-4) to the amino-terminal wHTH domain present in each monomer of the MAEfa 
dimer. They estimated that the distance between the predicted wHTH recognition 
helices was 95 Å to 100 Å, corresponding to about 30 nucleotides. In this work, we 
have experimentally determined that the minimum DNA size required for MAEfa 
binding is between 26 and 32 bp. Thus, based on these observations, we propose that 
MAEfa binds to DNA as a dimer. 
 
MAEfa might facilitate the adaptation of E. faecalis to particular host 
niches 
 
The adaptation of a pathogenic bacterium to new host niches requires a 
coordinated regulation in the expression of numerous genes. Global transcriptional 
regulators that respond to specific signals are essential in the adaptation process. In 
Gram-positive pathogenic bacteria, various global response regulators have been 
implicated in virulence. Among them, the regulators of the Mga/AtxA family are found. 
For instance, the B. anthracis regulator AtxA was reported to have both positive and 
negative effects on gene expression (Bourgogne et al., 2003). It controls the 
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expression of chromosomal genes, in addition to genes located on the virulence 
plasmids pXO1 (anthrax toxin genes) and pXO2 (capsule synthesis genes). Other 
AtxA-regulated genes encode secreted proteins and proteins implicated in 
transcriptional regulation and signaling (Bourgogne et al., 2003). Regarding the 
pneumococcal MgaSpn regulator, microarray experiments showed that it influences 
negatively the expression of several genes located within the rlrA pathogenicity islet 
(Hemsley et al., 2003). Moreover, MgaSpn activates directly the expression of a four-
gene operon of unknown function (Solano-Collado et al., 2012). In S. pyogenes, the 
global regulator Mga is known to regulate, directly or indirectly, the expression of 
approximately 10% of its genome. It activates the transcription of numerous genes that 
enable the bacterium to colonize specific host tissues and evade the host immune 
response (Ribardo and McIver, 2006). Additionally, Mga has a positive or negative 
effect on the expression of various genes involved in the transport and utilization of 
sugars and other metabolites (Hondorp and McIver, 2007). In this Thesis, we have 
demonstrated that the MAEfa protein of E. faecalis, like the regulators of the Mga/AtxA 
family, influences the transcription of numerous genes. By genome-wide microarrays, 
quantitative RT-PCR assays, and complementation studies, we have shown that 
MAEfa increases the expression of many genes that encode components of PTS 
transporters, components of ABC transporters, and proteins involved in the metabolism 
of carbon sources.  
 
In bacteria, the PTS catalyzes the transport and phosphorylation of a variety of 
sugars and sugars derivatives (Deutscher et al., 2014). The PTS is usually composed 
of two general components, enzyme I (EI) and HPr, and the sugar-specific-
components, enzyme IIA (EIIA), enzyme IIB (EIIB), enzyme IIC (EIIC). In mannose-
type PTS there is an additional component, enzyme IID (EIID). Genes encoding the 
sugar-specific components are normally organized in an operon, which often contains 
the genes required for the catabolism of the transported sugar (Deutscher et al., 2014). 
The sugars most commonly metabolized by enterococci are PTS substrates (Ramsey 
et al., 2014). In addition, the PTS carries out regulatory functions (Deutscher et al., 
2014). In some pathogenic streptococci and Salmonella, mutagenesis screenings 
identified some PTS genes as virulence factors (Hava and Camilli, 2002; Jones et al., 
2000; Turner et al., 1998). Our microarray analysis showed that MAEfa influences 
positively the expression of numerous PTS genes, as mtlA2 and mltF2 (mannitol PTS 
transporter). Both genes and mtlD constitute the OG1RF_10296-98 operon. Associated 
to this result, the growth of the mutant strain (OG1RFΔmaEfa) was slightly reduced in 
M9YE medium supplemented with mannitol (compared to the OG1RF wild-type strain). 
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Gene mtlD was reported to be significantly up-regulated during growth of E. faecalis in 
the intestinal tract of mice (Lindenstraüss et al., 2014). In this study, genes encoding a 
mannose-class PTS transporter (the gluconate PTS transporter) were also up-
regulated (Lindenstraüss et al., 2014). Such genes are located within two operons 
(nine genes) involved in gluconate utilization (OG1RF_12399-97 and OG1RF_12405-
00). Our results showed that MAEfa has a positive effect on the expression of both 
operons. The expression of such operons was also enhanced during the growth of E. 
faecalis in blood (Vebø et al., 2009). Furthermore, MAEfa has a positive effect on the 
expression of the putative operon OG1RF_11616-11, which encodes another 
mannose-class PTS transporter. Zúñiga et al. (2005) suggested that mannose-class 
PTS transporters might play a significant role in the adaptation of bacteria to epithelial 
surfaces. In addition to PTS transporters, MAEfa influences positively the expression of 
several operons encoding ABC transporters. Among them, the OG1RF_11135-33 
operon (sugar substrate) was found to be up-regulated during growth of E. faecalis in 
blood (Vebø et al., 2009). Therefore, MAEfa increases the expression of PTS and ABC 
transporters that are apparently involved in the metabolic adaptation of E. faecalis to 
various environments.  
 
MAEfa has also a positive effect on the transcription of genes involved in the 
utilization of citrate (OG1RF_12572-73 and OG1RF_12571-60) and maltose (malP, 
malB and malT). Such genes were found to be up-regulated during growth of E. 
faecalis in blood (Vebø et al., 2009), as well as several genes of both pathways were 
up-regulated during its growth in human urine (Vebø et al., 2010). In our study, 
additionally, we observed that the OG1RFΔmaEfa strain showed a diminished growth 
in M9YE medium supplemented with maltose compared to the OG1RF strain. 
Regarding other carbon sources, MAEfa influences positively the transcription of the 
two operons involved in glycerol metabolism (the GlpO/GlpK and GldA/DhaK 
pathways), although the activator effect seems to be greater on the genes of the 
GldA/DhaK pathway. Moreover, we found that the growth of the OG1RFΔmaEfa strain 
is impaired in M9YE medium supplemented with glycerol. Vebo et al. (2009) found that 
the glpKOF operon (GlpO/GlpK pathway) was highly up-regulated during growth of E. 
faecalis in blood, and they suggested that glycerol and other C3-glycerides from blood 
serve as a source of energy. Glycerol seems to be also an important substrate for this 
bacterium in the intestinal tract of mice, as it was proposed by Lindenstraüss et al. 
(2014). They observed that both glycerol catabolic operons were up-regulated during 
the adaptation of E. faecalis to the intestinal tract of mice. Thus, we hypothesize that 
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MAEfa may facilitate the adaptation of E. faecalis to particular host niches activating 
the transcription of genes involved in the utilization of specific carbon sources.  
 
The potential role of MAEfa in virulence was studied at the Helmholtz Centre for 
Infection Research, under the supervision of Dr. Oliver Goldmann (Infection and 
Immunology Group). In a first approach, we used different in vitro infection models, as 
well as the wild-type strain (OG1RF) and the maEfa deletion mutant strain 
(OG1RFΔmaEfa). First, we compared several parameters of bacterial killing by both 
murine immortalized macrophages and bone-marrow derived macrophages (not 
shown). Then, by fluorescence microscopic approaches, we compared the adherence 
of both strains to human epithelial cells. In all cases, no significant differences were 
found between wild-type and mutant strains. Therefore, we tested a mouse peritonitis 
model. Using this model, some global regulators were shown to contribute to the 
pathogenesis of E. faecalis, for instance, FsrA. (Qin et al., 2000), PerA (Coburn et al., 
2008) and the PrfA-like regulator Ers (Giard et al., 2006). In this Thesis, we have 
shown that E. faecalis cells lacking MAEfa are less virulent in a mouse peritonitis 
model. Compared to the wild-type strain, the maEfa deletion mutant strain induced a 
more moderate inflammation in terms of infiltration of neutrophils and cytokine 
response (IL-6), but no significant reduction in the bacterial loads within the peritoneal 
cavity was observed. However, the precise underlying molecular mechanisms of how 
this regulatory axis is contributing to bacterial virulence need to be elucidated in further 
studies. Recently, Muller et al. (2015) analysed the transcriptome of E. faecalis isolated 
from an infection site (mouse peritonitis). Among the genes differentially expressed, 
they found that the OG1RF_10454-56 operon (lacR-fruk2-fruA) was down-regulated, 
whereas the OG1RF_11135-33 operon (ABC transporter) and the two operons 
involved in glycerol catabolism were highly induced. Moreover, Muller et al. (2015) 
found that mutants unable to metabolize glycerol are affected in organ colonization in a 
systemic murine infection model. Interestingly, MAEfa has a negative effect on the 
expression of the lacR-fruk2-fruA operon, but a positive effect on the expression of the 
other mentioned operons. Thus, some MAEfa-regulated genes are differentially 
expressed during the intraperitoneal infection process. Taken together, our results 
suggest that MAEfa facilitates the adaptation of E. faecalis to particular host niches 
through the transcriptional regulation of numerous genes and, consequently, it 
contributes to its potential virulence.  
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 The functional characterization of the E. faecalis MAEfa protein presented in 
this Thesis supports that MAEfa is a new member of the Mga/AtxA family of global 
transcriptional regulators. The main conclusions of this work are: 
 
1. We have developed new plasmid-based genetic tools suitable for E. faecalis and S. 
pneumoniae: a promoter-probe vector (plasmid pAST), a terminator-probe vector (pAS) 
and two expression vectors (pDLF and pDLS). All of them are based on broad host-
range plasmids. 
 
2. The maEfa gene is transcribed in vivo from the Pma promoter. The transcription 
start site of this gene is located 15 nucleotides upstream of the predicted translation 
start codon. 
 
3.  Upstream of the Pma promoter there is a functional intrinsic transcriptional 
terminator. 
 
4. We have set up a procedure to purify an untagged form of the MAEfa protein. This 
protein forms dimers in solution. 
 
5. MAEfa binds to linear double-stranded DNAs with little or no sequence specificity, 
generating multimeric DNA-protein complexes. 
 
6. The presence of a His-tag at the C-terminus of MAEfa does not affect the formation 
of multimeric DNA-protein complexes. 
 
7. MAEfa recognizes a site located upstream of the Pma promoter (positions -73 to -
110). This site has a potential intrinsic curvature. 
 
8. MAEfa influences positively the expression of numerous genes involved in the 
utilization of carbon sources, including genes that encode components of PTS and 
ABC membrane transporters. Associated to this fact, the growth of a maEfa deletion 
mutant strain is impaired in media containing glycerol, maltose or mannitol.  
 
9. E. faecalis cells deficient in MAEfa are less virulent in a mouse peritonitis model. 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 
  
 
REFERENCES 
 
 
151 
 
Agudelo Higuita, N., and Huycke, M. (2014). Enterococcal disease, epidemiology, and 
implications for treatment. In Gilmore MS, Clewell DB, Ike Y, et al, editors 
Enterococci: From Commensals to Leading Causes of Drug Resistant Infection 
[Internet] ( Boston: Massachusetts Eye and Ear Infirmary), pp. 1-27. 
Almengor, A.C., and McIver, K.S. (2004). Transcriptional activation of sclA by Mga 
requires a distal binding site in Streptococcus pyogenes. J Bacteriol 186, 7847-
7857. 
Almengor, A.C., Walters, M.S., and McIver, K.S. (2006). Mga is sufficient to activate 
transcription in vitro of sof-sfbX and other Mga-regulated virulence genes in the 
group A Streptococcus. J Bacteriol 188, 2038-2047. 
Arias, C.A., and Murray, B.E. (2012). The rise of the Enterococcus: beyond 
vancomycin resistance. Nat Rev Micro 10, 266-278. 
Ballering, K.S., Kristich, C.J., Grindle, S.M., Oromendia, A., Beattie, D.T., and Dunny, 
G.M. (2009). Functional genomics of Enterococcus faecalis: multiple novel 
genetic determinants for biofilm formation in the core genome. J Bacteriol 191, 
2806-2814. 
Benachour, A., Muller, C., Dabrowski-Coton, M., Le Breton, Y., Giard, J., Rincé, A., 
Auffray, Y., and Hartke, A. (2005). The Enterococcus faecalis SigV protein Is an 
extracytoplasmic function sigma factor contributing to survival following heat, 
acid, and ethanol treatments. J Bacteriol 187, 1022-1035. 
Bisno, A.L., Brito, M.O., and Collins, C.M. (2003). Molecular basis of group A 
streptococcal virulence. Lancet Infect Dis 3, 191-200. 
Biswas, I., Gruss, A., Ehrlich, S.D., and Maguin, E. (1993). High-efficiency gene 
inactivation and replacement system for gram-positive bacteria. J Bacteriol 175, 
3628-3635. 
Blancato, V.S., and Magni, C. (2010). A chimeric vector for efficient chromosomal 
modification in Enterococcus faecalis and other lactic acid bacteria. Lett Applied 
Microbiol 50, 542-546. 
Blancato, V.S., Repizo, G.D., Suárez, C.A., and Magni, C. (2008). Transcriptional 
regulation of the citrate gene cluster of Enterococcus faecalis involves the GntR 
family transcriptional activator CitO. J Bacteriol 190, 7419-7430. 
REFERENCES 
 
 
152 
 
Bogaert, D., de Groot, R., and Hermans, P.W. (2004). Streptococcus pneumoniae 
colonisation: the key to pneumococcal disease. Lancet Infect Dis 4, 144-154. 
Bongiorni, C., Fukushima, T., Wilson, A.C., Chiang, C., Mansilla, M.C., Hoch, J.A., and 
Perego, M. (2008). Dual promoters control expression of the Bacillus anthracis 
virulence factor AtxA. J Bacteriol 190, 6483-6492. 
Bourgogne, A., Drysdale, M., Hilsenbeck, S.G., Peterson, S.N., and Koehler, T.M. 
(2003). Global effects of virulence gene regulators in a Bacillus anthracis strain 
with both virulence plasmids. Infect Immun 71, 2736-2743. 
Bourgogne, A., Garsin, D.A., Qin, X., Singh, K.V., Sillanpaa, J., Yerrapragada, S., Ding, 
Y., Dugan-Rocha, S., Buhay, C., Shen, H., Chen G., Williams G., Muzny D., 
Maadani A., Fox K.A., Gioia J., Chen L., Shang Y., Arias C.A., Nallapareddy 
S.R., Zhao M., Prakash V.P., Chowdhury S., Jiang H., Gibbs R.A., Murray B.E., 
Highlander S.K., and Weinstock G.M. (2008). Large scale variation in 
Enterococcus faecalis illustrated by the genome analysis of strain OG1RF. 
Genome Biol 9, R110-R110. 
Bourgogne, A., Hilsenbeck, S.G., Dunny, G.M., and Murray, B.E. (2006). Comparison 
of OG1RF and an isogenic fsrB deletion mutant by transcriptional analysis: the 
Fsr system of Enterococcus faecalis is more than the activator of gelatinase and 
serine protease. J Bacteriol 188, 2875-2884. 
Brosius, J. (1984). Plasmid vectors for the selection of promoters. Gene 27, 151-160. 
Brosius, J., Dull, T.J., Sleeter, D.D., and Noller, H.F. (1981). Gene organization and 
primary structure of a ribosomal RNA operon from Escherichia coli. J Mol Biol 
148, 107-127. 
Capra, E., J., and Laub, M., T. (2012). Evolution of Two-Component Signal 
Transduction Systems. Annu Rev Microbiol 66, 325-347. 
Carey, J. (1991). Gel retardation. Methods Enzymol 208, 103-117. 
Clewell, D., Weaver, K., Dunny, G., Coque, T.M., Francia, M.V., and Hayes, F. (2014). 
Extrachromosomal and mobile elements in enterococci: transmission, 
maintenance, and epidemiology. In Gilmore M.S., Clewell D.B., Ike Y., et al, 
editors Enterococci: From Commensals to Leading Causes of Drug Resistant 
Infection [Internet] ( Boston: Massachusetts Eye and Ear Infirmary). 
REFERENCES 
 
 
153 
 
Coburn, P.S., Baghdayan, A.S., Dolan, G.T., and Shankar, N. (2008). An AraC-type 
transcriptional regulator encoded on the Enterococcus faecalis pathogenicity 
island contributes to pathogenesis and intracellular macrophage survival. Infect 
Immun 76, 5668-5676. 
Cohen, A.L.V., Roh, J.H., Nallapareddy, S.R., Hook, M., and Murray, B.E. (2013). 
Expression of the collagen adhesin ace by Enterococcus faecalis strain OG1RF 
is not repressed by Ers but requires the Ers box. FEMS Microbiol Lett 344, 18-24. 
Cole, J.L. (2004). Analysis of heterogeneous interactions. Methods Enzymol 384, 212-
232. 
Cormack, B.P., Valdivia, R.H., Falkow, S. (1996). FACS-optimized mutants of the 
green fluorescent protein (GFP). Gene 173, 33-38. 
Cunningham, M.W. (2000). Pathogenesis of group A streptococcal infections. Clin 
Microbiol Rev 13, 470-511. 
Chan, P.F., O'Dwyer, K.M., Palmer, L.M., Ambrad, J.D., Ingraham, K.A., So, C., 
Lonetto, M.A., Biswas, S., Rosenberg, M., Holmes, D.J., Zalacain, M. (2003). 
Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene 
essentiality and antibacterial mode-of-action studies in Streptococcus 
pneumoniae. J Bacteriol 185, 2051-2058. 
Chan, W.T., Yeo, C.C., Sadowy, E., and Espinosa, M. (2014). Functional validation of 
putative toxin-antitoxin genes from the Gram-positive pathogen Streptococcus 
pneumoniae: phd-doc is the fourth bona-fide operon. Front Microbiol 5: 677. 
Dai, Z., and Koehler, T.M. (1997). Regulation of anthrax toxin activator gene (atxA) 
expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA 
synthesis. Infect Immun 65, 2576-2582. 
de Jong, A., Pietersma, H., Cordes, M., Kuipers, O., and Kok, J. (2012). PePPER: a 
webserver for prediction of prokaryote promoter elements and regulons. BMC 
Genomics 13, 299. 
del Solar, G., Giraldo, R., Ruiz-Echevarria, M.J., Espinosa, M., and Diaz-Orejas, R. 
(1998). Replication and control of circular bacterial plasmids. Microbiol Mol Biol 
Rev 62, 434-464. 
REFERENCES 
 
 
154 
 
del Solar, G., Kramer, G., Ballester, S., and Espinosa, M. (1993). Replication of the 
promiscuous plasmid pLS1: a region encompassing the minus origin of 
replication is associated with stable plasmid inheritance. Mol Gen Genet 241, 97-
105. 
Deutscher, J., Aké, F.M.D., Derkaoui, M., Zébré, A.C., Cao, T.N., Bouraoui, H., 
Kentache, T., Mokhtari, A., Milohanic, E., and Joyet, P. (2014). The bacterial 
phosphoenolpyruvate:carbohydrate phosphotransferase system: regulation by 
protein phosphorylation and phosphorylation-dependent protein-protein 
interactions. Microbiol Mol Biol Rev 78, 231-256. 
Dower, W.J., Miller, J.F., and Ragsdale, C.W. (1988). High efficiency transformation of 
E.coli by high voltage electroporation. Nucleic Acids Res 16, 6127-6145. 
Dunny, G.M., Brown, B.L., and Clewell, D.B. (1978). Induced cell aggregation and 
mating in Streptococcus faecalis: evidence for a bacterial sex pheromone. Proc 
Natl Acad Sci USA 75, 3479-3483. 
Engelbert, M., Mylonakis, E., Ausubel, F.M., Calderwood, S.B., and Gilmore, M.S. 
(2004). Contribution of gelatinase, serine protease, and fsr to the pathogenesis of 
Enterococcus faecalis endophthalmitis. Infect Immun 72, 3628-3633. 
Fabretti, F., Theilacker, C., Baldassarri, L., Kaczynski, Z., Kropec, A., Holst, O., and 
Huebner, J. (2006). Alanine esters of enterococcal lipoteichoic acid play a role in 
biofilm formation and resistance to antimicrobial peptides. Infect Immun 74, 4164-
4171. 
Fisher, K., and Phillips, C. (2009). The ecology, epidemiology and virulence of 
Enterococcus. Microbiology 155 1749-1757. 
Fouet, A. (2010). AtxA, a Bacillus anthracis global virulence regulator. Res Microbio, 
161, 735-742. 
Fujimoto, D.F., Brunskill, E.W., and Bayles, K.W. (2000). Analysis of genetic elements 
controlling Staphylococcus aureus lrgAB expression: potential role of DNA 
topology in SarA regulation. J Bacteriol 182, 4822-4828. 
Gabrielian, A., Vlahovicek, K., and Pongor, S. (1997). Distribution of sequence-
dependent curvature in genomic DNA sequences. FEBS Lett 406, 69-74. 
REFERENCES 
 
 
155 
 
Garsin, D., Frank, K., and Silanpää J.(2014). Pathogenesis and models of enterococcal 
infection. In Gilmore MS, Clewell DB, Ike Y, et al, editors Enterococci: From 
Commensals to Leading Causes of Drug Resistant Infection [Internet] (Boston: 
Massachusetts Eye and Ear Infirmary). 
Garsin, D.A., Sifri, C.D., Mylonakis, E., Qin, X., Singh, K.V., Murray, B.E., Calderwood, 
S.B., and Ausubel, F.M. (2001). A simple model host for identifying Gram-positive 
virulence factors. Proc Natl Acad Sci USA 98, 10892-10897. 
Giard, J.C., Riboulet, E., Verneuil, N., Sanguinetti, M., Auffray, Y., and Hartke, A. 
(2006). Characterization of Ers, a PrfA-like regulator of Enterococcus faecalis. 
FEMS Immunol Med Microbiol 46, 410-418. 
Gruber, S. (2014). Multilayer chromosome organization through DNA bending, bridging 
and extrusion. Curr Opin Microbiol 22, 102-110. 
Gruber, T.M., and Gross, C.A. (2003). Multiple sigma subunits and the partition of the 
transcriptional space. Annu Rev Microbiol 57, 441-466. 
Hadjifrangiskou, M., and Koehler, T.M. (2008). Intrinsic curvature associated with the 
coordinately regulated anthrax toxin gene promoters. Microbiology 154, 2501-
2512. 
Hammerstrom, T.G., Horton, L.B., Swick, M.C., Joachimiak, A., Osipiuk, J., and 
Koehler, T.M. (2015). Crystal structure of Bacillus anthracis virulence regulator 
AtxA and effects of phosphorylated histidines on multimerization and activity. Mol 
Microbiol 95, 426-441. 
Hammerstrom, T.G., Roh, J.H., Nikonowicz, E.P., and Koehler, T.M. (2011). Bacillus 
anthracis virulence regulator AtxA: oligomeric state, function and CO2 -signalling. 
Mol Microbiol 82, 634-647. 
Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. J Mol 
Biol 166, 557-580. 
Hancock, L., and Perego, M. (2002). Two-Component signal transduction in 
Enterococcus faecalis. J Bacteriol 184, 5819-5825. 
REFERENCES 
 
 
156 
 
Hancock, L.E., and Gilmore, M.S. (2002). The capsular polysaccharide of 
Enterococcus faecalis and its relationship to other polysaccharides in the cell 
wall. Proc Natl Acad Sci USA 99, 1574-1579. 
Hancock, L.E., Shepard, B.D., and Gilmore, M.S. (2003). Molecular analysis of the 
Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol 185, 
4393-4401. 
Hause, L.L., and McIver, K.S. (2012). Nucleotides critical for the interaction of the 
Streptococcus pyogenes Mga virulence regulator with Mga-regulated promoter 
sequences. J Bacteriol 194, 4904-4919. 
Hava, D.L., and Camilli, A. (2002). Large-scale identification of serotype 4 
Streptococcus pneumoniae virulence factors. Mol Microbiol 45, 1389-1406. 
Heim, R., Cubitt, A.B., Tsien, R.Y. (1995). Improved green fluorescence. Nature 373, 
663-664. 
Hemsley, C., Joyce, E., Hava, D.L., Kawale, A., and Camilli, A. (2003). MgrA, an 
orthologue of Mga, acts as a transcriptional repressor of the genes within the rlrA 
pathogenicity islet in Streptococcus pneumoniae. J Bacteriol 185, 6640-6647. 
Hendrickx, A.P, Willems, R.J., Bonten, M.J., and van Schaik, W. (2009). LPxTG 
surface proteins of enterococci. Trends Microbiol 17, 423-430. 
Hollenbeck, B.L., and Rice, L.B. (2012). Intrinsic and acquired resistance mechanisms 
in Enterococcus. Virulence 3, 421-569. 
Hondorp, E.R., Hou, S.C., Hause, L.L., Gera, K., Lee, C.-E., and McIver, K.S. (2013). 
PTS phosphorylation of Mga modulates regulon expression and virulence in the 
group A streptococcus. Mol Microbiol 88, 1176-1193. 
Hondorp, E.R., Hou, S.C., Hempstead, A.D., Hause, L.L., Beckett, D.M., and McIver, 
K.S. (2012). Characterization of the Group A Streptococcus Mga virulence 
regulator reveals a role for the C-terminal region in oligomerization and 
transcriptional activation. Mol Microbiol 83, 953-967. 
Hondorp, E.R., and McIver, K.S. (2007). The Mga virulence regulon: infection where 
the grass is greener. Mol Microbiol 66, 1056-1065. 
REFERENCES 
 
 
157 
 
Hufnagel, M., Hancock, L.E., Koch, S., Theilacker, C., Gilmore, M.S., and Huebner, J. 
(2004a). Serological and genetic diversity of capsular polysaccharides in 
Enterococcus faecalis. J Clin Microbiol 42, 2548-2557. 
Hufnagel, M., Koch, S., Creti, R., Baldassarri, L., and Huebner, J. (2004b). A putative 
sugar-binding transcriptional regulator in a novel gene locus in Enterococcus 
faecalis contributes to production of biofilm and prolonged bacteremia in mice. J 
Infect Dis 189, 420-430. 
Huycke, M.M., and Gilmore, M.S. (1995). Frequency of aggregation substance and 
cytolysin genes among enterococcal endocarditis isolates. Plasmid 34, 152-156. 
Huycke, M.M., Spiegel, C.A., and Gilmore, M.S. (1991). Bacteremia caused by 
hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob 
Agents Chemother 35, 1626-1634. 
Ike, Y., Hashimoto, H., and Clewell, D.B. (1984). Hemolysin of Streptococcus faecalis 
subspecies zymogenes contributes to virulence in mice. Infect Immun 45, 528-
530. 
Ike, Y., Hashimoto, H., and Clewell, D.B. (1987). High incidence of hemolysin 
production by Enterococcus (Streptococcus) faecalis strains associated with 
human parenteral infections. J Clin Microbiol 25, 1524-1528. 
Innocenti, N., Golumbeanu, M., Fouquier d'Hérouël, A., Lacoux, C., Bonnin, R.A., 
Kennedy, S.P., Wessner, F., Serror, P., Bouloc, P., Repoila, F., Aurell E. (2015). 
Whole-genome mapping of 5' RNA ends in bacteria by tagged sequencing: a 
comprehensive view in Enterococcus faecalis. RNA 21, 1018-1030. 
Jacob, A.E., and Hobbs, S.J. (1974). Conjugal transfer of plasmid-borne multiple 
antibiotic resistance in Streptococcus faecalis var. zymogenes. J Bacteriol 117, 
360-372 
Johnson, M., Zaretskaya, I., Raytselis, Y., Merezhuk, Y., McGinnis, S., and Madden, 
T.L. (2008). NCBI BLAST: a better web interface. Nucleic Acids Res 36, W5-9. 
 
Jones, A.L., Knoll, K.M., and Rubens, C.E. (2000). Identification of Streptococcus 
agalactiae virulence genes in the neonatal rat sepsis model using signature-
tagged mutagenesis. Mol Microbiol 37, 1444-1455. 
REFERENCES 
 
 
158 
 
Kelley, L.A., and Sternberg, M.J.E. (2009). Protein structure prediction on the Web: a 
case study using the Phyre server. Nat Protoc 4, 363-371. 
Kemp, K.D., Singh, K.V., Nallapareddy, S.R., and Murray, B.E. (2007). Relative 
contributions of Enterococcus faecalis OG1RF sortase-encoding genes, srtA and 
bps (srtC), to biofilm formation and a murine model of urinary tract infection. 
Infect Immun 75, 5399-5404. 
Kreft, B., Marre, R., Schramm, U., and Wirth, R. (1992). Aggregation substance of 
Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect 
Immun 60, 25-30. 
Lacks, S., and Greenberg, B. (1977). Complementary specificity of restriction 
endonucleases of Diplococcus pneumoniae with respect to DNA methylation. J 
Mol Biol 114, 153-168. 
Lacks, S.A. (1966). Integration efficiency and genetic recombination in pneumococcal 
transformation. Genetics 53, 207-235. 
Lacks, S.A., Greenberg, B., and Lopez, P. (1995). A cluster of four genes encoding 
enzymes for five steps in the folate biosynthetic pathway of Streptococcus 
pneumoniae. J Bacteriol 177, 66-74. 
Lacks, S.A., Lopez, P., Greenberg, B., and Espinosa, M. (1986). Identification and 
analysis of genes for tetracycline resistance and replication functions in the 
broad-host-range plasmid pLS1. J Mol Biol 192, 753-765. 
Laniel, M.-A., Béliveau, A., and Guérin, S.L. (2001). Electrophoretic mobility shift 
assays for the analysis of DNA-Protein interactions. In DNA-Protein Interactions 
(Humana Press), pp. 13-30. 
Laue, T.M., Shah, B.D., Ridgeway, T.M., and Pelletier, S.L. (1992). Analytical 
ultracentrifugation in biochemistry and polymer sciences. Harding S.E., Rowe A., 
Horton J.C editors Cambridge: Royal Society of Chemistry, pp. 90-125 
LeBlanc, D.J., Chen, Y.Y., and Lee, L.N. (1993). Identification and characterization of a 
mobilization gene in the streptococcal plasmid, pVA380-1. Plasmid 30, 296-302. 
Lebreton, F., Riboulet-Bisson, E., Serror, P., Sanguinetti, M., Posteraro, B., Torelli, R., 
Hartke, A., Auffray, Y., and Giard, J.C. (2009). ace, which encodes an adhesin in 
REFERENCES 
 
 
159 
 
Enterococcus faecalis, is regulated by Ers and is involved in virulence. Infect 
Immun 77, 2832-2839. 
Lebreton, F., Willems, R., and Gilmore, M. (2014). Enterococcus diversity, origins in 
nature, and gut colonization. In Gilmore MS, Clewell DB, Ike Y, et al, editors 
Enterococci: From Commensals to Leading Causes of Drug Resistant Infection 
[Internet] (Boston: Massachusetts Eye and Ear Infirmary). 
Le Breton, Y., Pichereau, V., Sauvageot, N., Auffray, Y., and Rincé, A. (2005). Maltose 
utilization in Enterococcus faecalis. J Appl Microbiol 98, 806-813. 
Lin, H., Deng, E.-Z., Ding, H., Chen, W., and Chou, K.-C. (2014). iPro54-PseKNC: a 
sequence-based predictor for identifying sigma-54 promoters in prokaryote with 
pseudo k-tuple nucleotide composition. Nucleic Acids Res 42, 12961-12972. 
Lindenstraüss, A.G., Ehrmann, M.A., Behr, J., Landstorfer, R., Haller, D., Sartor, R.B., 
and Vogel, R.F. (2014). Transcriptome analysis of Enterococcus faecalis toward 
its adaption to surviving in the mouse intestinal tract. Arch Microbiol 196, 423-
433. 
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data 
using real-time quantitative PCR and the CT Method. Methods 25, 402-408. 
López, P., Espinosa, M., Greenberg, B., and Lacks, S.A. (1987). Sulfonamide 
resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding 
dihydropteroate synthase and characterization of the enzyme. J Bacteriol 169, 
4320-4326. 
López, P., Martínez, S., Díaz, A., Espinosa, M., and Lacks, S.A. (1989). 
Characterization of the polA gene of Streptococcus pneumoniae and comparison 
of the DNA polymerase I it encodes to homologous enzymes from Escherichia 
coli and phage T7. J Biol Chem 264, 4255-4263. 
Maddox, S.M., Coburn, P.S., Shankar, N., and Conway, T. (2012). Transcriptional 
regulator PerA influences biofilm-associated, platelet binding, and metabolic gene 
expression in Enterococcus faecalis. PLoS ONE 7, e34398. 
Maniatis, T., Fritsch, E.F., and Sambrook, J. (1982). Molecular cloning: a laboratory 
manual. Cold Spring Harbor Laboratory Press New York. 
REFERENCES 
 
 
160 
 
Marchler-Bauer, A., Derbyshire, M.K., Gonzales, N.R., Lu, S., Chitsaz, F., Geer, L.Y., 
Geer, R.C., He, J., Gwadz, M., Hurwitz, D.I., Lanczycki, C.J.,Lu, F.,Marchler, G.H., 
Song, J.S.,Thanki, N.,Wang, Z.,Yamashita, R. A., Zhang, D.,Zheng, C., and Bryant, S. 
H.(2015). CDD: NCBI's conserved domain database. Nucleic Acids Res 43, D222-
D226. 
 
McIver, K.S. (2009). Stand-alone response regulators controlling global virulence 
networks in Streptococcus pyogenes. Contrib Microbiol 16, 103-119. 
 
McIver, K.S., Heath, A.S., Green, B.D., and Scott, J.R. (1995). Specific binding of the 
activator Mga to promoter sequences of the emm and scpA genes in the group A 
Streptococcus. J Bacteriol 177, 6619-6624. 
McIver, K.S., and Myles, R.L. (2002). Two DNA-binding domains of Mga are required 
for virulence gene activation in the group A streptococcus. Mol Microbiol 43, 
1591-1601. 
McIver, K.S., Thurman, A.S., and Scott, J.R. (1999). Regulation of mga transcription in 
the Group A Streptococcus: specific binding of Mga within its own promoter and 
evidence for a negative regulator. J Bacteriol 181, 5373-5383. 
Méjean, V., Rives, I., and Claverys, J.P. (1990). Nucleotide sequence of the 
Streptococcus pneumoniae ung gene encoding uracil-DNA glycosylase. Nucleic 
Acids Res 18, 6693. 
Merino, E., and Yanofsky, C. (2005). Transcription attenuation: a highly conserved 
regulatory strategy used by bacteria. Trends Genet 21, 260-264. 
Michaux, C., Sanguinetti, M., Reffuveille, F., Auffray, Y., Posteraro, B., Gilmore, M.S., 
Hartke, A., and Giard, J.-C. (2011). SlyA Is a transcriptional regulator involved in 
the virulence of Enterococcus faecalis. Infect Immun 79, 2638-2645. 
Miller, W.G., and Lindow, S.E. (1997). An improved GFP cloning cassette designed for 
prokaryotic transcriptional fusions. Gene 191, 149-153. 
Minchin, S.D., and Busby, S.J.W. (2009). Analysis of mechanisms of activation and 
repression at bacterial promoters. Methods 47, 6-12. 
REFERENCES 
 
 
161 
 
Mitchell, J.E., Zheng, D., Busby, S.J.W., and Minchin, S.D. (2003). Identification and 
analysis of ‘extended –10’ promoters in Escherichia coli. Nucleic Acids Res 31, 
4689-4695. 
Mitra, A., Kesarwani, A.K., Pal, D., and Nagaraja, V. (2010). WebGeSTer DB-a 
transcription terminator database. Nucleic Acids Res 39, D129-D135. 
Mohamed, J.A., Huang, W., Nallapareddy, S.R., Teng, F., and Murray, B.E. (2005). 
Influence of origin of isolates, especially endocarditis isolates, and various genes 
on biofilm formation by Enterococcus faecalis. Infect Immun 72, 3658-3663. 
Muller, C., Cacaci, M., Sauvageot, N., Sanguinetti, M., Rattei, T., Eder, T., Giard, J.-C., 
Kalinowski, J., Hain, T., and Hartke, A. (2015). The intraperitoneal transcriptome 
of the opportunistic pathogen Enterococcus faecalis in mice. PLoS ONE 10, 
e0126143. 
Murray, B.E. (1990). The life and times of the Enterococcus. Clin Microbiol Rev 3, 46-
65. 
Mylonakis, E., Engelbert, M., Qin, X., Sifri, C.D., Murray, B.E., Ausubel, F.M., Gilmore, 
M.S., and Calderwood, S.B. (2002). The Enterococcus faecalis fsrB gene, a key 
component of the fsr quorum-sensing system, is associated with virulence in the 
rabbit endophthalmitis model. Infect Immun 70, 4678-4681. 
Nakayama, J., Chen, S., Oyama, N., Nishiguchi, K., Azab, E.A., Tanaka, E., Kariyama, 
R., and Sonomoto, K. (2006). Revised model for Enterococcus faecalis fsr 
quorum-sensing system: the small open reading frame fsrD encodes the 
gelatinase biosynthesis-activating pheromone propeptide corresponding to 
staphylococcal AgrD. J Bacteriol 188, 8321-8326. 
Nallapareddy, S.R., Qin, X., Weinstock, G.M., Höok, M., and Murray, B.E. (2000a). 
Enterococcus faecalis adhesin, Ace, mediates attachment to extracellular matrix 
proteins collagen type IV and laminin as well as collagen type I. Infect Immun 68, 
5218-5224. 
Nallapareddy, S.R., Sillanpää, J., Mitchell, J., Singh, K.V., Chowdhury, S.A., 
Weinstock, G.M., Sullam, P.M., and Murray, B.E. ( 2011). Conservation of Ebp-
type pilus genes among enterococci and demonstration of their role in adherence 
of Enterococcus faecalis to human platelets. Infect Immun 79, 2911-2920. 
REFERENCES 
 
 
162 
 
Nallapareddy, S.R., Singh, K.V., Duh, R.-W., Weinstock, G.M., and Murray, B.E. 
(2000b). Diversity of ace, a gene encoding a microbial surface component 
recognizing adhesive matrix molecules, from different strains of Enterococcus 
faecalis and evidence for production of Ace during human infections. Infect 
Immun 68, 5210-5217. 
Nallapareddy, S.R., Singh, K.V., Sillanpää, J., Garsin, D.A., Höök, M., Erlandsen, S.L., 
and Murray, B.E. (2006). Endocarditis and biofilm-associated pili of Enterococcus 
faecalis. J Clini Invest 116, 2799-2807. 
Naville, M., and Gautheret, D. (2009). Transcription attenuation in bacteria: theme and 
variations. Brief Funct Genomic Proteomic 8, 482-492. 
 
Naville, M., Ghuillot-Gaudeffroy, A., Marchais, A., and Gautheret, D. (2011). ARNold: a 
web tool for the prediction of Rho-independent transcription terminators. RNA 
Biol 8, 11-13. 
Nieto, C., and Espinosa, M. (2003). Construction of the mobilizable plasmid 
pMV158GFP, a derivative of pMV158 that carries the gene encoding the green 
fluorescent protein. Plasmid 49, 281-285. 
Okada, N., Geist, R.T., and Caparon, M.G. (1993). Positive transcriptional control of 
mry regulates virulence in the group A streptococcus. Mol Microbiol 7, 893-903. 
Olmsted, S.B., Kao, S.M., van Putte, L.J., Gallo, J.C., and Dunny, G.M. (1991). Role of 
the pheromone-inducible surface protein Asc10 in mating aggregate formation 
and conjugal transfer of the Enterococcus faecalis plasmid pCF10. J Bacteriol 
173, 7665-7672 
Osipiuk, J., Wu, R., Jedrzejczak, R., Moy, S., and Joachimiak, A. (2011). Putative Mga 
family transcriptional regulator from Enterococcus faecalis. 
Park, S.Y., Shin, Y.P., Kim, C.H., Park, H.J., Seong, Y.S., Kim, B.S., Seo, S.J., and 
Lee, I.H. (2008). Immune evasion of Enterococcus faecalis by an extracellular 
gelatinase that cleaves C3 and iC3b. J Immunol 181, 6328-6336. 
Paterson, G.K., and Mitchell, T.J. (2006). The role of Streptococcus pneumoniae 
sortase A in colonisation and pathogenesis. Microbes Infec 8, 145-153. 
REFERENCES 
 
 
163 
 
Paulsen, I.T., Banerjei, L., Myers, G.S.A., Nelson, K.E., Seshadri, R., Read, T.D., 
Fouts, D.E., Eisen, J.A., Gill, S.R., Heidelberg, J.F., Tettelin H., Dodson R.J., 
Umayam L., Brinkac L., Beanan M., Daugherty S., DeBoy R.T., Durkin S., 
Kolonay J., Madupu R., Nelson W., Vamathevan J., Tran B., Upton J., Hansen T., 
Shetty J., Khouri H., Utterback T., Radune D., Ketchum K.A., Dougherty B.A., 
and Fraser C.M. (2003). Role of mobile DNA in the evolution of vancomycin-
resistant Enterococcus faecalis. Science 299, 2071-2074. 
Pessen, H., and Kumosinski, T.F. (1985). Measurements of protein hydration by 
various techniques. Methods Enzymol 117, 219-255. 
Qin, X., Singh, K.V., Weinstock, G.M., and Murray, B.E. (2000). Effects of 
Enterococcus faecalis fsr genes on production of gelatinase and a serine 
protease and virulence. Infect Immun 68, 2579-2586. 
Rakita, R.M., Vanek, N.N., Jacques-Palaz, K., Mee, M., Mariscalco, M.M., Dunny, 
G.M., Snuggs, M., Van Winkle, W.B., and Simon, S.I. (1999). Enterococcus 
faecalis bearing aggregation substance is resistant to killing by human 
neutrophils despite phagocytosis and neutrophil activation. Infect Immun 67, 
6067-6075. 
Ramsey, M., Hartke, A., and Huycke, M. (2014). The physiology and metabolism of 
Enterococci. In Gilmore MS, Clewell DB, Ike Y, et al Enterococci: From 
Commensals to Leading Causes of Drug Resistant Infection [Internet] (Boston: 
Massachusetts Eye and Ear Infirmary). 
Repizo, G.D., Blancato, V.S., Mortera, P., Lolkema, J.S., and Magni, C. (2013). 
Biochemical and genetic characterization of the Enterococcus faecalis 
oxaloacetate decarboxylase complex. Appl Environ Microbiol 79, 2882-2890. 
Ribardo, D.A., and McIver, K.S. (2006). Defining the Mga regulon: comparative 
transcriptome analysis reveals both direct and indirect regulation by Mga in the 
group A Streptococcus. Mol Microbiol 62, 491-508. 
Riboulet-Bisson, E., Hartke, A., Auffray, Y., and Giard, J.-C. (2009). Ers controls 
glycerol metabolism in Enterococcus faecalis. Curr Microbiol 58, 201-204. 
REFERENCES 
 
 
164 
 
Riboulet-Bisson, E., Sanguinetti, M., Budin-Verneuil, A.l., Auffray, Y., Hartke, A., and 
Giard, J.-C. (2008). Characterization of the Ers regulon of Enterococcus faecalis. 
Infect Immun 76, 3064-3074. 
Rice, P., Longden, I., and Bleasby, A. (2000). EMBOSS: The European Molecular 
Biology Open Software Suite. Trends Genet 16, 276-277. 
Rich, R.L., Kreikemeyer, B., Owens, R.T., LaBrenz, S., Narayana, S.V.L., Weinstock, 
G.M., Murray, B.E., and Höok, M. (1999). Ace is a collagen-binding MSCRAMM 
from Enterococcus faecalis. J Biol Chem 274, 26939-26945. 
Rohs, R., Jin, X., West, S.M., Joshi, R., Honig, B., and Mann, R.S. (2010). Origins of 
Specificity in Protein-DNA Recognition. Annu Rev Biochem 79, 233-269. 
Ross, W., and Gourse, R.L. (2009). Analysis of RNA polymerase-promoter complex 
formation. Methods 47, 13-24. 
Rozen, S., and Skaletsky, H. J. (2000) Primer3 on the WWW for general users and for 
biologist programmers. In: Krawetz S, Misener S (eds) Bioinformatics Methods 
and Protocols: Methods in Molecular Biology. Humana Press, Totowa, NJ, pp 
365-386. 
Ruiz-Cruz, S., Solano-Collado, V., Espinosa, M., and Bravo, A. (2010). Novel plasmid-
based genetic tools for the study of promoters and terminators in Streptococcus 
pneumoniae and Enterococcus faecalis. J Microbiol Methods 83, 156-163. 
Sabelnikov, A.G., Greenberg, B., and Lacks, S.A. (1995). An extended -10 promoter 
alone directs transcription of the DpnII operon of Streptococcus pneumoniae. J 
Mol Biol 250, 144-155. 
Sahm, D., Kissinger, J., Gilmore, M.S., Murray, P.R., Mulder, R., Solliday, J, and 
Clarke B. (1989). In vitro susceptibility studies of vancomycin-resistant 
Enterococcus faecalis. Antimicrob Agents Chemother 33, 1588-1591. 
Sanger, F., Nicklen, S., and Coulson, A.R. (1977). DNA sequencing with chain-
terminating inhibitors. Proc Natl Acad Sci USA 74, 5463-5467. 
Sanson, M., Makthal, N., Gavagan, M., Cantu, C., Olsen, R.J., Musser, J.M., and 
Kumaraswami, M. ( 2015). Phosphorylation events in the multiple gene regulator 
REFERENCES 
 
 
165 
 
of Group A Streptococcus significantly influence global gene expression and 
virulence. Infect Immun 83, 2382-2395. 
Sartingen, S., Rozdzinski, E., Muscholl-Silberhorn, A., and Marre, R. (2000). 
Aggregation substance increases adherence and internalization, but not 
translocation, of Enterococcus faecalis through different intestinal epithelial cells 
in vitro. Infect Immun 68, 6044-6047. 
Sava, I.G., Heikens, E., and Huebner, J. (2010). Pathogenesis and immunity in 
enterococcal infections. Clin Microbiol Infec 16, 533-540. 
Scott, J.A.G. (2007). The preventable burden of pneumococcal disease in the 
developing world. Vaccine 25, 2398-2405. 
Schägger, H., and von Jagow, G. (1987). Tricine-sodium dodecyl sulfate-
polyacrylamide gel electrophoresis for the separation of proteins in the range 
from 1 to 100 kDa. Anal Biochem 166, 368-379. 
Schlievert, P.M., Gahr, P.J., Assimacopoulos, A.P., Dinges, M.M., Stoehr, J.A., 
Harmala, J.W., Hirt, H., and Dunny, G.M. (1998). Aggregation and binding 
substances enhance pathogenicity in rabbit models of Enterococcus faecalis 
endocarditis. Infect Immun 66, 218-223. 
Schmittgen, T.D., and Livak, K.J. (2008). Analyzing real-time PCR data by the 
comparative CT method. Nat Protoc 3, 1101-1108. 
Schuck, P., and Rossmanith, P. (2000). Determination of the sedimentation coefficient 
distribution by least-squares boundary modeling. Biopolymers 54, 328-341. 
Serrano-Heras, G., Salas, M., and Bravo, A. (2005). A new plasmid vector for regulated 
gene expression in Bacillus subtilis. Plasmid 54, 278-282. 
Shankar, N., Baghdayan, A.S., and Gilmore, M.S. (2002). Modulation of virulence 
within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. 
Nature 417, 746-750. 
Shankar, N., Lockatell, C.V., Baghdayan, A.S., Drachenberg, C., Gilmore, M.S., and 
Johnson, D.E. (2001). Role of Enterococcus faecalis surface protein Esp in the 
pathogenesis of ascending urinary tract infection. Infect Immun 69, 4366-4372. 
REFERENCES 
 
 
166 
 
Shepard, B.D., and Gilmore, M.S. (1995). Electroporation and efficient transformation 
of Enterococcus faecalis grown in high concentrations of glycine. Methods Mol 
Biol 47, 217-226. 
Sifri, C.D., Mylonakis, E., Singh, K.V., Qin, X., Garsin, D.A., Murray, B.E., Ausubel, 
F.M., and Calderwood, S.B. (2002). Virulence effect of Enterococcus faecalis 
protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and 
mice. Infect Immun 70, 5647-5650. 
Sillanpää, J., Xu, Y., Nallapareddy, S.R., Murray, B.E., and Höök, M. (2004). A family 
of putative MSCRAMMs from Enterococcus faecalis. Microbiology 150, 2069-
2078. 
Simons, R.W.H., F. and Kleckner, N. (1987). Improved single and multicopy lac-based 
cloning vectors for protein and operon fusions. Gene 53, 85-96. 
Singh, K.V., Lewis, R.J., and Murray, B.E. (2009a). Importance of the epa locus of 
Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract 
infection. J Infect Dis 200, 417-420. 
Singh, K.V., Nallapareddy, S.R., Nannini, E.C., and Murray, B.E. (2005). Fsr-
independent production of protease(s) may explain the lack of attenuation of an 
Enterococcus faecalis fsr mutant versus a gelE-sprE mutant in induction of 
endocarditis. Infect Immun 73, 4888-4894. 
Singh, K.V., Nallapareddy, S.R., Sillanpää, J., and Murray, B.E. (2009b). Importance of 
the collagen adhesin Ace in pathogenesis and protection against Enterococcus 
faecalis experimental endocarditis. PLoS Pathog 6, e1000716. 
Singh, K.V., Qin, X., Weinstock, G.M., and Murray, B.E. (1998). Generation and testing 
of mutants of Enterococcus faecalis in a mouse peritonitis model. J Infect Dis 
178, 1416-1420. 
Solano-Collado, M.V. (2014). Caracterización molecular del regulador transcripcional 
MgaSpn de Streptococcus pneumoniae. Doctoral Thesis , Universidad 
Complutense de Madrid 
 
REFERENCES 
 
 
167 
 
Solano-Collado, V., Espinosa, M., and Bravo, A. (2012). Activator role of the 
pneumococcal Mga-like virulence transcriptional regulator. J Bacteriol 194, 4197-
4207. 
Solano-Collado, V., Lurz, R., Espinosa, M., and Bravo, A. (2013). The pneumococcal 
MgaSpn virulence transcriptional regulator generates multimeric complexes on 
linear double-stranded DNA. Nucleic Acids Res 41, 6975-6991. 
Song, K. (2012). Recognition of prokaryotic promoters based on a novel variable-
window Z-curve method. Nucleic Acids Res 40, 963-971. 
Srivastava, M., Mallard, C., Barke, T., Hancock, L.E., and Self, W.T. (2011). A 
selenium-dependent xanthine dehydrogenase triggers biofilm proliferation in 
Enterococcus faecalis through oxidant production. J Bacteriol 193, 1643-1652. 
Stassi, D.L., Lopez, P., Espinosa, M., and Lacks, S.A. (1981). Cloning of chromosomal 
genes in Streptococcus pneumoniae. Proc Natl Acad Sci USA 78, 7028-7032. 
Stella, S., Cascio, D., and Johnson, R.C. (2009). The shape of the DNA minor groove 
directs binding by the DNA-bending protein Fis. Genes Dev 24, 814-826. 
Sterba, K.M., Mackintosh, S.G., Blevins, J.S., Hurlburt, B.K., and Smeltzer, M.S. 
(2003). Characterization of Staphylococcus aureus SarA binding sites. J Bacteriol 
185, 4410-4417. 
Strauch, M.A., Ballar, P., Rowshan, A.J., and Zoller, K.L. (2005). The DNA-binding 
specificity of the Bacillus anthracis AbrB protein. Microbiology 151, 1751-1759. 
Studier, F.W., and Moffatt, B.A. (1986). Use of bacteriophage T7 RNA polymerase to 
direct selective high-level expression of cloned genes. J Mol Biol 189, 113-130. 
Suárez, C., Blancato, V., Poncet, S., Deutscher, J., and Magni, C. (2011). CcpA 
represses the expression of the divergent cit operons of Enterococcus faecalis 
through multiple cre sites. BMC Microbiol 11, 227-240. 
Süssmuth, S.D., Muscholl-Silberhorn, A., Wirth, R., Susa, M., Marre, R., and 
Rozdzinski, E. (2000). Aggregation substance promotes adherence, 
phagocytosis, and intracellular survival of Enterococcus faecalis within human 
macrophages and suppresses respiratory burst. Infect Immun 68, 4900-4906. 
REFERENCES 
 
 
168 
 
Teng, F., Jacques-Palaz, K.D., Weinstock, G.M., and Murray, B.E. (2002). Evidence 
that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in 
Enterococcus faecalis and influences resistance to phagocytic killing of E. 
faecalis. Infect Immun 70, 2010-2015. 
Theilacker, C., Sánchez-Carballo, P., Toma, I., Fabretti, F., Sava, I., Kropec, A., Holst, 
O., and Huebner, J. (2009). Glycolipids are involved in biofilm accumulation and 
prolonged bacteraemia in Enterococcus faecalis. Mol Microbiol 71, 1055-1069. 
Thomas, V.C., Hiromasa, Y., Harms, N., Thurlow, L., Tomich, J., and Hancock, L.E. 
(2009). A fratricidal mechanism is responsible for eDNA release and contributes 
to biofilm development of Enterococcus faecalis. Mol Microbiol 72, 1022-1036. 
Thurlow, L.R., Thomas, V.C., Fleming, S.D., and Hancock, L.E. (2009a). Enterococcus 
faecalis capsular polysaccharide serotypes C and D and their contributions to 
host innate immune evasion. Infect Immun 77, 5551-5557. 
Thurlow, L.R., Thomas, V.C., and Hancock, L.E. (2009b). Capsular polysaccharide 
production in Enterococcus faecalis and contribution of CpsF to capsule 
serospecificity. J Bacteriol 191, 6203-6210. 
Thurlow, L.R., Thomas, V.C., Narayanan, S., Olson, S., Fleming, S.D., and Hancock, 
L.E. (2009c). Gelatinase contributes to the pathogenesis of endocarditis caused 
by Enterococcus faecalis. Infect Immun 78, 4936-4943. 
Tsvetanova, B., Wilson, A.C., Bongiorni, C., Chiang, C., Hoch, J.A., and Perego, M. 
(2007). Opposing effects of histidine phosphorylation regulate the AtxA virulence 
transcription factor in Bacillus anthracis. Mol Microbiol 63, 644-655. 
Turner, A.K., Lovell, M.A., Hulme, S.D., Zhang-Barber, L., and Barrow, P.A. (1998). 
Identification of Salmonella typhimurium genes required for colonization of the 
chicken alimentary tract and for virulence in newly hatched chicks. Infect Immun 
66, 2099-2106. 
Vahling, C.M., and McIver, K.S. (2006). Domains required for transcriptional activation 
show conservation in the Mga family of virulence gene regulators. J Bacteriol 
188, 863-873. 
van Holde, K.E. (1985). Physical Biochemistry. 2nd edn. Prentice Hall: Englewoods 
Cliffs  
REFERENCES 
 
 
169 
 
van Schaik, W., Château, A., Dillies, M.-A., Coppée, J.-Y., Sonenshein, A.L., and 
Fouet, A. (2009). The global regulator CodY regulates toxin gene expression in 
Bacillus anthracis and is required for full virulence. Infect Immun 77, 4437-4445. 
Van Tyne, D., Martin, M.J., and Gilmore, M.S. (2013). Structure, function, and biology 
of the Enterococcus faecalis cytolysin. Toxins 5, 895-911. 
Vebø, H.C., Snipen, L., Nes, I.F., and Brede, D.A. (2009). The transcriptome of the 
nosocomial pathogen Enterococcus faecalis V583 reveals adaptive responses to 
growth in blood. PLoS ONE 4, e7660. 
Vebø, H.C., Solheim, M., Snipen, L., Nes, I.F., and Brede, D.A. (2010). Comparative 
genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and 
their transcriptional responses to growth in human urine. PLoS ONE 5, e12489. 
Vlahovicek, K., Kaján, L., and Pongor, S. (2003). DNA analysis servers: plot.it, bend.it, 
model.it and IS. Nucleic Acids Res 31, 3686-3687. 
Voskuil, M.I., and Chambliss, G.H. (1998). The -16 region of Bacillus subtilis and other 
gram-positive bacterial promoters. Nucleic Acids Res 26, 3584-3590. 
Wigneshweraraj, S., Bose, D., Burrows, P.C., Joly, N., Schumacher, J.r., Rappas, M., 
Pape, T., Zhang, X., Stockley, P., Severinov, K., Buck, M. (2008). Modus 
operandi of the bacterial RNA polymerase containing the σ54 promoter-specificity 
factor. Mol Microbiol 68, 538-546. 
Xu, Y., Jiang, L., Murray, B.E., and Weinstock, G.M. (1997). Enterococcus faecalis 
antigens in human infections. Infect Immun 65, 4207-4215. 
Xu, Y., Singh, K.V., Qin, X., Murray, B.E., and Weinstock, G.M. (2000). Analysis of a 
gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. 
Infect Immun 68, 815-823. 
Yanisch-Perron, C., Vieira, J., and Messing, J. (1985). Improved M13 phage cloning 
vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 
vectors. Gene 33, 103-119. 
Ye, J., Coulouris, G., Zaretskaya, I., Cutcutache, I., Rozen, S., and Madden, T.L. 
(2012). Primer-BLAST: A tool to design target-specific primers for polymerase 
chain reaction. BMC Bioinform 13, 134-134. 
REFERENCES 
 
 
170 
 
Zeng, J., Teng, F., Weinstock, G.M., and Murray, B.E. (2004). Translocation of 
Enterococcus faecalis strains across a monolayer of polarized human enterocyte-
like T84 cells. J Clin Microbiol 42, 1149-1154. 
Zúñiga, M., Comas, I., Linaje, R., Monedero, V., Yebra, M.J., Esteban, C.D., 
Deutscher, J., Pérez-Martínez, G., and González-Candelas, F. (2005). Horizontal 
gene transfer in the molecular evolution of mannose PTS transporters. Mol Biol 
Evol 22, 1673-1685. 
 
ANNEXES 

173 
Table 1: Genes differentially expressed in MAEfa-lacking cells 
Locus tag 
OG1RF_10064 
OG1RF_10107 
OG1RF_10108 
OG1RF_10198 
OG1RF_10296 
OG1RF_10297 
OG1RF_10298 
OG1RF_10433 
OG1RF_10434 
OG1RF_10682 
OG1RF_10683 
OG1RF_10684 
OG1RF_10746 
OG1RF_10747 
OG1RF_10748 
OG1RF_10749 
OG1RF_10979 
OG1RF_11004 
V583 
EF0071 
EF0114 
EF0115 
EF0253 
EF0411 
EF0412 
EF0413 
EF0695 
EF0696 
EF0956 
EF0957 
EF0958 
EF1013 
EF1014 
EF1015 
EF1016 
EF1207 
EF1233 
Gene 
aldA 
mtlA2 
mltF2 
mtlD 
lacD1 
pgmB 
map 
exp5 
 Log2FC 
-4.68 
-4.52 
-3.89 
-3.52 
-6.40 
-6.40 
-6.37 
-3.67 
-3.44 
-3.98 
-4.00 
-4.11 
-4.50 
-3.70 
-4.09 
-4.06 
-3.37 
-3.61 
Description 
glycoside  hydrolase 
family 20 glycosyl 
hydrolase 
endoribonuclease L-
PSP 
aldehyde 
dehydrogenase 
PTS family mannitol 
porter, EIICB 
component 
PTS family 
fructose/mannitol 
porter component IIA 
mannitol-1-
phosphate 5-
dehydrogenase 
PTS family 
fructose/mannitol 
(fru) porter 
component IIA 
tagatose-
bisphosphate 
aldolase 
beta-
phosphoglucomutase 
family 65 glycosyl 
hydrolase 
PTS family porter 
component IIABC 
PTS family 
lactose/cellobiose porter 
component IIC 
hypothetical protein 
hypothetical protein 
hypothetical protein 
CCS family citrate 
carrier protein 
ABC superfamily ATP 
binding cassette 
transporter, membrane 
protein 
KEGG pathways 
ND 
Other glycan degradation 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Biosynthesis of secondary 
metabolites 
ND 
ND 
Fructose and mannose metabolism 
Phosphotransferase system (PTS) 
Fructose and mannose metabolism 
Phosphotransferase system (PTS) 
Fructose and mannose metabolism 
Fructose and mannose metabolism 
Metabolic pathways 
Microbial metabolism in diverse 
environments 
Phosphotransferase system (PTS) 
Galactose metabolism 
Metabolic pathways 
Starch and sucrose metabolism 
Starch and sucrose metabolism 
Metabolic pathways 
Glycolysis/Gluconeogenesis 
Starch and sucrose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Phosphotransferase system (PTS) 
Phosphotransferase system (PTS) 
ND 
ND 
ND 
ND 
ABC transporters 
174 
OG1RF_11005 
OG1RF_11008 
OG1RF_11009 
OG1RF_11133 
OG1RF_11134 
OG1RF_11135 
OG1RF_11136 
OG1RF_11137 
OG1RF_11138 
OG1RF_11146 
OG1RF_11147 
OG1RF_11148 
OG1RF_11149 
OG1RF_11150 
OG1RF_11184 
OG1RF_11185 
OG1RF_11186 
OG1RF_11584 
OG1RF_11585 
OG1RF_11590 
OG1RF_11591 
EF1234 
EF1237 
EF1238 
EF1343 
EF1344 
EF1345 
EF1347 
EF1348 
EF1349 
EF1358 
EF1359 
EF1360 
EF1361 
EF1362 
EF1395 
EF1396 
EF1397 
EF1920 
EF1921 
EF1927 
EF1928 
bglX 
nplT 
dexB 
malL 
gldA 
dhaK 
moaB 
modA 
glpF2 
glpO 
-3.72 
-3.17 
-3.46 
-4.20 
-4.20 
-4.48 
-3.73 
-4.11 
-4.25 
-4.92 
-5.04 
-5.01 
-4.95 
-3.20 
-3.30 
-3.10 
-3.70 
-3.43 
-3.47 
-3.26 
-3.31 
ABC superfamily ATP 
binding cassette 
transporter, substrate-
binding protein 
endonuclease/exonucle
ase/phosphatase 
putative beta-
glucosidase 
sugar ABC transporter 
ATP-binding protein 
sugar ABC transporter 
ATP-binding protein 
sugar ABC superfamily 
ATP binding cassette 
transporter, sugar-
binding protein 
neopullulanase 
glucan 1,6-alpha-
glucosidase 
oligo-1,6-glucosidase 
glycerol dehydrogenase 
glycerone kinase PTS 
family porter component 
IIA 
dihydroxyacetone kinase 
dihydroxyacetone kinase 
hypothetical protein 
molybdenum cofactor 
biosynthesis protein B 
molybdopterin-binding 
domain protein 
molybdenum ABC 
superfamily ATP binding 
cassette transporter, 
binding protein 
C4-dicarboxylate 
anaerobic carrier 
Putative 
ribosylpyrimidine 
nucleosidase 
MIP family glycerol 
uptake facilitator protein 
GlpF 
glycerol-3-phosphate 
oxidase 
ABC transporters 
ND 
Cyanoamino acid metabolism 
Starch and sucrose metabolism 
Metabolic pathways 
Biosynthesis of secondary 
metabolites 
ABC transporters 
ABC transporters 
ABC transporters 
ND 
ND 
Galactose metabolism 
Starch and sucrose metabolism 
Metabolic pathways 
Glycerolipid metabolism 
Metabolic pathways 
ND 
Glycerolipid metabolism 
Metabolic pathways 
Glycerolipid metabolism 
Metabolic pathways 
ND 
ND 
ND 
ABC transporters 
ND 
ND 
ND 
ND 
 175 
 
 
OG1RF_11592 
 
 
OG1RF_11611 
 
 
OG1RF_11612 
 
 
OG1RF_11613 
 
 
 
 
 
OG1RF_11614 
 
 
 
 
 
OG1RF_11615 
 
 
 
 
 
OG1RF_11616 
 
 
 
 
 
OG1RF_11753 
 
 
OG1RF_11761 
 
 
 
 
OG1RF_11762 
 
 
 
 
OG1RF_11763 
 
 
 
 
OG1RF_11775 
 
OG1RF_11940 
 
 
 
 
OG1RF_11944 
 
 
 
 
OG1RF_11948 
 
 
OG1RF_11949 
 
 
OG1RF_11950 
 
 
 
 
 
 
EF1929 
 
 
EF1950 
 
 
EF1951 
 
 
EF1952 
 
 
 
 
 
EF1953 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EF2213 
 
 
EF2221 
 
 
 
 
EF2222 
 
 
 
 
EF2223 
 
 
 
 
EF2235 
 
EF2559 
 
 
 
 
EF2563 
 
 
 
 
EF2567 
 
 
EF2568 
 
 
EF2569 
 
 
 
 
 
 
glpK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ulaB 
 
 
 
 
 
 
 
 
 
 
 
treB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
nifJ2 
 
 
 
 
 
 
 
 
 
 
 
selD 
 
 
 
 
 
ygfJ 
 
 
 
 
 
 
-3.32 
 
 
-3.84 
 
 
-4.03 
 
 
-3.34 
 
 
 
 
 
-4.81 
 
 
 
 
 
-3.66 
 
 
 
 
 
-4.14 
 
 
 
 
 
-5.09 
 
 
-4.98 
 
 
 
 
-5.39 
 
 
 
 
-6.05 
 
 
 
 
-3.28 
 
-3.12 
 
 
 
 
-3.03 
 
 
 
 
-3.53 
 
 
-3.15 
 
 
-3.12 
 
 
 
 
 
 
glycerol kinase 
 
 
phosphosugar 
isomerase 
 
phosphosugar-binding 
protein 
 
PTS system 
mannose/fruct
ose/sorbose 
transporter 
subunit IID 
 
PTS family 
mannose/fructose/sorbo
se porter component IIC 
 
 
 
PTS family ascorbate 
porter, IIB component 
 
 
 
 
PTS system  
mannose/fructose/sorbo
se transporter subunit 
IIA 
 
 
PTS family trehalose 
porter, IIBC component 
 
ABC superfamily ATP 
binding cassette 
transporter, binding 
protein 
 
carbohydrate ABC 
superfamily ATP binding 
cassette transporter, 
membrane protein 
 
ABC superfamily ATP 
binding cassette 
transporter, membrane 
protein 
 
glucuronyl hydrolase 
 
pyruvate:ferredoxin 
oxidoreductase 
 
 
 
YqeB family selenium-
dependent molybdenum 
hydroxylase system 
protein 
 
selenide, water dikinase 
 
 
putative cysteine 
desulfurase 
 
YgfJ family molybdenum 
hydroxylase accessory 
protein 
 
 
 
 
Glycerolipid metabolism 
Metabolic pathways 
 
ND 
 
 
ND 
 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Starch and sucrose metabolism 
Phosphotransferase system (PTS) 
 
ABC transporters 
 
 
 
 
ABC transporters 
 
 
 
 
ABC transporters 
 
 
 
 
ND 
 
Metabolic pathways 
Microbial metabolism in diverse 
environments 
Carbon metabolism 
 
ND 
 
 
 
 
Selenocompound metabolism 
Metabolic pathways 
 
ND 
 
 
ND 
 
 
 
 
 
 176 
 
 
OG1RF_11951 
 
 
 
OG1RF_11956 
 
 
 
 
 
 
OG1RF_11957 
 
 
OG1RF_11958 
 
 
OG1RF_11959 
 
 
OG1RF_12167 
 
 
 
OG1RF_12249 
 
 
 
OG1RF_12303 
 
 
OG1RF_12397 
 
 
 
 
 
 
 
OG1RF_12398 
 
 
 
OG1RF_12399 
 
 
 
 
 
OG1RF_12400 
 
 
 
 
 
OG1RF_12401 
 
 
 
 
 
OG1RF_12402 
 
 
 
 
 
OG1RF_12403 
 
 
OG1RF_12404 
 
 
 
 
 
EF2570 
 
 
 
EF2575 
 
 
 
 
 
 
EF2577 
 
 
EF2578 
 
 
EF2579 
 
 
EF2863 
 
 
 
EF2966 
 
 
 
EF3023 
 
 
EF3134 
 
 
 
 
 
 
 
EF3135 
 
 
 
EF3136 
 
 
 
 
 
EF3137 
 
 
 
 
 
EF3138 
 
 
 
 
 
EF3139 
 
 
 
 
 
EF3140 
 
 
EF3141 
 
 
 
 
 
 
 
 
 
arcC3 
 
 
 
 
 
 
ygeW 
 
 
ygeY 
 
 
dpaL 
 
 
endOF
3 
 
 
 
 
 
 
 
 
 
eda 
 
 
 
 
 
 
 
uxuA 
 
 
 
sorA 
 
 
 
 
 
sorB2 
 
 
 
 
 
sorD 
 
 
 
 
 
sorC 
 
 
 
 
 
gldA2 
 
 
 
 
 
 
 
 
-3.13 
 
 
 
-3.21 
 
 
 
 
 
 
-3.39 
 
 
-3.88 
 
 
-3.21 
 
 
-4.43 
 
 
 
-3.17 
 
 
 
-4.49 
 
 
-4.17 
 
 
 
 
 
 
 
-4.34 
 
 
 
-4.60 
 
 
 
 
 
4.64 
 
 
 
 
 
-4.87 
 
 
 
 
 
-4.35 
 
 
 
 
 
-3.94 
 
 
-3.97 
 
 
 
 
 
selenium-dependent 
molybdenum 
hydroxylase 1 
 
carbamate kinase 
 
 
 
 
 
 
carbamoyltransferase 
YgeW 
 
M20/DapE family protein 
YgeY 
 
diaminopropionate 
ammonia-lyase 
 
mannosyl-glycoprotein 
endo-beta-N-
acetylglucosaminidase 
 
BglG family 
transcriptional 
antiterminator 
 
family 8 polysaccharide 
lyase 
 
2-dehydro-3-
deoxyphosphogluconate 
aldolase 
 
 
 
 
 
mannonate dehydratase 
 
 
 
PTS system 
mannose/fructose/sorbo
se transporter subunit 
IIA 
 
 
PTS family 
mannose/fructose/sorbo
se porter, IIB component 
 
 
 
PTS system 
mannose/fructose/sorbo
se transporter subunit 
IID 
 
 
PTS family 
mannose/fructose/sorbo
se porter component IIC 
 
 
 
putative glycerol 
dehydrogenase 
 
D-isomer specific 2-
hydroxyacid 
dehydrogenase 
 
 
 
ND 
 
 
 
Purine metabolism 
Arginine and proline metabolism 
Nitrogen metabolism 
Microbial metabolism in diverse 
environments 
Carbon metabolism 
 
ND 
 
 
ND 
 
 
ND 
 
 
ND 
 
 
 
ND 
 
 
ND 
 
 
 
Pentose phosphate pathway 
Glyoxylate and dicarboxylate 
metabolism 
Metabolic pathways 
Microbial metabolism in diverse 
environments 
Carbon metabolism 
 
Pentose and glucuronate 
interconversions 
Metabolic pathways 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
Fructose and mannose metabolism 
Amino sugar and nucleotide sugar 
metabolism 
Metabolic pathways 
Phosphotransferase system (PTS) 
 
ND 
 
 
ND 
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OG1RF_12405 
 
 
 
 
 
 
 
 
OG1RF_12425 
 
OG1RF_12426 
 
 
OG1RF_12561 
 
 
 
 
 
OG1RF_12562 
 
 
OG1RF_12563 
 
 
 
OG1RF_12564 
 
OG1RF_12565 
 
OG1RF_12566 
 
 
OG1RF_12567 
 
 
OG1RF_12568 
 
OG1RF_12569 
 
 
OG1RF_12570 
 
 
OG1RF_12571 
 
OG1RF_12572 
 
 
 
EF3142 
 
 
 
 
 
 
 
 
EF3157 
 
EF3158 
 
 
EF3316 
 
 
 
 
 
EF3317 
 
 
EF3318 
 
 
 
EF3319 
 
EF3320 
 
EF3321 
 
 
EF3322 
 
 
EF3323 
 
EF3324 
 
 
EF3325 
 
 
EF3326 
 
EF3327 
 
 
 
gnd2 
 
 
 
 
 
 
 
 
trePP 
 
yvdM 
 
 
mdh2 
 
 
 
 
 
oadA 
 
 
citX 
 
 
 
citF 
 
citE 
 
citD 
 
 
citC 
 
 
 
 
gcdB 
 
 
 
 
 
 
 
 
 
 
 
-3.73 
 
 
 
 
 
 
 
 
-4.07 
 
-3.97 
 
 
-3.07 
 
 
 
 
 
-3.6 
 
 
-3.86 
 
 
 
-3.98 
 
-4.19 
 
-4.30 
 
 
-4.39 
 
 
-3.06 
 
-4.68 
 
 
-4.91 
 
 
-5.38 
 
-4.66 
 
 
 
6-phosphogluconate 
dehydrogenase 
 
 
 
 
 
 
 
glycosyl hydrolase 
 
beta-
phosphoglucomutase 
 
malate dehydrogenase 
(oxaloacetate-
decarboxylating) 
(NADP(+)) 
 
 
oxaloacetate 
decarboxylase 
 
2-(5''-triphosphoribosyl)-
3'-dephosphocoenzyme-
A synthase 
 
citrate (pro-3S)-lyase 
 
citrate (Pro-3S)-lyase 
 
citrate lyase acyl carrier 
protein 
 
[citrate [pro-3S]-lyase] 
ligase 
 
hypothetical protein 
 
glutaconyl-CoA 
decarboxylase 
 
sodium ion-translocating 
decarboxylase 
 
hypothetical protein 
 
citrate transporter 
 
 
 
Pentose phosphate pathway 
Glutathione metabolism 
Metabolic pathways 
Biosynthesis of secondary 
metabolites 
Microbial metabolism in diverse 
environments 
Carbon metabolism 
 
ND 
 
Starch and sucrose metabolism 
 
 
Pyruvate metabolism 
Carbon metabolism 
Two-component system 
 
Pyruvate metabolism 
Metabolic pathways 
 
Two-component system 
 
Two-component system 
 
Two-component system 
 
Two-component system 
 
Two-component system 
 
ND 
 
 
Pyruvate metabolism 
Metabolic pathways 
 
ND 
 
ND 
 
 
ND 
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